MIME-Version: 1.0
Content-Type: multipart/related; boundary="----=_NextPart_01D75948.5EEE6C80"

This document is a Single File Web Page, also known as a Web Archive file.  If you are seeing this message, your browser or editor doesn't support Web Archive files.  Please download a browser that supports Web Archive.

------=_NextPart_01D75948.5EEE6C80
Content-Location: file:///C:/C467A08E/Ovaleap_clean.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="windows-1252"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"
xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:w=3D"urn:schemas-microsoft-com:office:word"
xmlns:dt=3D"uuid:C2F41010-65B3-11d1-A29F-00AA00C14882"
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dwindows-125=
2">
<meta name=3DProgId content=3DWord.Document>
<meta name=3DGenerator content=3D"Microsoft Word 15">
<meta name=3DOriginator content=3D"Microsoft Word 15">
<link rel=3DFile-List href=3D"Ovaleap_clean_files/filelist.xml">
<title>Ovaleap, INN-follitropin alfa</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Subject>EPAR</o:Subject>
  <o:Author>CHMP</o:Author>
  <o:Keywords>Ovaleap, INN-follitropin alfa</o:Keywords>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>Manish Kumar</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>0</o:TotalTime>
  <o:LastPrinted>2018-02-23T11:02:00Z</o:LastPrinted>
  <o:Created>2021-06-04T08:18:00Z</o:Created>
  <o:LastSaved>2021-06-04T08:18:00Z</o:LastSaved>
  <o:Pages>1</o:Pages>
  <o:Words>9178</o:Words>
  <o:Characters>52320</o:Characters>
  <o:Company>PharmaLex GmbH</o:Company>
  <o:Lines>436</o:Lines>
  <o:Paragraphs>122</o:Paragraphs>
  <o:CharactersWithSpaces>61376</o:CharactersWithSpaces>
  <o:Version>16.00</o:Version>
 </o:DocumentProperties>
 <o:CustomDocumentProperties>
  <o:ContentTypeId dt:dt=3D"string">0x010100726F91DD1AE57B44B1BCEB7F1056F5D=
0</o:ContentTypeId>
  <o:DM_Author dt:dt=3D"string"></o:DM_Author>
  <o:DM_Authors dt:dt=3D"string"></o:DM_Authors>
  <o:DM_Category dt:dt=3D"string">Product Information</o:DM_Category>
  <o:DM_Creation_Date dt:dt=3D"string">16/03/2018 11:13:20</o:DM_Creation_D=
ate>
  <o:DM_Creator_Name dt:dt=3D"string">Belonina Irina</o:DM_Creator_Name>
  <o:DM_DocRefId dt:dt=3D"string">EMA/171655/2018</o:DM_DocRefId>
  <o:DM_emea_bcc dt:dt=3D"string"></o:DM_emea_bcc>
  <o:DM_emea_cc dt:dt=3D"string"></o:DM_emea_cc>
  <o:DM_emea_doc_category dt:dt=3D"string">General</o:DM_emea_doc_category>
  <o:DM_emea_doc_lang dt:dt=3D"string"></o:DM_emea_doc_lang>
  <o:DM_emea_doc_number dt:dt=3D"string">423415</o:DM_emea_doc_number>
  <o:DM_emea_doc_ref_id dt:dt=3D"string">EMA/171655/2018</o:DM_emea_doc_ref=
_id>
  <o:DM_emea_from dt:dt=3D"string"></o:DM_emea_from>
  <o:DM_emea_internal_label dt:dt=3D"string">EMA</o:DM_emea_internal_label>
  <o:DM_emea_legal_date dt:dt=3D"string">nulldate</o:DM_emea_legal_date>
  <o:DM_emea_meeting_action dt:dt=3D"string"></o:DM_emea_meeting_action>
  <o:DM_emea_meeting_flags dt:dt=3D"string"></o:DM_emea_meeting_flags>
  <o:DM_emea_meeting_hyperlink dt:dt=3D"string"></o:DM_emea_meeting_hyperli=
nk>
  <o:DM_emea_meeting_ref dt:dt=3D"string"></o:DM_emea_meeting_ref>
  <o:DM_emea_meeting_status dt:dt=3D"string"></o:DM_emea_meeting_status>
  <o:DM_emea_meeting_title dt:dt=3D"string"></o:DM_emea_meeting_title>
  <o:DM_emea_message_subject dt:dt=3D"string"></o:DM_emea_message_subject>
  <o:DM_emea_received_date dt:dt=3D"string">nulldate</o:DM_emea_received_da=
te>
  <o:DM_emea_resp_body dt:dt=3D"string"></o:DM_emea_resp_body>
  <o:DM_emea_revision_label dt:dt=3D"string"></o:DM_emea_revision_label>
  <o:DM_emea_sent_date dt:dt=3D"string">nulldate</o:DM_emea_sent_date>
  <o:DM_emea_to dt:dt=3D"string"></o:DM_emea_to>
  <o:DM_emea_year dt:dt=3D"string">2010</o:DM_emea_year>
  <o:DM_Keywords dt:dt=3D"string"></o:DM_Keywords>
  <o:DM_Language dt:dt=3D"string"></o:DM_Language>
  <o:DM_Modifer_Name dt:dt=3D"string">Belonina Irina</o:DM_Modifer_Name>
  <o:DM_Modified_Date dt:dt=3D"string">21/03/2018 12:40:44</o:DM_Modified_D=
ate>
  <o:DM_Modifier_Name dt:dt=3D"string">Belonina Irina</o:DM_Modifier_Name>
  <o:DM_Modify_Date dt:dt=3D"string">21/03/2018 12:40:44</o:DM_Modify_Date>
  <o:DM_Name dt:dt=3D"string">Ovaleap R-23 EN PI highlighted</o:DM_Name>
  <o:DM_Owner dt:dt=3D"string">Espinasse Claire</o:DM_Owner>
  <o:DM_Path dt:dt=3D"string">/01. Evaluation of Medicines/H-C/M-O/Ovaleap =
(Follitropin alfa) - 002608/05 Post Authorisation/Post Activities/2017-xx-x=
x-2608-R-0023/03. Opinion</o:DM_Path>
  <o:DM_Status dt:dt=3D"string"></o:DM_Status>
  <o:DM_Subject dt:dt=3D"string"></o:DM_Subject>
  <o:DM_Title dt:dt=3D"string"></o:DM_Title>
  <o:DM_Type dt:dt=3D"string">emea_document</o:DM_Type>
  <o:DM_Version dt:dt=3D"string">1.0,CURRENT</o:DM_Version>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Enabled dt:dt=3D"strin=
g">true</o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Enabled>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_SetDate dt:dt=3D"strin=
g">2021-05-18T11:46:50Z</o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_=
SetDate>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Method dt:dt=3D"string=
">Standard</o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Method>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Name dt:dt=3D"string">=
0eea11ca-d417-4147-80ed-01a58412c458</o:MSIP_Label_0eea11ca-d417-4147-80ed-=
01a58412c458_Name>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_SiteId dt:dt=3D"string=
">bc9dc15c-61bc-4f03-b60b-e5b6d8922839</o:MSIP_Label_0eea11ca-d417-4147-80e=
d-01a58412c458_SiteId>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_ActionId dt:dt=3D"stri=
ng">993ec51e-7cca-422b-9343-a9bad1beacde</o:MSIP_Label_0eea11ca-d417-4147-8=
0ed-01a58412c458_ActionId>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_ContentBits dt:dt=3D"s=
tring">2</o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_ContentBits>
 </o:CustomDocumentProperties>
 <o:OfficeDocumentSettings>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=3DdataStoreItem href=3D"Ovaleap_clean_files/item0001.xml"
target=3D"Ovaleap_clean_files/props002.xml">
<link rel=3DdataStoreItem href=3D"Ovaleap_clean_files/item0003.xml"
target=3D"Ovaleap_clean_files/props004.xml">
<link rel=3DdataStoreItem href=3D"Ovaleap_clean_files/item0005.xml"
target=3D"Ovaleap_clean_files/props006.xml">
<link rel=3DdataStoreItem href=3D"Ovaleap_clean_files/item0007.xml"
target=3D"Ovaleap_clean_files/props008.xml">
<link rel=3DthemeData href=3D"Ovaleap_clean_files/themedata.thmx">
<link rel=3DcolorSchemeMapping href=3D"Ovaleap_clean_files/colorschememappi=
ng.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:TrackMoves/>
  <w:TrackFormatting/>
  <w:HyphenationZone>21</w:HyphenationZone>
  <w:DisplayHorizontalDrawingGridEvery>0</w:DisplayHorizontalDrawingGridEve=
ry>
  <w:DisplayVerticalDrawingGridEvery>0</w:DisplayVerticalDrawingGridEvery>
  <w:UseMarginsForDrawingGridOrigin/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>EN-GB</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>AR-SA</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:SplitPgBreakAndParaMark/>
   <w:EnableOpenTypeKerning/>
   <w:DontFlipMirrorIndents/>
   <w:OverrideTableStyleHps/>
   <w:UseFELayout/>
  </w:Compatibility>
  <w:DocumentVariables>
   <w:Registered>-1</w:Registered>
   <w:Version>0</w:Version>
  </w:DocumentVariables>
  <m:mathPr>
   <m:mathFont m:val=3D"Cambria Math"/>
   <m:brkBin m:val=3D"before"/>
   <m:brkBinSub m:val=3D"&#45;-"/>
   <m:smallFrac m:val=3D"off"/>
   <m:dispDef/>
   <m:lMargin m:val=3D"0"/>
   <m:rMargin m:val=3D"0"/>
   <m:defJc m:val=3D"centerGroup"/>
   <m:wrapIndent m:val=3D"1440"/>
   <m:intLim m:val=3D"subSup"/>
   <m:naryLim m:val=3D"undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState=3D"false" DefUnhideWhenUsed=3D"false"
  DefSemiHidden=3D"false" DefQFormat=3D"false" LatentStyleCount=3D"376">
  <w:LsdException Locked=3D"false" QFormat=3D"true" Name=3D"Normal"/>
  <w:LsdException Locked=3D"false" QFormat=3D"true" Name=3D"heading 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   QFormat=3D"true" Name=3D"heading 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   QFormat=3D"true" Name=3D"heading 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   QFormat=3D"true" Name=3D"heading 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   QFormat=3D"true" Name=3D"heading 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   QFormat=3D"true" Name=3D"heading 6"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   QFormat=3D"true" Name=3D"heading 7"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   QFormat=3D"true" Name=3D"heading 8"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   QFormat=3D"true" Name=3D"heading 9"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 6"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 7"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 8"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 9"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"toc 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"toc 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"toc 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"toc 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"toc 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"toc 6"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"toc 7"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"toc 8"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"toc 9"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Normal Indent"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"footnote text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"annotation text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"header"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"footer"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index heading"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   QFormat=3D"true" Name=3D"caption"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"table of figures"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"envelope address"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"envelope return"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"footnote reference"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"annotation reference"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"line number"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"page number"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"endnote reference"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"endnote text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"table of authorities"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"toa heading"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number 5"/>
  <w:LsdException Locked=3D"false" QFormat=3D"true" Name=3D"Title"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Closing"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Signature"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Default Paragraph Font"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text Indent"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Continue"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Continue 2"/>
  <w:LsdException Locked=3D"false" QFormat=3D"true" Name=3D"Subtitle"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Salutation"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Date"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text First Indent"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text First Indent 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Note Heading"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text Indent 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text Indent 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Block Text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Hyperlink"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"FollowedHyperlink"/>
  <w:LsdException Locked=3D"false" QFormat=3D"true" Name=3D"Strong"/>
  <w:LsdException Locked=3D"false" QFormat=3D"true" Name=3D"Emphasis"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Document Map"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Plain Text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"E-mail Signature"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Top of Form"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Bottom of Form"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Normal (Web)"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Acronym"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Address"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Cite"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Code"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Definition"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Keyboard"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Preformatted"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Sample"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Typewriter"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Variable"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Normal Table"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"annotation subject"/>
  <w:LsdException Locked=3D"false" Priority=3D"99" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"No List"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Outline List 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Outline List 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Outline List 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Simple 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Simple 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Simple 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Colorful 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Colorful 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Colorful 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 6"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 7"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 8"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 6"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 7"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 8"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table 3D effects 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table 3D effects 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table 3D effects 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Contemporary"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Elegant"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Professional"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Subtle 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Subtle 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Web 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Web 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Web 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Balloon Text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Theme"/>
  <w:LsdException Locked=3D"false" Priority=3D"99" SemiHidden=3D"true"
   Name=3D"Placeholder Text"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" QFormat=3D"true" Name=3D"=
No Spacing"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"99" SemiHidden=3D"true" Name=
=3D"Revision"/>
  <w:LsdException Locked=3D"false" Priority=3D"34" QFormat=3D"true"
   Name=3D"List Paragraph"/>
  <w:LsdException Locked=3D"false" Priority=3D"29" QFormat=3D"true" Name=3D=
"Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"30" QFormat=3D"true"
   Name=3D"Intense Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"19" QFormat=3D"true"
   Name=3D"Subtle Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"21" QFormat=3D"true"
   Name=3D"Intense Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"31" QFormat=3D"true"
   Name=3D"Subtle Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"32" QFormat=3D"true"
   Name=3D"Intense Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"33" QFormat=3D"true" Name=3D=
"Book Title"/>
  <w:LsdException Locked=3D"false" Priority=3D"37" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Bibliography"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" QFormat=3D"true" Name=3D"TOC Heading"/>
  <w:LsdException Locked=3D"false" Priority=3D"41" Name=3D"Plain Table 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"42" Name=3D"Plain Table 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"43" Name=3D"Plain Table 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"44" Name=3D"Plain Table 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"45" Name=3D"Plain Table 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"40" Name=3D"Grid Table Light=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"46" Name=3D"Grid Table 1 Lig=
ht"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k"/>
  <w:LsdException Locked=3D"false" Priority=3D"51" Name=3D"Grid Table 6 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"52" Name=3D"Grid Table 7 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"46" Name=3D"List Table 1 Lig=
ht"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k"/>
  <w:LsdException Locked=3D"false" Priority=3D"51" Name=3D"List Table 6 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"52" Name=3D"List Table 7 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"99" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Mention"/>
  <w:LsdException Locked=3D"false" Priority=3D"99" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Smart Hyperlink"/>
  <w:LsdException Locked=3D"false" Priority=3D"99" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Hashtag"/>
  <w:LsdException Locked=3D"false" Priority=3D"99" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Unresolved Mention"/>
  <w:LsdException Locked=3D"false" Priority=3D"99" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Smart Link"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;
	mso-font-alt:"\FF2D\FF33 \660E\671D";
	mso-font-charset:128;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
@font-face
	{font-family:SimSun;
	panose-1:2 1 6 0 3 1 1 1 1 1;
	mso-font-alt:\5B8B\4F53;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:3 680460288 22 0 262145 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536869121 1107305727 33554432 0 415 0;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610610945 1073750107 16 0 415 0;}
@font-face
	{font-family:TimesNewRoman;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:"MS Gothic";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:auto;
	mso-font-signature:0 134676480 16 0 131073 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-520081665 -1073717157 41 0 66047 0;}
@font-face
	{font-family:Consolas;
	panose-1:2 11 6 9 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536869121 64767 1 0 415 0;}
@font-face
	{font-family:TimesNewRomanPSMT;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:"Times New Roman";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:auto;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"\@SimSun";
	panose-1:2 1 6 0 3 1 1 1 1 1;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:3 680460288 22 0 262145 0;}
@font-face
	{font-family:"\@MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;
	mso-font-charset:128;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
h1
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 1 Char";
	mso-style-next:Normal;
	margin-top:24.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:1;
	tab-stops:28.35pt;
	font-size:14.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#365F91;
	mso-themecolor:accent1;
	mso-themeshade:191;
	mso-font-kerning:0pt;
	mso-ansi-language:EN-GB;
	font-weight:bold;}
h2
	{mso-style-noshow:yes;
	mso-style-qformat:yes;
	mso-style-link:"Heading 2 Char";
	mso-style-next:Normal;
	margin-top:10.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:2;
	tab-stops:28.35pt;
	font-size:13.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#4F81BD;
	mso-themecolor:accent1;
	mso-ansi-language:EN-GB;
	font-weight:bold;}
h3
	{mso-style-noshow:yes;
	mso-style-qformat:yes;
	mso-style-link:"Heading 3 Char";
	mso-style-next:Normal;
	margin-top:10.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:3;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#4F81BD;
	mso-themecolor:accent1;
	mso-ansi-language:EN-GB;
	font-weight:bold;}
h4
	{mso-style-noshow:yes;
	mso-style-qformat:yes;
	mso-style-link:"Heading 4 Char";
	mso-style-next:Normal;
	margin-top:10.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:4;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#4F81BD;
	mso-themecolor:accent1;
	mso-ansi-language:EN-GB;
	font-weight:bold;
	font-style:italic;}
h5
	{mso-style-noshow:yes;
	mso-style-qformat:yes;
	mso-style-link:"Heading 5 Char";
	mso-style-next:Normal;
	margin-top:10.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:5;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#243F60;
	mso-themecolor:accent1;
	mso-themeshade:127;
	mso-ansi-language:EN-GB;
	font-weight:normal;}
h6
	{mso-style-noshow:yes;
	mso-style-qformat:yes;
	mso-style-link:"Heading 6 Char";
	mso-style-next:Normal;
	margin-top:10.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:6;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#243F60;
	mso-themecolor:accent1;
	mso-themeshade:127;
	mso-ansi-language:EN-GB;
	font-weight:normal;
	font-style:italic;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-noshow:yes;
	mso-style-qformat:yes;
	mso-style-link:"Heading 7 Char";
	mso-style-next:Normal;
	margin-top:10.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:7;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#404040;
	mso-themecolor:text1;
	mso-themetint:191;
	mso-ansi-language:EN-GB;
	font-style:italic;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-noshow:yes;
	mso-style-qformat:yes;
	mso-style-link:"Heading 8 Char";
	mso-style-next:Normal;
	margin-top:10.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:8;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#404040;
	mso-themecolor:text1;
	mso-themetint:191;
	mso-ansi-language:EN-GB;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-noshow:yes;
	mso-style-qformat:yes;
	mso-style-link:"Heading 9 Char";
	mso-style-next:Normal;
	margin-top:10.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	mso-outline-level:9;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#404040;
	mso-themecolor:text1;
	mso-themetint:191;
	mso-ansi-language:EN-GB;
	font-style:italic;}
p.MsoIndex1, li.MsoIndex1, div.MsoIndex1
	{mso-style-update:auto;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:11.0pt;
	text-indent:-11.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoIndex2, li.MsoIndex2, div.MsoIndex2
	{mso-style-update:auto;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:22.0pt;
	text-indent:-11.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoIndex3, li.MsoIndex3, div.MsoIndex3
	{mso-style-update:auto;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:33.0pt;
	text-indent:-11.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoIndex4, li.MsoIndex4, div.MsoIndex4
	{mso-style-update:auto;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:44.0pt;
	text-indent:-11.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoIndex5, li.MsoIndex5, div.MsoIndex5
	{mso-style-update:auto;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:55.0pt;
	text-indent:-11.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoIndex6, li.MsoIndex6, div.MsoIndex6
	{mso-style-update:auto;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:66.0pt;
	text-indent:-11.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoIndex7, li.MsoIndex7, div.MsoIndex7
	{mso-style-update:auto;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:77.0pt;
	text-indent:-11.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoIndex8, li.MsoIndex8, div.MsoIndex8
	{mso-style-update:auto;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:88.0pt;
	text-indent:-11.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoIndex9, li.MsoIndex9, div.MsoIndex9
	{mso-style-update:auto;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:99.0pt;
	text-indent:-11.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoToc1, li.MsoToc1, div.MsoToc1
	{mso-style-update:auto;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:5.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoToc2, li.MsoToc2, div.MsoToc2
	{mso-style-update:auto;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:5.0pt;
	margin-left:11.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoToc3, li.MsoToc3, div.MsoToc3
	{mso-style-update:auto;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:5.0pt;
	margin-left:22.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoToc4, li.MsoToc4, div.MsoToc4
	{mso-style-update:auto;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:5.0pt;
	margin-left:33.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoToc5, li.MsoToc5, div.MsoToc5
	{mso-style-update:auto;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:5.0pt;
	margin-left:44.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoToc6, li.MsoToc6, div.MsoToc6
	{mso-style-update:auto;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:5.0pt;
	margin-left:55.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoToc7, li.MsoToc7, div.MsoToc7
	{mso-style-update:auto;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:5.0pt;
	margin-left:66.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoToc8, li.MsoToc8, div.MsoToc8
	{mso-style-update:auto;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:5.0pt;
	margin-left:77.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoToc9, li.MsoToc9, div.MsoToc9
	{mso-style-update:auto;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:5.0pt;
	margin-left:88.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoNormalIndent, li.MsoNormalIndent, div.MsoNormalIndent
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-unhide:no;
	mso-style-link:"Footnote Text Char";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-link:"Comment Text Char";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-unhide:no;
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt center 207.65pt right 415.3pt;
	font-size:10.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-unhide:no;
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt center 3.15in right 415.3pt;
	font-size:8.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-no-proof:yes;}
p.MsoIndexHeading, li.MsoIndexHeading, div.MsoIndexHeading
	{mso-style-unhide:no;
	mso-style-next:"Index 1";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	mso-ansi-language:EN-GB;
	font-weight:bold;}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-noshow:yes;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:10.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:9.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	color:#4F81BD;
	mso-themecolor:accent1;
	mso-ansi-language:EN-GB;
	font-weight:bold;}
p.MsoTof, li.MsoTof, div.MsoTof
	{mso-style-unhide:no;
	mso-style-next:Normal;
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoEnvelopeAddress, li.MsoEnvelopeAddress, div.MsoEnvelopeAddress
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	mso-element:frame;
	mso-element-frame-width:5.5in;
	mso-element-frame-height:99.0pt;
	mso-element-frame-hspace:9.0pt;
	mso-element-wrap:auto;
	mso-element-anchor-horizontal:page;
	mso-element-left:center;
	mso-element-top:bottom;
	mso-height-rule:exactly;
	font-size:12.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	mso-ansi-language:EN-GB;}
p.MsoEnvelopeReturn, li.MsoEnvelopeReturn, div.MsoEnvelopeReturn
	{mso-style-unhide:no;
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	mso-ansi-language:EN-GB;}
span.MsoCommentReference
	{mso-style-unhide:no;
	mso-style-parent:"";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
p.MsoEndnoteText, li.MsoEndnoteText, div.MsoEndnoteText
	{mso-style-unhide:no;
	mso-style-link:"Endnote Text Char";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoToa, li.MsoToa, div.MsoToa
	{mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:11.0pt;
	text-indent:-11.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoMacroText, li.MsoMacroText, div.MsoMacroText
	{mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-link:"Macro Text Char";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:24.0pt 48.0pt 1.0in 96.0pt 120.0pt 2.0in 168.0pt 192.0pt 3.0in;
	font-size:10.0pt;
	font-family:Consolas;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoToaHeading, li.MsoToaHeading, div.MsoToaHeading
	{mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:12.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	mso-ansi-language:EN-GB;
	font-weight:bold;}
p.MsoList, li.MsoList, div.MsoList
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:14.15pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListCxSpFirst, li.MsoListCxSpFirst, div.MsoListCxSpFirst
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:14.15pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListCxSpMiddle, li.MsoListCxSpMiddle, div.MsoListCxSpMiddle
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:14.15pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListCxSpLast, li.MsoListCxSpLast, div.MsoListCxSpLast
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:14.15pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListBullet, li.MsoListBullet, div.MsoListBullet
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l9 level1 lfo27;
	tab-stops:list .25in left 28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListBulletCxSpFirst, li.MsoListBulletCxSpFirst, div.MsoListBulletCxSpF=
irst
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l9 level1 lfo27;
	tab-stops:list .25in left 28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListBulletCxSpMiddle, li.MsoListBulletCxSpMiddle, div.MsoListBulletCxS=
pMiddle
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l9 level1 lfo27;
	tab-stops:list .25in left 28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListBulletCxSpLast, li.MsoListBulletCxSpLast, div.MsoListBulletCxSpLast
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l9 level1 lfo27;
	tab-stops:list .25in left 28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListNumber, li.MsoListNumber, div.MsoListNumber
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l8 level1 lfo32;
	tab-stops:list .25in left 28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListNumberCxSpFirst, li.MsoListNumberCxSpFirst, div.MsoListNumberCxSpF=
irst
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l8 level1 lfo32;
	tab-stops:list .25in left 28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListNumberCxSpMiddle, li.MsoListNumberCxSpMiddle, div.MsoListNumberCxS=
pMiddle
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l8 level1 lfo32;
	tab-stops:list .25in left 28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListNumberCxSpLast, li.MsoListNumberCxSpLast, div.MsoListNumberCxSpLast
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l8 level1 lfo32;
	tab-stops:list .25in left 28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoList2, li.MsoList2, div.MsoList2
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.3pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoList2CxSpFirst, li.MsoList2CxSpFirst, div.MsoList2CxSpFirst
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.3pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoList2CxSpMiddle, li.MsoList2CxSpMiddle, div.MsoList2CxSpMiddle
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.3pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoList2CxSpLast, li.MsoList2CxSpLast, div.MsoList2CxSpLast
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.3pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoList3, li.MsoList3, div.MsoList3
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:42.45pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoList3CxSpFirst, li.MsoList3CxSpFirst, div.MsoList3CxSpFirst
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:42.45pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoList3CxSpMiddle, li.MsoList3CxSpMiddle, div.MsoList3CxSpMiddle
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:42.45pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoList3CxSpLast, li.MsoList3CxSpLast, div.MsoList3CxSpLast
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:42.45pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoList4, li.MsoList4, div.MsoList4
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.6pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoList4CxSpFirst, li.MsoList4CxSpFirst, div.MsoList4CxSpFirst
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.6pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoList4CxSpMiddle, li.MsoList4CxSpMiddle, div.MsoList4CxSpMiddle
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.6pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoList4CxSpLast, li.MsoList4CxSpLast, div.MsoList4CxSpLast
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.6pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoList5, li.MsoList5, div.MsoList5
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:70.75pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoList5CxSpFirst, li.MsoList5CxSpFirst, div.MsoList5CxSpFirst
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:70.75pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoList5CxSpMiddle, li.MsoList5CxSpMiddle, div.MsoList5CxSpMiddle
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:70.75pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoList5CxSpLast, li.MsoList5CxSpLast, div.MsoList5CxSpLast
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:70.75pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListBullet2, li.MsoListBullet2, div.MsoListBullet2
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:32.15pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l7 level1 lfo28;
	tab-stops:28.35pt list 32.15pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListBullet2CxSpFirst, li.MsoListBullet2CxSpFirst, div.MsoListBullet2Cx=
SpFirst
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:32.15pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l7 level1 lfo28;
	tab-stops:28.35pt list 32.15pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListBullet2CxSpMiddle, li.MsoListBullet2CxSpMiddle, div.MsoListBullet2=
CxSpMiddle
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:32.15pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l7 level1 lfo28;
	tab-stops:28.35pt list 32.15pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListBullet2CxSpLast, li.MsoListBullet2CxSpLast, div.MsoListBullet2CxSp=
Last
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:32.15pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l7 level1 lfo28;
	tab-stops:28.35pt list 32.15pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListBullet3, li.MsoListBullet3, div.MsoListBullet3
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:46.3pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l6 level1 lfo29;
	tab-stops:28.35pt list 46.3pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListBullet3CxSpFirst, li.MsoListBullet3CxSpFirst, div.MsoListBullet3Cx=
SpFirst
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:46.3pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l6 level1 lfo29;
	tab-stops:28.35pt list 46.3pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListBullet3CxSpMiddle, li.MsoListBullet3CxSpMiddle, div.MsoListBullet3=
CxSpMiddle
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:46.3pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l6 level1 lfo29;
	tab-stops:28.35pt list 46.3pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListBullet3CxSpLast, li.MsoListBullet3CxSpLast, div.MsoListBullet3CxSp=
Last
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:46.3pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l6 level1 lfo29;
	tab-stops:28.35pt list 46.3pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListBullet4, li.MsoListBullet4, div.MsoListBullet4
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:60.45pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l5 level1 lfo30;
	tab-stops:28.35pt list 60.45pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListBullet4CxSpFirst, li.MsoListBullet4CxSpFirst, div.MsoListBullet4Cx=
SpFirst
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:60.45pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l5 level1 lfo30;
	tab-stops:28.35pt list 60.45pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListBullet4CxSpMiddle, li.MsoListBullet4CxSpMiddle, div.MsoListBullet4=
CxSpMiddle
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:60.45pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l5 level1 lfo30;
	tab-stops:28.35pt list 60.45pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListBullet4CxSpLast, li.MsoListBullet4CxSpLast, div.MsoListBullet4CxSp=
Last
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:60.45pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l5 level1 lfo30;
	tab-stops:28.35pt list 60.45pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListBullet5, li.MsoListBullet5, div.MsoListBullet5
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:74.6pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l4 level1 lfo31;
	tab-stops:28.35pt list 74.6pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListBullet5CxSpFirst, li.MsoListBullet5CxSpFirst, div.MsoListBullet5Cx=
SpFirst
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:74.6pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l4 level1 lfo31;
	tab-stops:28.35pt list 74.6pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListBullet5CxSpMiddle, li.MsoListBullet5CxSpMiddle, div.MsoListBullet5=
CxSpMiddle
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:74.6pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l4 level1 lfo31;
	tab-stops:28.35pt list 74.6pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListBullet5CxSpLast, li.MsoListBullet5CxSpLast, div.MsoListBullet5CxSp=
Last
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:74.6pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l4 level1 lfo31;
	tab-stops:28.35pt list 74.6pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListNumber2, li.MsoListNumber2, div.MsoListNumber2
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:32.15pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l3 level1 lfo33;
	tab-stops:28.35pt list 32.15pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListNumber2CxSpFirst, li.MsoListNumber2CxSpFirst, div.MsoListNumber2Cx=
SpFirst
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:32.15pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l3 level1 lfo33;
	tab-stops:28.35pt list 32.15pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListNumber2CxSpMiddle, li.MsoListNumber2CxSpMiddle, div.MsoListNumber2=
CxSpMiddle
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:32.15pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l3 level1 lfo33;
	tab-stops:28.35pt list 32.15pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListNumber2CxSpLast, li.MsoListNumber2CxSpLast, div.MsoListNumber2CxSp=
Last
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:32.15pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l3 level1 lfo33;
	tab-stops:28.35pt list 32.15pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListNumber3, li.MsoListNumber3, div.MsoListNumber3
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:46.3pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l2 level1 lfo34;
	tab-stops:28.35pt list 46.3pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListNumber3CxSpFirst, li.MsoListNumber3CxSpFirst, div.MsoListNumber3Cx=
SpFirst
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:46.3pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l2 level1 lfo34;
	tab-stops:28.35pt list 46.3pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListNumber3CxSpMiddle, li.MsoListNumber3CxSpMiddle, div.MsoListNumber3=
CxSpMiddle
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:46.3pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l2 level1 lfo34;
	tab-stops:28.35pt list 46.3pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListNumber3CxSpLast, li.MsoListNumber3CxSpLast, div.MsoListNumber3CxSp=
Last
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:46.3pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l2 level1 lfo34;
	tab-stops:28.35pt list 46.3pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListNumber4, li.MsoListNumber4, div.MsoListNumber4
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:60.45pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l1 level1 lfo35;
	tab-stops:28.35pt list 60.45pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListNumber4CxSpFirst, li.MsoListNumber4CxSpFirst, div.MsoListNumber4Cx=
SpFirst
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:60.45pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l1 level1 lfo35;
	tab-stops:28.35pt list 60.45pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListNumber4CxSpMiddle, li.MsoListNumber4CxSpMiddle, div.MsoListNumber4=
CxSpMiddle
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:60.45pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l1 level1 lfo35;
	tab-stops:28.35pt list 60.45pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListNumber4CxSpLast, li.MsoListNumber4CxSpLast, div.MsoListNumber4CxSp=
Last
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:60.45pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l1 level1 lfo35;
	tab-stops:28.35pt list 60.45pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListNumber5, li.MsoListNumber5, div.MsoListNumber5
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:74.6pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l0 level1 lfo36;
	tab-stops:28.35pt list 74.6pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListNumber5CxSpFirst, li.MsoListNumber5CxSpFirst, div.MsoListNumber5Cx=
SpFirst
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:74.6pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l0 level1 lfo36;
	tab-stops:28.35pt list 74.6pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListNumber5CxSpMiddle, li.MsoListNumber5CxSpMiddle, div.MsoListNumber5=
CxSpMiddle
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:74.6pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l0 level1 lfo36;
	tab-stops:28.35pt list 74.6pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListNumber5CxSpLast, li.MsoListNumber5CxSpLast, div.MsoListNumber5CxSp=
Last
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:74.6pt;
	mso-add-space:auto;
	text-indent:-.25in;
	mso-pagination:widow-orphan;
	mso-list:l0 level1 lfo36;
	tab-stops:28.35pt list 74.6pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Title Char";
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:15.0pt;
	margin-left:0in;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	border:none;
	mso-border-bottom-alt:solid #4F81BD 1.0pt;
	mso-border-bottom-themecolor:accent1;
	padding:0in;
	mso-padding-alt:0in 0in 4.0pt 0in;
	font-size:26.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#17365D;
	mso-themecolor:text2;
	mso-themeshade:191;
	letter-spacing:.25pt;
	mso-font-kerning:14.0pt;
	mso-ansi-language:EN-GB;}
p.MsoTitleCxSpFirst, li.MsoTitleCxSpFirst, div.MsoTitleCxSpFirst
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Title Char";
	mso-style-next:Normal;
	mso-style-type:export-only;
	margin:0in;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	border:none;
	mso-border-bottom-alt:solid #4F81BD 1.0pt;
	mso-border-bottom-themecolor:accent1;
	padding:0in;
	mso-padding-alt:0in 0in 4.0pt 0in;
	font-size:26.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#17365D;
	mso-themecolor:text2;
	mso-themeshade:191;
	letter-spacing:.25pt;
	mso-font-kerning:14.0pt;
	mso-ansi-language:EN-GB;}
p.MsoTitleCxSpMiddle, li.MsoTitleCxSpMiddle, div.MsoTitleCxSpMiddle
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Title Char";
	mso-style-next:Normal;
	mso-style-type:export-only;
	margin:0in;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	border:none;
	mso-border-bottom-alt:solid #4F81BD 1.0pt;
	mso-border-bottom-themecolor:accent1;
	padding:0in;
	mso-padding-alt:0in 0in 4.0pt 0in;
	font-size:26.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#17365D;
	mso-themecolor:text2;
	mso-themeshade:191;
	letter-spacing:.25pt;
	mso-font-kerning:14.0pt;
	mso-ansi-language:EN-GB;}
p.MsoTitleCxSpLast, li.MsoTitleCxSpLast, div.MsoTitleCxSpLast
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Title Char";
	mso-style-next:Normal;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:15.0pt;
	margin-left:0in;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	border:none;
	mso-border-bottom-alt:solid #4F81BD 1.0pt;
	mso-border-bottom-themecolor:accent1;
	padding:0in;
	mso-padding-alt:0in 0in 4.0pt 0in;
	font-size:26.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#17365D;
	mso-themecolor:text2;
	mso-themeshade:191;
	letter-spacing:.25pt;
	mso-font-kerning:14.0pt;
	mso-ansi-language:EN-GB;}
p.MsoClosing, li.MsoClosing, div.MsoClosing
	{mso-style-unhide:no;
	mso-style-link:"Closing Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:212.6pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoSignature, li.MsoSignature, div.MsoSignature
	{mso-style-unhide:no;
	mso-style-link:"Signature Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:212.6pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{mso-style-unhide:no;
	mso-style-link:"Body Text Char";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	color:green;
	mso-ansi-language:EN-GB;
	font-style:italic;
	mso-bidi-font-style:normal;}
p.MsoBodyTextIndent, li.MsoBodyTextIndent, div.MsoBodyTextIndent
	{mso-style-unhide:no;
	mso-style-link:"Body Text Indent Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListContinue, li.MsoListContinue, div.MsoListContinue
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListContinueCxSpFirst, li.MsoListContinueCxSpFirst, div.MsoListContinu=
eCxSpFirst
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:14.15pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListContinueCxSpMiddle, li.MsoListContinueCxSpMiddle, div.MsoListConti=
nueCxSpMiddle
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:14.15pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListContinueCxSpLast, li.MsoListContinueCxSpLast, div.MsoListContinueC=
xSpLast
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListContinue2, li.MsoListContinue2, div.MsoListContinue2
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:28.3pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListContinue2CxSpFirst, li.MsoListContinue2CxSpFirst, div.MsoListConti=
nue2CxSpFirst
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.3pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListContinue2CxSpMiddle, li.MsoListContinue2CxSpMiddle, div.MsoListCon=
tinue2CxSpMiddle
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.3pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListContinue2CxSpLast, li.MsoListContinue2CxSpLast, div.MsoListContinu=
e2CxSpLast
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:28.3pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListContinue3, li.MsoListContinue3, div.MsoListContinue3
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:42.45pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListContinue3CxSpFirst, li.MsoListContinue3CxSpFirst, div.MsoListConti=
nue3CxSpFirst
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:42.45pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListContinue3CxSpMiddle, li.MsoListContinue3CxSpMiddle, div.MsoListCon=
tinue3CxSpMiddle
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:42.45pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListContinue3CxSpLast, li.MsoListContinue3CxSpLast, div.MsoListContinu=
e3CxSpLast
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:42.45pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListContinue4, li.MsoListContinue4, div.MsoListContinue4
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:56.6pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListContinue4CxSpFirst, li.MsoListContinue4CxSpFirst, div.MsoListConti=
nue4CxSpFirst
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.6pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListContinue4CxSpMiddle, li.MsoListContinue4CxSpMiddle, div.MsoListCon=
tinue4CxSpMiddle
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.6pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListContinue4CxSpLast, li.MsoListContinue4CxSpLast, div.MsoListContinu=
e4CxSpLast
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:56.6pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListContinue5, li.MsoListContinue5, div.MsoListContinue5
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:70.75pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListContinue5CxSpFirst, li.MsoListContinue5CxSpFirst, div.MsoListConti=
nue5CxSpFirst
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:70.75pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListContinue5CxSpMiddle, li.MsoListContinue5CxSpMiddle, div.MsoListCon=
tinue5CxSpMiddle
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:70.75pt;
	margin-bottom:.0001pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListContinue5CxSpLast, li.MsoListContinue5CxSpLast, div.MsoListContinu=
e5CxSpLast
	{mso-style-unhide:no;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:70.75pt;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoMessageHeader, li.MsoMessageHeader, div.MsoMessageHeader
	{mso-style-unhide:no;
	mso-style-link:"Message Header Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	text-indent:-56.7pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	background:#CCCCCC;
	mso-shading:windowtext;
	mso-pattern:gray-20 auto;
	border:none;
	mso-border-alt:solid windowtext .75pt;
	padding:0in;
	mso-padding-alt:1.0pt 1.0pt 1.0pt 1.0pt;
	font-size:12.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	mso-ansi-language:EN-GB;}
p.MsoSubtitle, li.MsoSubtitle, div.MsoSubtitle
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Subtitle Char";
	mso-style-next:Normal;
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:12.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#4F81BD;
	mso-themecolor:accent1;
	letter-spacing:.75pt;
	mso-ansi-language:EN-GB;
	font-style:italic;}
p.MsoSalutation, li.MsoSalutation, div.MsoSalutation
	{mso-style-unhide:no;
	mso-style-link:"Salutation Char";
	mso-style-next:Normal;
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoDate, li.MsoDate, div.MsoDate
	{mso-style-unhide:no;
	mso-style-link:"Date Char";
	mso-style-next:Normal;
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoBodyTextFirstIndent, li.MsoBodyTextFirstIndent, div.MsoBodyTextFirstIn=
dent
	{mso-style-unhide:no;
	mso-style-parent:"Body Text";
	mso-style-link:"Body Text First Indent Char";
	margin:0in;
	text-indent:.25in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoBodyTextFirstIndent2, li.MsoBodyTextFirstIndent2, div.MsoBodyTextFirst=
Indent2
	{mso-style-unhide:no;
	mso-style-parent:"Body Text Indent";
	mso-style-link:"Body Text First Indent 2 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	text-indent:.25in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoNoteHeading, li.MsoNoteHeading, div.MsoNoteHeading
	{mso-style-unhide:no;
	mso-style-link:"Note Heading Char";
	mso-style-next:Normal;
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{mso-style-unhide:no;
	mso-style-link:"Body Text 2 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	line-height:200%;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{mso-style-unhide:no;
	mso-style-link:"Body Text 3 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:8.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{mso-style-unhide:no;
	mso-style-link:"Body Text Indent 2 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	line-height:200%;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{mso-style-unhide:no;
	mso-style-link:"Body Text Indent 3 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:8.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoBlockText, li.MsoBlockText, div.MsoBlockText
	{mso-style-unhide:no;
	margin-top:0in;
	margin-right:.8in;
	margin-bottom:0in;
	margin-left:.8in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	border:none;
	mso-border-alt:solid #4F81BD .25pt;
	mso-border-themecolor:accent1;
	padding:0in;
	mso-padding-alt:10.0pt 10.0pt 10.0pt 10.0pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:minor-fareast;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;
	color:#4F81BD;
	mso-themecolor:accent1;
	mso-ansi-language:EN-GB;
	font-style:italic;}
a:link, span.MsoHyperlink
	{mso-style-unhide:no;
	mso-style-parent:"";
	color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-unhide:no;
	color:purple;
	mso-themecolor:followedhyperlink;
	text-decoration:underline;
	text-underline:single;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-unhide:no;
	mso-style-link:"Document Map Char";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:8.0pt;
	font-family:"Tahoma",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoPlainText, li.MsoPlainText, div.MsoPlainText
	{mso-style-unhide:no;
	mso-style-link:"Plain Text Char";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.5pt;
	font-family:Consolas;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoAutoSig, li.MsoAutoSig, div.MsoAutoSig
	{mso-style-unhide:no;
	mso-style-link:"E-mail Signature Char";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p
	{mso-style-unhide:no;
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
address
	{mso-style-unhide:no;
	mso-style-link:"HTML Address Char";
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	font-style:italic;}
pre
	{mso-style-unhide:no;
	mso-style-link:"HTML Preformatted Char";
	margin:0in;
	margin-bottom:.0001pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:Consolas;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
	{mso-style-unhide:no;
	mso-style-parent:"Comment Text";
	mso-style-link:"Comment Subject Char";
	mso-style-next:"Comment Text";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	font-weight:bold;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	mso-style-unhide:no;
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:8.0pt;
	font-family:"Tahoma",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoNoSpacing, li.MsoNoSpacing, div.MsoNoSpacing
	{mso-style-priority:1;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParag=
raphCxSpFirst
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListPar=
agraphCxSpMiddle
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagra=
phCxSpLast
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoQuote, li.MsoQuote, div.MsoQuote
	{mso-style-priority:29;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Quote Char";
	mso-style-next:Normal;
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	color:black;
	mso-themecolor:text1;
	mso-ansi-language:EN-GB;
	font-style:italic;}
p.MsoIntenseQuote, li.MsoIntenseQuote, div.MsoIntenseQuote
	{mso-style-priority:30;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Intense Quote Char";
	mso-style-next:Normal;
	margin-top:10.0pt;
	margin-right:.65in;
	margin-bottom:14.0pt;
	margin-left:.65in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	border:none;
	mso-border-bottom-alt:solid #4F81BD .5pt;
	mso-border-bottom-themecolor:accent1;
	padding:0in;
	mso-padding-alt:0in 0in 4.0pt 0in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	color:#4F81BD;
	mso-themecolor:accent1;
	mso-ansi-language:EN-GB;
	font-weight:bold;
	font-style:italic;}
p.MsoBibliography, li.MsoBibliography, div.MsoBibliography
	{mso-style-noshow:yes;
	mso-style-priority:37;
	mso-style-next:Normal;
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
p.MsoTocHeading, li.MsoTocHeading, div.MsoTocHeading
	{mso-style-noshow:yes;
	mso-style-priority:39;
	mso-style-qformat:yes;
	mso-style-parent:"Heading 1";
	mso-style-next:Normal;
	margin-top:24.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	tab-stops:28.35pt;
	font-size:14.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#365F91;
	mso-themecolor:accent1;
	mso-themeshade:191;
	mso-ansi-language:EN-GB;
	font-weight:bold;}
p.MemoHeaderStyle, li.MemoHeaderStyle, div.MemoHeaderStyle
	{mso-style-name:MemoHeaderStyle;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:70.9pt;
	text-align:justify;
	text-justify:inter-ideograph;
	mso-line-height-alt:6.0pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	font-variant:small-caps;
	mso-ansi-language:EN-GB;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.EMEAEnBodyText, li.EMEAEnBodyText, div.EMEAEnBodyText
	{mso-style-name:"EMEA En Body Text";
	mso-style-unhide:no;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:justify;
	text-justify:inter-ideograph;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-US;}
p.BodytextAgency, li.BodytextAgency, div.BodytextAgency
	{mso-style-name:"Body text \(Agency\)";
	mso-style-unhide:no;
	mso-style-link:"Body text \(Agency\) Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;}
span.BodytextAgencyChar
	{mso-style-name:"Body text \(Agency\) Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Body text \(Agency\)";
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-ascii-font-family:Verdana;
	mso-fareast-font-family:Verdana;
	mso-hansi-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;
	mso-bidi-language:AR-SA;}
p.DraftingNotesAgency, li.DraftingNotesAgency, div.DraftingNotesAgency
	{mso-style-name:"Drafting Notes \(Agency\)";
	mso-style-unhide:no;
	mso-style-link:"Drafting Notes \(Agency\) Char";
	mso-style-next:"Body text \(Agency\)";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:11.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:"Times New Roman";
	color:#339966;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;
	font-style:italic;
	mso-bidi-font-style:normal;}
span.DraftingNotesAgencyChar
	{mso-style-name:"Drafting Notes \(Agency\) Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Drafting Notes \(Agency\)";
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Courier New";
	mso-ascii-font-family:"Courier New";
	mso-fareast-font-family:Verdana;
	mso-hansi-font-family:"Courier New";
	color:#339966;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;
	mso-bidi-language:AR-SA;
	font-style:italic;
	mso-bidi-font-style:normal;}
p.NormalAgency, li.NormalAgency, div.NormalAgency
	{mso-style-name:"Normal \(Agency\)";
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-link:"Normal \(Agency\) Char";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;}
p.TableheadingrowsAgency, li.TableheadingrowsAgency, div.TableheadingrowsAg=
ency
	{mso-style-name:"Table heading rows \(Agency\)";
	mso-style-unhide:no;
	mso-style-parent:"Body text \(Agency\)";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	tab-stops:.5in;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Verdana;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;
	font-weight:bold;
	mso-bidi-font-weight:normal;}
p.TabletextrowsAgency, li.TabletextrowsAgency, div.TabletextrowsAgency
	{mso-style-name:"Table text rows \(Agency\)";
	mso-style-unhide:no;
	margin:0in;
	line-height:14.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:.5in;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:Verdana;
	mso-ansi-language:EN-GB;
	mso-fareast-language:ZH-CN;}
span.NormalAgencyChar
	{mso-style-name:"Normal \(Agency\) Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Normal \(Agency\)";
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-ascii-font-family:Verdana;
	mso-fareast-font-family:Verdana;
	mso-hansi-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;
	mso-bidi-language:AR-SA;}
p.TitleA, li.TitleA, div.TitleA
	{mso-style-name:"Title A";
	mso-style-unhide:no;
	margin:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	tab-stops:-1.0in -.5in 28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	font-weight:bold;
	mso-bidi-font-weight:normal;
	mso-no-proof:yes;}
p.TitleB, li.TitleB, div.TitleB
	{mso-style-name:"Title B";
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.35pt;
	text-indent:-28.35pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	font-weight:bold;
	mso-bidi-font-weight:normal;
	mso-no-proof:yes;}
span.CommentTextChar
	{mso-style-name:"Comment Text Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Comment Text";
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.CommentSubjectChar
	{mso-style-name:"Comment Subject Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"Comment Text Char";
	mso-style-link:"Comment Subject";
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.Heading1Char
	{mso-style-name:"Heading 1 Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 1";
	mso-ansi-font-size:14.0pt;
	mso-bidi-font-size:14.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#365F91;
	mso-themecolor:accent1;
	mso-themeshade:191;
	mso-fareast-language:EN-US;
	font-weight:bold;}
span.Heading2Char
	{mso-style-name:"Heading 2 Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 2";
	mso-ansi-font-size:13.0pt;
	mso-bidi-font-size:13.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#4F81BD;
	mso-themecolor:accent1;
	mso-fareast-language:EN-US;
	font-weight:bold;}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 3";
	mso-ansi-font-size:11.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#4F81BD;
	mso-themecolor:accent1;
	mso-fareast-language:EN-US;
	font-weight:bold;}
span.Heading4Char
	{mso-style-name:"Heading 4 Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 4";
	mso-ansi-font-size:11.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#4F81BD;
	mso-themecolor:accent1;
	mso-fareast-language:EN-US;
	font-weight:bold;
	font-style:italic;}
span.Heading5Char
	{mso-style-name:"Heading 5 Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 5";
	mso-ansi-font-size:11.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#243F60;
	mso-themecolor:accent1;
	mso-themeshade:127;
	mso-fareast-language:EN-US;}
span.Heading6Char
	{mso-style-name:"Heading 6 Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 6";
	mso-ansi-font-size:11.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#243F60;
	mso-themecolor:accent1;
	mso-themeshade:127;
	mso-fareast-language:EN-US;
	font-style:italic;}
span.Heading7Char
	{mso-style-name:"Heading 7 Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 7";
	mso-ansi-font-size:11.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#404040;
	mso-themecolor:text1;
	mso-themetint:191;
	mso-fareast-language:EN-US;
	font-style:italic;}
span.Heading8Char
	{mso-style-name:"Heading 8 Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 8";
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#404040;
	mso-themecolor:text1;
	mso-themetint:191;
	mso-fareast-language:EN-US;}
span.Heading9Char
	{mso-style-name:"Heading 9 Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Heading 9";
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#404040;
	mso-themecolor:text1;
	mso-themetint:191;
	mso-fareast-language:EN-US;
	font-style:italic;}
span.SalutationChar
	{mso-style-name:"Salutation Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Salutation;
	mso-ansi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-language:EN-US;}
span.DateChar
	{mso-style-name:"Date Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Date;
	mso-ansi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-language:EN-US;}
span.DocumentMapChar
	{mso-style-name:"Document Map Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Document Map";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;
	font-family:"Tahoma",sans-serif;
	mso-ascii-font-family:Tahoma;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;
	mso-fareast-language:EN-US;}
span.E-mailSignatureChar
	{mso-style-name:"E-mail Signature Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"E-mail Signature";
	mso-ansi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-language:EN-US;}
span.EndnoteTextChar
	{mso-style-name:"Endnote Text Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Endnote Text";
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-language:EN-US;}
span.NoteHeadingChar
	{mso-style-name:"Note Heading Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Note Heading";
	mso-ansi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-language:EN-US;}
span.FootnoteTextChar
	{mso-style-name:"Footnote Text Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Footnote Text";
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-language:EN-US;}
span.ClosingChar
	{mso-style-name:"Closing Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Closing;
	mso-ansi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-language:EN-US;}
span.HTMLAddressChar
	{mso-style-name:"HTML Address Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"HTML Address";
	mso-ansi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-language:EN-US;
	font-style:italic;}
span.HTMLPreformattedChar
	{mso-style-name:"HTML Preformatted Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"HTML Preformatted";
	font-family:Consolas;
	mso-ascii-font-family:Consolas;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Consolas;
	mso-fareast-language:EN-US;}
span.IntenseQuoteChar
	{mso-style-name:"Intense Quote Char";
	mso-style-priority:30;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Intense Quote";
	mso-ansi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	color:#4F81BD;
	mso-themecolor:accent1;
	mso-fareast-language:EN-US;
	font-weight:bold;
	font-style:italic;}
span.MacroTextChar
	{mso-style-name:"Macro Text Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Macro Text";
	font-family:Consolas;
	mso-ascii-font-family:Consolas;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Consolas;
	mso-fareast-language:EN-US;}
span.MessageHeaderChar
	{mso-style-name:"Message Header Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Message Header";
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	background:#CCCCCC;
	mso-shading:windowtext;
	mso-pattern:gray-20 auto;
	mso-fareast-language:EN-US;}
span.PlainTextChar
	{mso-style-name:"Plain Text Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Plain Text";
	mso-ansi-font-size:10.5pt;
	mso-bidi-font-size:10.5pt;
	font-family:Consolas;
	mso-ascii-font-family:Consolas;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Consolas;
	mso-fareast-language:EN-US;}
span.BodyText2Char
	{mso-style-name:"Body Text 2 Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Body Text 2";
	mso-ansi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-language:EN-US;}
span.BodyText3Char
	{mso-style-name:"Body Text 3 Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Body Text 3";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-language:EN-US;}
span.BodyTextIndent2Char
	{mso-style-name:"Body Text Indent 2 Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Body Text Indent 2";
	mso-ansi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-language:EN-US;}
span.BodyTextIndent3Char
	{mso-style-name:"Body Text Indent 3 Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Body Text Indent 3";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-language:EN-US;}
span.BodyTextChar
	{mso-style-name:"Body Text Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Body Text";
	mso-ansi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	color:green;
	mso-fareast-language:EN-US;
	font-style:italic;
	mso-bidi-font-style:normal;}
span.BodyTextFirstIndentChar
	{mso-style-name:"Body Text First Indent Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"Body Text Char";
	mso-style-link:"Body Text First Indent";
	mso-ansi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	color:green;
	mso-fareast-language:EN-US;
	font-style:normal;}
span.BodyTextIndentChar
	{mso-style-name:"Body Text Indent Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:"Body Text Indent";
	mso-ansi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-language:EN-US;}
span.BodyTextFirstIndent2Char
	{mso-style-name:"Body Text First Indent 2 Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"Body Text Indent Char";
	mso-style-link:"Body Text First Indent 2";
	mso-ansi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-language:EN-US;}
span.TitleChar
	{mso-style-name:"Title Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Title;
	mso-ansi-font-size:26.0pt;
	mso-bidi-font-size:26.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#17365D;
	mso-themecolor:text2;
	mso-themeshade:191;
	letter-spacing:.25pt;
	mso-font-kerning:14.0pt;
	mso-fareast-language:EN-US;}
span.SignatureChar
	{mso-style-name:"Signature Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Signature;
	mso-ansi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-language:EN-US;}
span.SubtitleChar
	{mso-style-name:"Subtitle Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Subtitle;
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-ascii-theme-font:major-latin;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-theme-font:major-fareast;
	mso-hansi-font-family:Cambria;
	mso-hansi-theme-font:major-latin;
	mso-bidi-font-family:"Times New Roman";
	mso-bidi-theme-font:major-bidi;
	color:#4F81BD;
	mso-themecolor:accent1;
	letter-spacing:.75pt;
	mso-fareast-language:EN-US;
	font-style:italic;}
span.QuoteChar
	{mso-style-name:"Quote Char";
	mso-style-priority:29;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-link:Quote;
	mso-ansi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	color:black;
	mso-themecolor:text1;
	mso-fareast-language:EN-US;
	font-style:italic;}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-size:10.0pt;
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;}
 /* Page Definitions */
 @page
	{mso-footnote-separator:url("Ovaleap_clean_files/header.htm") fs;
	mso-footnote-continuation-separator:url("Ovaleap_clean_files/header.htm") =
fcs;
	mso-endnote-separator:url("Ovaleap_clean_files/header.htm") es;
	mso-endnote-continuation-separator:url("Ovaleap_clean_files/header.htm") e=
cs;
	mso-endnote-numbering-style:arabic;}
@page WordSection1
	{size:595.35pt 842.0pt;
	margin:56.7pt 70.9pt 56.7pt 70.9pt;
	mso-header-margin:36.85pt;
	mso-footer-margin:36.85pt;
	mso-title-page:yes;
	mso-footer:url("Ovaleap_clean_files/header.htm") f1;
	mso-first-footer:url("Ovaleap_clean_files/header.htm") ff1;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;
	mso-endnote-numbering-style:arabic;}
 /* List Definitions */
 @list l0
	{mso-list-id:-132;
	mso-list-type:simple;
	mso-list-template-ids:-224355100;}
@list l0:level1
	{mso-level-style-link:"List Number 5";
	mso-level-tab-stop:74.6pt;
	mso-level-number-position:left;
	margin-left:74.6pt;
	text-indent:-.25in;}
@list l1
	{mso-list-id:-131;
	mso-list-type:simple;
	mso-list-template-ids:-1822261232;}
@list l1:level1
	{mso-level-style-link:"List Number 4";
	mso-level-tab-stop:60.45pt;
	mso-level-number-position:left;
	margin-left:60.45pt;
	text-indent:-.25in;}
@list l2
	{mso-list-id:-130;
	mso-list-type:simple;
	mso-list-template-ids:1332795872;}
@list l2:level1
	{mso-level-style-link:"List Number 3";
	mso-level-tab-stop:46.3pt;
	mso-level-number-position:left;
	margin-left:46.3pt;
	text-indent:-.25in;}
@list l3
	{mso-list-id:-129;
	mso-list-type:simple;
	mso-list-template-ids:1386389820;}
@list l3:level1
	{mso-level-style-link:"List Number 2";
	mso-level-tab-stop:32.15pt;
	mso-level-number-position:left;
	margin-left:32.15pt;
	text-indent:-.25in;}
@list l4
	{mso-list-id:-128;
	mso-list-type:simple;
	mso-list-template-ids:598387170;}
@list l4:level1
	{mso-level-number-format:bullet;
	mso-level-style-link:"List Bullet 5";
	mso-level-text:\F0B7;
	mso-level-tab-stop:74.6pt;
	mso-level-number-position:left;
	margin-left:74.6pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l5
	{mso-list-id:-127;
	mso-list-type:simple;
	mso-list-template-ids:1723648698;}
@list l5:level1
	{mso-level-number-format:bullet;
	mso-level-style-link:"List Bullet 4";
	mso-level-text:\F0B7;
	mso-level-tab-stop:60.45pt;
	mso-level-number-position:left;
	margin-left:60.45pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l6
	{mso-list-id:-126;
	mso-list-type:simple;
	mso-list-template-ids:-968717610;}
@list l6:level1
	{mso-level-number-format:bullet;
	mso-level-style-link:"List Bullet 3";
	mso-level-text:\F0B7;
	mso-level-tab-stop:46.3pt;
	mso-level-number-position:left;
	margin-left:46.3pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l7
	{mso-list-id:-125;
	mso-list-type:simple;
	mso-list-template-ids:1263183362;}
@list l7:level1
	{mso-level-number-format:bullet;
	mso-level-style-link:"List Bullet 2";
	mso-level-text:\F0B7;
	mso-level-tab-stop:32.15pt;
	mso-level-number-position:left;
	margin-left:32.15pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l8
	{mso-list-id:-120;
	mso-list-type:simple;
	mso-list-template-ids:1716167524;}
@list l8:level1
	{mso-level-style-link:"List Number";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;}
@list l9
	{mso-list-id:-119;
	mso-list-type:simple;
	mso-list-template-ids:-590074884;}
@list l9:level1
	{mso-level-number-format:bullet;
	mso-level-style-link:"List Bullet";
	mso-level-text:\F0B7;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l10
	{mso-list-id:-2;
	mso-list-type:simple;
	mso-list-template-ids:-1;}
@list l10:level1
	{mso-level-start-at:0;
	mso-level-text:*;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:0in;
	text-indent:0in;}
@list l11
	{mso-list-id:590061;
	mso-list-type:hybrid;
	mso-list-template-ids:1023986052 1999685684 85891706 -361964272 879675876 =
-954453076 -550991436 1416375400 484055376 2069771566;}
@list l11:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l11:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l11:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l11:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l11:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.25in;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l11:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.75in;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l11:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.25in;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l11:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:3.75in;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l11:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.25in;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l12
	{mso-list-id:72942370;
	mso-list-type:simple;
	mso-list-template-ids:-1460387854;}
@list l12:level1
	{mso-level-text:"Figure\: %1\. ";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;}
@list l13
	{mso-list-id:163859649;
	mso-list-type:hybrid;
	mso-list-template-ids:2146616686 -1488924704 1999009762 -1656041676 -20548=
99858 1726113396 -236696286 1724575106 1539237942 -540493628;}
@list l13:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l13:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l13:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l13:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l13:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l13:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l13:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l13:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l13:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l14
	{mso-list-id:542013103;
	mso-list-template-ids:-311163578;}
@list l14:level1
	{mso-level-start-at:4;
	mso-level-text:%1;
	mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l14:level2
	{mso-level-start-at:2;
	mso-level-text:"%1\.%2";
	mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l14:level3
	{mso-level-text:"%1\.%2\.%3";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:-.5in;}
@list l14:level4
	{mso-level-text:"%1\.%2\.%3\.%4";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:-.5in;}
@list l14:level5
	{mso-level-text:"%1\.%2\.%3\.%4\.%5";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l14:level6
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l14:level7
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l14:level8
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l14:level9
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.%9";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l15
	{mso-list-id:591552003;
	mso-list-type:hybrid;
	mso-list-template-ids:1592436250 -1411057328 742397010 -12527120 196924607=
6 -1184488838 -268142944 1916282992 -1661585262 -1447281736;}
@list l15:level1
	{mso-level-start-at:19;
	mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";}
@list l15:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l15:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l15:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l15:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l15:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l15:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l15:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l15:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:4.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l16
	{mso-list-id:773020633;
	mso-list-type:hybrid;
	mso-list-template-ids:-623460128 -1437725558 1555829984 1282077634 3265076=
70 722258900 230208650 -1507968742 -171932740 1837660348;}
@list l16:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:19.85pt;
	mso-level-number-position:left;
	margin-left:19.85pt;
	text-indent:-19.85pt;
	font-family:Symbol;}
@list l16:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l16:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l16:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l16:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l16:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l16:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l16:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l16:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l17
	{mso-list-id:777262601;
	mso-list-type:hybrid;
	mso-list-template-ids:509258728 -732677148 -501723774 -428724112 -99023973=
0 -1765659100 1990071812 430490026 478430990 1034311186;}
@list l17:level1
	{mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l17:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;}
@list l17:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:1.25in;
	mso-level-number-position:right;
	margin-left:1.25in;
	text-indent:-9.0pt;}
@list l17:level4
	{mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;}
@list l17:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:2.25in;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;}
@list l17:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:2.75in;
	mso-level-number-position:right;
	margin-left:2.75in;
	text-indent:-9.0pt;}
@list l17:level7
	{mso-level-tab-stop:3.25in;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;}
@list l17:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:3.75in;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;}
@list l17:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:4.25in;
	mso-level-number-position:right;
	margin-left:4.25in;
	text-indent:-9.0pt;}
@list l18
	{mso-list-id:915288275;
	mso-list-template-ids:-2011128472;}
@list l18:level1
	{mso-level-start-at:6;
	mso-level-text:%1;
	mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l18:level2
	{mso-level-start-at:5;
	mso-level-text:"%1\.%2";
	mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l18:level3
	{mso-level-text:"%1\.%2\.%3";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:-.5in;}
@list l18:level4
	{mso-level-text:"%1\.%2\.%3\.%4";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:-.5in;}
@list l18:level5
	{mso-level-text:"%1\.%2\.%3\.%4\.%5";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l18:level6
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l18:level7
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l18:level8
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l18:level9
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.%9";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l19
	{mso-list-id:940798210;
	mso-list-type:hybrid;
	mso-list-template-ids:-952221844 -1862889092 -516286430 1224488986 -135053=
6054 800111340 -1492617712 -804852680 -908826774 -716804620;}
@list l19:level1
	{mso-level-start-at:19;
	mso-level-number-format:bullet;
	mso-level-text:;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"TimesNewRoman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:TimesNewRoman;}
@list l19:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l19:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l19:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l19:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l19:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l19:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l19:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l19:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:4.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l20
	{mso-list-id:1047798480;
	mso-list-type:simple;
	mso-list-template-ids:-1;}
@list l20:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	mso-level-legacy:yes;
	mso-level-legacy-indent:14.15pt;
	mso-level-legacy-space:0in;
	margin-left:14.15pt;
	text-indent:-14.15pt;
	font-family:Symbol;}
@list l21
	{mso-list-id:1107773539;
	mso-list-type:hybrid;
	mso-list-template-ids:-2091209358 -921000098 1685105516 -487307824 -148976=
1706 -287029546 336890254 -1511748866 -754041696 1303960402;}
@list l21:level1
	{mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	mso-level-legacy:yes;
	mso-level-legacy-indent:.25in;
	mso-level-legacy-space:0in;
	margin-left:.25in;
	text-indent:-.25in;}
@list l21:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l21:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l21:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l21:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l21:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l21:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l21:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l21:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l22
	{mso-list-id:1249968153;
	mso-list-type:simple;
	mso-list-template-ids:-1;}
@list l22:level1
	{mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	mso-level-legacy:yes;
	mso-level-legacy-indent:.25in;
	mso-level-legacy-space:0in;
	margin-left:1.25in;
	text-indent:-.25in;}
@list l23
	{mso-list-id:1443644261;
	mso-list-type:simple;
	mso-list-template-ids:-1;}
@list l23:level1
	{mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	mso-level-legacy:yes;
	mso-level-legacy-indent:.25in;
	mso-level-legacy-space:0in;
	margin-left:1.25in;
	text-indent:-.25in;}
@list l24
	{mso-list-id:1488284787;
	mso-list-type:hybrid;
	mso-list-template-ids:1537483048 -1027457102 -585990102 765904562 47111729=
2 -1122984572 1242995480 -1753725494 -837137234 424948902;}
@list l24:level1
	{mso-level-start-at:2;
	mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l24:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;}
@list l24:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:1.25in;
	mso-level-number-position:right;
	margin-left:1.25in;
	text-indent:-9.0pt;}
@list l24:level4
	{mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;}
@list l24:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:2.25in;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;}
@list l24:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:2.75in;
	mso-level-number-position:right;
	margin-left:2.75in;
	text-indent:-9.0pt;}
@list l24:level7
	{mso-level-tab-stop:3.25in;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;}
@list l24:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:3.75in;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;}
@list l24:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:4.25in;
	mso-level-number-position:right;
	margin-left:4.25in;
	text-indent:-9.0pt;}
@list l25
	{mso-list-id:1680696663;
	mso-list-template-ids:509258728;}
@list l25:level1
	{mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l25:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;}
@list l25:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:1.25in;
	mso-level-number-position:right;
	margin-left:1.25in;
	text-indent:-9.0pt;}
@list l25:level4
	{mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;}
@list l25:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:2.25in;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;}
@list l25:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:2.75in;
	mso-level-number-position:right;
	margin-left:2.75in;
	text-indent:-9.0pt;}
@list l25:level7
	{mso-level-tab-stop:3.25in;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;}
@list l25:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:3.75in;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;}
@list l25:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:4.25in;
	mso-level-number-position:right;
	margin-left:4.25in;
	text-indent:-9.0pt;}
@list l26
	{mso-list-id:1703674529;
	mso-list-type:simple;
	mso-list-template-ids:-405659258;}
@list l26:level1
	{mso-level-number-format:roman-upper;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;}
@list l27
	{mso-list-id:1747220272;
	mso-list-type:simple;
	mso-list-template-ids:1620494122;}
@list l27:level1
	{mso-level-start-at:5;
	mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l28
	{mso-list-id:1776900692;
	mso-list-type:hybrid;
	mso-list-template-ids:1008267184 -875380574 -1180649490 -578498210 -150649=
4028 -1023914832 -2070775792 -2139470224 -875535406 -785250156;}
@list l28:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:19.85pt;
	mso-level-number-position:left;
	margin-left:19.85pt;
	text-indent:-19.85pt;
	font-family:Symbol;}
@list l28:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l28:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l28:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l28:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l28:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l28:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l28:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l28:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l29
	{mso-list-id:1795246133;
	mso-list-template-ids:-810765714;}
@list l29:level1
	{mso-level-start-at:4;
	mso-level-text:%1;
	mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l29:level2
	{mso-level-start-at:8;
	mso-level-text:"%1\.%2";
	mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l29:level3
	{mso-level-text:"%1\.%2\.%3";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:-.5in;}
@list l29:level4
	{mso-level-text:"%1\.%2\.%3\.%4";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:-.5in;}
@list l29:level5
	{mso-level-text:"%1\.%2\.%3\.%4\.%5";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l29:level6
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l29:level7
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l29:level8
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l29:level9
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.%9";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l30
	{mso-list-id:1838421848;
	mso-list-type:simple;
	mso-list-template-ids:-1735361676;}
@list l30:level1
	{mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	mso-ansi-font-weight:bold;}
@list l31
	{mso-list-id:1871919056;
	mso-list-type:hybrid;
	mso-list-template-ids:-1228372506 -1135019514 1936259230 2002310182 141453=
4078 -1192209228 -426242218 -1254868270 463474164 -2012441436;}
@list l31:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l31:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l31:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l31:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l31:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l31:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l31:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l31:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l31:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l32
	{mso-list-id:1923830001;
	mso-list-type:hybrid;
	mso-list-template-ids:1691264716 -919153094 421065530 -1013137084 -7693722=
34 1482442088 -81516312 -721416478 1374579460 -61320998;}
@list l32:level1
	{mso-level-text:"%1\)";
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l32:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l32:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l32:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l32:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l32:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l32:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l32:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l32:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l33
	{mso-list-id:2020764974;
	mso-list-template-ids:-311163578;}
@list l33:level1
	{mso-level-start-at:4;
	mso-level-text:%1;
	mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l33:level2
	{mso-level-start-at:2;
	mso-level-text:"%1\.%2";
	mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l33:level3
	{mso-level-text:"%1\.%2\.%3";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:-.5in;}
@list l33:level4
	{mso-level-text:"%1\.%2\.%3\.%4";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:-.5in;}
@list l33:level5
	{mso-level-text:"%1\.%2\.%3\.%4\.%5";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l33:level6
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l33:level7
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l33:level8
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l33:level9
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.%9";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l10:level1 lfo3
	{mso-level-start-at:1;
	mso-level-number-format:bullet;
	mso-level-numbering:continue;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	mso-level-legacy:yes;
	mso-level-legacy-indent:.25in;
	mso-level-legacy-space:0in;
	margin-left:.25in;
	text-indent:-.25in;}
@list l10:level1 lfo4
	{mso-level-start-at:1;
	mso-level-number-format:bullet;
	mso-level-numbering:continue;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	mso-level-legacy:yes;
	mso-level-legacy-indent:.25in;
	mso-level-legacy-space:0in;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l10:level1 lfo15
	{mso-level-start-at:1;
	mso-level-number-format:bullet;
	mso-level-numbering:continue;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	mso-level-legacy:yes;
	mso-level-legacy-indent:.25in;
	mso-level-legacy-space:0in;
	margin-left:.25in;
	text-indent:-.25in;}
ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;}
table.MsoTableGrid
	{mso-style-name:"Table Grid";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-unhide:no;
	border:solid black 1.0pt;
	mso-border-alt:solid black .5pt;
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-border-insideh:.5pt solid black;
	mso-border-insidev:.5pt solid black;
	mso-para-margin:0in;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;}
table.TablegridAgencyblack
	{mso-style-name:"Table grid \(Agency\) black";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-unhide:no;
	border:solid windowtext 1.0pt;
	mso-border-alt:solid windowtext .5pt;
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-border-insideh:.75pt solid windowtext;
	mso-border-insidev:.75pt solid windowtext;
	mso-para-margin:0in;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Verdana",sans-serif;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;}
table.TablegridAgencyblackFirstRow
	{mso-style-name:"Table grid \(Agency\) black";
	mso-table-condition:first-row;
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-tstyle-border-top:.5pt solid windowtext;
	mso-tstyle-border-left:.5pt solid windowtext;
	mso-tstyle-border-bottom:.5pt solid windowtext;
	mso-tstyle-border-right:.5pt solid windowtext;
	mso-tstyle-diagonal-down:cell-none;
	mso-tstyle-diagonal-up:cell-none;
	mso-tstyle-border-insideh:.75pt solid windowtext;
	mso-tstyle-border-insidev:.75pt solid windowtext;
	font-size:9.0pt;
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-ascii-font-family:Verdana;
	mso-hansi-font-family:Verdana;
	color:windowtext;
	mso-ansi-font-weight:bold;
	mso-ansi-font-style:normal;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext=3D"edit" spidmax=3D"4097"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext=3D"edit">
  <o:idmap v:ext=3D"edit" data=3D"1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=3DEN-US link=3Dblue vlink=3Dpurple style=3D'tab-interval:.5in;wo=
rd-wrap:
break-word'>

<div class=3DWordSection1>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-paginati=
on:none;
tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>ANNEX I</span></b><span lang=3DEN-GB style=3D'mso-=
bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DTitleA><span lang=3DEN-GB>SUMMARY OF PRODUCT CHARACTERISTICS</sp=
an></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;tab-stops:-1=
.0in -.5in 28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-farea=
st-language:
EN-US;mso-bidi-language:AR-SA;mso-no-proof:yes'><br clear=3Dall style=3D'ms=
o-special-character:
line-break;page-break-before:always'>
</span>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>1.<span
style=3D'mso-tab-count:1'> </span>NAME OF THE MEDICINAL PRODUCT</span=
></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Ovaleap
300&nbsp;IU/0.5&nbsp;mL solution for injection<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Ovaleap
450&nbsp;IU/0.75&nbsp;mL solution for injection<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Ovaleap
900&nbsp;IU/1.5&nbsp;mL solution for injection<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-bidi-font-style:italic;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-bidi-font-style:italic;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>2.<span
style=3D'mso-tab-count:1'> </span>QUALITATIVE AND QUANTITATIVE COMPOS=
ITION</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Each mL of the solution contains
600&nbsp;IU (equivalent to 44&nbsp;micrograms) follitropin alfa*.<o:p></o:p=
></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Ovaleap
300&nbsp;IU/0.5&nbsp;mL solution for injection<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Each cartridge contains 300&nbsp;IU (e=
quivalent
to 22&nbsp;micrograms) follitropin alfa in 0.5&nbsp;mL solution for injecti=
on.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Ovaleap
450&nbsp;IU/0.75&nbsp;mL solution for injection<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Each cartridge contains 450&nbsp;IU
(equivalent to 33&nbsp;micrograms) follitropin alfa in 0.75&nbsp;mL solution
for injection.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Ovaleap 90=
0&nbsp;IU/1.5&nbsp;mL
solution for injection<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Each cartridge contains 900&nbsp;IU
(equivalent to 66&nbsp;micrograms) follitropin alfa in 1.5&nbsp;mL solution=
 for
injection.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>*Follitrop=
in
alfa</span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:blac=
k;
mso-bidi-font-weight:bold'> (recombinant human follicle&#8209;stimulating
hormone [r&#8209;hFSH]) is produced in Chinese Hamster Ovary Cells
(CHO&nbsp;DHFR<sup>-</sup>) by recombinant DNA technology.<o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'mso-pagination:none;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-bidi-font-weight:bold;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none;tab-stops:.5in'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;font-family:"TimesNewRomanP=
SMT",serif;
mso-fareast-font-family:SimSun;mso-bidi-font-family:TimesNewRomanPSMT;
mso-fareast-language:EN-GB'>Excipient(s) with known effect:</span></u><u><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-bidi-font-w=
eight:
bold;mso-no-proof:yes'><o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt;color:black;mso-no-proof:yes'>Ovaleap contains 0.02 mg per mL of ben=
zalkonium
chloride<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt;color:black;mso-no-proof:yes'>Ovaleap </span><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-themecolor:text1;mso-no-=
proof:
yes'>contains </span><span lang=3DEN-GB style=3D'color:black;mso-themecolor=
:text1'>10.0
mg per mL of benzyl alcohol</span><span lang=3DEN-GB style=3D'color:#1F497D=
'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-bidi-font-weight:bold;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>For the fu=
ll
list of excipients, see section 6.1.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>3.<span style=3D'mso-tab-count:1'> </span>PH=
ARMACEUTICAL
FORM</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;text-t=
ransform:
uppercase;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Solution f=
or
injection (injection).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Clear, colourless solution.<o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>The pH of the solution is 6.8-7.2.<o:p=
></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;text-transform:uppercase;mso-no-proof:yes'>4.<span style=3D'mso-tab-=
count:
1'> </span></span></b><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>CLINICAL
PARTICULARS</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
text-transform:uppercase;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'>4.1<span style=3D'mso-tab-count:1'> </span>The=
rapeutic
indications</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid;tab-stops:.5in'><u><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-bidi-font-s=
tyle:
italic;mso-no-proof:yes'>In adult women<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;page=
-break-after:
avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;page=
-break-after:
avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-no-proof:yes'><span style=3D'mso-tab-count:1'> </sp=
an>Anovulation
(including polycystic ovarian syndrome) in women who have been unresponsive=
 to
treatment with clomifene citrate.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;tab-=
stops:
.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso=
-no-proof:
yes'><span style=3D'mso-tab-count:1'> </span>Stimulation of
multifollicular development in women undergoing superovulation for assisted
reproductive technologies (ART) such as <i>in vitro </i>fertilisation (IVF),
gamete intra-fallopian transfer and zygote intra&#8209;fallopian transfer.<=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;tab-=
stops:
.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso=
-no-proof:
yes'><span style=3D'mso-tab-count:1'> </span>Ovaleap in association=
 with
a luteinising hormone (LH) preparation is recommended for the stimulation of
follicular development in women with severe LH and FSH deficiency. In clini=
cal
trials these patients were defined by an endogenous serum LH level
&lt;&nbsp;1.2&nbsp;IU/L.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid;tab-stops:.5in'><u><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-bidi-font-s=
tyle:
italic;mso-no-proof:yes'>In adult men<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;page=
-break-after:
avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;page=
-break-after:
avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-no-proof:yes'><span style=3D'mso-tab-count:1'> </sp=
an>Ovaleap
is indicated for the stimulation of spermatogenesis in men who have congeni=
tal
or acquired hypogonadotropic hypogonadism with concomitant human chorionic =
gonadotropin
(hCG) therapy.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;mso-outline-level:1'><b style=3D'mso-bidi-font-weigh=
t:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>4.2<span
style=3D'mso-tab-count:1'> </span>Posology and method of administration=
<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><i style=3D'mso-bidi-font-style:normal'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></i></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;mso-outline-level:1;tab-stops:.5in'><span lang=3DEN-=
GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;mso-outline-level:1;tab-stops:.5in'><span lang=3DEN-=
GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Treatment =
with follitropin
alfa should be initiated under the supervision of a physician experienced in
the treatment of fertility disorders.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:ye=
s'>Posology<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>The dose
recommendations given for follitropin alfa are those in use for urinary FSH.
Clinical assessment of follitropin alfa indicates that its daily doses,
regimens of administration and treatment monitoring procedures should not be
different from those currently used for urinary FSH&#8209;containing medici=
nal
products. It is advised to adhere to the recommended starting doses indicat=
ed
below.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Comparative
clinical studies have shown that on average patients require a lower cumula=
tive
dose and shorter treatment duration with follitropin alfa compared with uri=
nary
FSH. Therefore, it is considered appropriate to give a lower total dose of
follitropin alfa than generally used for urinary FSH, not only in order to
optimise follicular development but also to minimise the risk of unwanted
ovarian hyperstimulation (see section 5.1).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-bidi-font-style:italic;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><i
style=3D'mso-bidi-font-style:normal'><u><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
11.0pt;color:black;mso-no-proof:yes'>Women with anovulation (including poly=
cystic
ovarian syndrome)<o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Follitropi=
n alfa
may be given as a course of daily injections. In menstruating women treatme=
nt
should commence within the first 7&nbsp;days of the menstrual cycle.<o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>A commonly=
 used
regimen commences at 75&#8209;150&nbsp;IU FSH daily and is increased prefer=
ably
by 37.5 or 75&nbsp;IU at 7 or preferably 14&nbsp;day intervals if necessary=
, to
obtain an adequate, but not excessive, response. Treatment should be tailor=
ed
to the individual patients response as assessed by measuring follicle size=
 by
ultrasound and/or oestrogen secretion. The maximal daily dose is usually not
higher than 225&nbsp;IU FSH. If a patient fails to respond adequately after
4&nbsp;weeks of treatment, that cycle should be abandoned and the patient
should undergo further evaluation after which she may recommence treatment =
at a
higher starting dose than in the abandoned cycle.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>When an op=
timal
response is obtained, a single injection of 250&nbsp;micrograms recombinant
human choriogonadotropin alfa (r-hCG) or 5,000&nbsp;IU up to 10,000&nbsp;IU=
 hCG
should be administered 24&#8209;48&nbsp;hours after the last follitropin al=
fa
injection. The patient is recommended to have coitus on the day of, and the=
 day
following, hCG administration. Alternatively intrauterine insemination (IUI)
may be performed.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>If an exce=
ssive
response is obtained, treatment should be stopped and hCG withheld (see sec=
tion
4.4). Treatment should recommence in the next cycle at a dose lower than th=
at
of the previous cycle.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><i><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:ye=
s'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid;mso-outline-level:1;
tab-stops:.5in'><i><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-no-proof:yes'>Women undergoing ovarian stimulation for mult=
iple
follicular development prior to in vitro fertilisation or other ART<o:p></o=
:p></span></u></i></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid;mso-outline-level:1;
tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color=
:black;
mso-no-proof:yes'>A commonly used regimen for superovulation involves the
administration of 150&#8209;225&nbsp;IU of follitropin alfa daily, commenci=
ng
on days 2 or 3 of the cycle. Treatment is continued until adequate follicul=
ar
development has been achieved (as assessed by monitoring of serum oestrogen
concentrations and/or ultrasound examination), with the dose adjusted accor=
ding
to the patients response, to usually not higher than 450&nbsp;IU daily. In
general adequate follicular development is achieved on average by the tenth=
 day
of treatment (range 5 to 20&nbsp;days).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>A single
injection of 250&nbsp;micrograms r&#8209;hCG or 5,000&nbsp;IU up to
10,000&nbsp;IU hCG is administered 24&#8209;48&nbsp;hours after the last
follitropin alfa injection to induce final follicular maturation.<o:p></o:p=
></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Down&#8209=
;regulation
with a gonadotropin&#8209;releasing hormone (GnRH) agonist or antagonist is=
 now
commonly used in order to suppress the endogenous LH surge and to control t=
onic
levels of LH. In a commonly used protocol, follitropin alfa is started
approximately 2&nbsp;weeks after the start of agonist treatment, both being
continued until adequate follicular development is achieved. For example,
following two&nbsp;weeks of treatment with an agonist, 150&#8209;225&nbsp;IU
follitropin alfa are administered for the first 7&nbsp;days. The dose is th=
en
adjusted according to the ovarian response.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Overall
experience with IVF indicates that in general the treatment success rate
remains stable during the first four attempts and gradually declines
thereafter.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><i><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:ye=
s'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><i><u><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:ye=
s'>Women
with anovulation resulting from severe LH and FSH deficiency<o:p></o:p></sp=
an></u></i></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>In LH and =
FSH
deficient women (hypogonadotropic hypogonadism), the objective of follitrop=
in
alfa therapy in association with lutropin alfa is to develop a single mature
Graafian follicle from which the oocyte will be liberated after the
administration of hCG. Follitropin alfa should be given as a course of daily
injections simultaneously with lutropin alfa. Since these patients are
amenorrhoeic and have low endogenous oestrogen secretion, treatment can
commence at any time.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>A recommen=
ded
regimen commences at 75&nbsp;IU of lutropin alfa daily with 75&#8209;150&nb=
sp;IU
FSH. Treatment should be tailored to the individual patients response as
assessed by measuring follicle size by ultrasound and oestrogen response.<o=
:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>If an FSH =
dose
increase is deemed appropriate, dose adaptation should preferably be after =
7&#8209;14&nbsp;day
intervals and preferably by 37.5&#8209;75&nbsp;IU increments. It may be
acceptable to extend the duration of stimulation in any one cycle to up to
5&nbsp;weeks.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>When an op=
timal
response is obtained, a single injection of 250&nbsp;micrograms r&#8209;hCG=
 or
5,000&nbsp;IU up to 10,000&nbsp;IU hCG should be administered 24&#8209;48&n=
bsp;hours
after the last follitropin alfa and lutropin alfa injections. The patient is
recommended to have coitus on the day of, and on the day following, hCG
administration. Alternatively, IUI may be performed.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Luteal pha=
se
support may be considered since lack of substances with luteotropic activity
(LH/hCG) after ovulation may lead to premature failure of the corpus luteum=
.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>If an exce=
ssive
response is obtained, treatment should be stopped and hCG withheld. Treatme=
nt
should recommence in the next cycle at a dose of FSH lower than that of the
previous cycle.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><i><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:ye=
s'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><i><u><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:ye=
s'>Men
with hypogonadotropic hypogonadism<o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Follitropi=
n alfa
should be given at a dose of 150&nbsp;IU three times a week, concomitantly =
with
hCG, for a minimum of 4&nbsp;months. If after this period, the patient has =
not
responded, the combination treatment may be continued; current clinical
experience indicates that treatment for at least 18&nbsp;months may be
necessary to achieve spermatogenesis.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid;mso-outline-level:1;
tab-stops:.5in'><i style=3D'mso-bidi-font-style:normal'><u><span lang=3DEN-=
GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Special
population<o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid;mso-outline-level:1;
tab-stops:.5in'><i><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid;mso-outline-level:1;
tab-stops:.5in'><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-bidi-font-style:italic;mso-no-proof:yes'>Elderly population=
<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>There is no
relevant use of follitropin alfa in the elderly population. Safety and
effectiveness of follitropin alfa in elderly patients have not been
established.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><i><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:ye=
s'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-bidi-font-s=
tyle:
italic;mso-no-proof:yes'>Renal or hepatic impairment<o:p></o:p></span></u><=
/p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Safety, ef=
ficacy
and pharmacokinetics of follitropin alfa in patients with renal or hepatic
impairment have not been established.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;mso-outline-level:1;tab-stops:.5in'><u><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Paediatric
population<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;mso-outline-level:1;tab-stops:.5in'><span lang=3DEN-=
GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>There is n=
o relevant
use of follitropin alfa in the paediatric population.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><i
style=3D'mso-bidi-font-style:normal'><u><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
11.0pt;color:black;mso-no-proof:yes'>Method of administration<o:p></o:p></s=
pan></u></i></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Ovaleap is
intended for subcutaneous use. The first injection should be performed under
direct medical supervision. Self-administration should only be performed by=
 patients
who are well motivated, adequately trained and have access to expert advice=
.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>As the mul=
tidose
cartridge is intended for several injections, clear instructions should be
provided to the patients to avoid misuse of the medicine.<o:p></o:p></span>=
</p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>The Ovaleap cartridge is designed for =
use
in conjunction with the Ovaleap Pen only, which is separately available. For
instructions on the administration with the<a name=3D"OLE_LINK3"> Ovaleap P=
en</a>,
see section 6.6.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>4.3<span style=3D'mso-tab-count:1'> </span>Con=
traindications</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;tab-=
stops:
.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso=
-no-proof:
yes'><span style=3D'mso-tab-count:1'> </span>Hypersensitivity to the
active substance follitropin alfa, FSH or to any of the excipients</span><s=
pan
lang=3DEN-GB> </span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-no-proof:yes'>listed in section 6.1;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;tab-=
stops:
.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso=
-no-proof:
yes'><span style=3D'mso-tab-count:1'> </span>tumours of the hypotha=
lamus
or pituitary gland;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;tab-=
stops:
.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso=
-no-proof:
yes'><span style=3D'mso-tab-count:1'> </span>ovarian enlargement or
ovarian cyst not due to polycystic ovarian syndrome;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;tab-=
stops:
.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso=
-no-proof:
yes'><span style=3D'mso-tab-count:1'> </span>gynaecological haemorr=
hages
of unknown aetiology;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;tab-=
stops:
.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso=
-no-proof:
yes'><span style=3D'mso-tab-count:1'> </span>ovarian, uterine or ma=
mmary
carcinoma.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;tab-=
stops:
.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;tab-=
stops:
.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso=
-no-proof:
yes'>Ovaleap must not be used when an effective response cannot be obtained,
such as:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;tab-=
stops:
.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso=
-no-proof:
yes'><span style=3D'mso-tab-count:1'> </span>primary ovarian failur=
e;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;tab-=
stops:
.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso=
-no-proof:
yes'><span style=3D'mso-tab-count:1'> </span>malformations of sexual
organs incompatible with pregnancy;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;tab-=
stops:
.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso=
-no-proof:
yes'><span style=3D'mso-tab-count:1'> </span>fibroid tumours of the
uterus incompatible with pregnancy;<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;tab-=
stops:
.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso=
-no-proof:
yes'><span style=3D'mso-tab-count:1'> </span>primary testicular
insufficiency.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>4.4<span style=3D'mso-tab-count:1'> </span>Spe=
cial
warnings and precautions for use<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><u><span lang=
=3DEN-GB>Traceability<o:p></o:p></span></u></i></p>

<p class=3DMsoNormal><span lang=3DEN-GB>In order to improve the traceabilit=
y of
biological medicinal products, the trade name and batch number of the
administered medicinal product should be clearly recorded in the patient fi=
le.</span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i style=3D'mso-bidi-font-sty=
le:normal'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:ye=
s'>General<o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Follitropin alfa is a potent gonadotro=
pic
substance capable of causing mild to severe adverse reactions and should on=
ly
be used by physicians who are thoroughly familiar with infertility problems=
 and
their management.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Gonadotropin therapy requires a certain
time commitment by physicians and supportive health professionals, as well =
as
the availability of appropriate monitoring facilities. In women, safe and
effective use of follitropin alfa calls for monitoring of ovarian response =
with
ultrasound, alone or preferably in combination with measurement of serum
oestradiol levels, on a regular basis. There may be a degree of interpatient
variability in response to FSH administration, with a poor response to FSH =
in
some patients and exaggerated response in others. The lowest effective dose=
 in
relation to the treatment objective should be used in both men and women.<o=
:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid;tab-stops:.5in'><i
style=3D'mso-bidi-font-style:normal'><u><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
11.0pt;color:black;mso-no-proof:yes'>Porphyria<o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid;tab-stops:.5in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:ye=
s'>Patients
with porphyria or a family history of porphyria should be closely monitored
during treatment with follitropin alfa. Deterioration or a first appearance=
 of
this condition may require cessation of treatment.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><u><span lang=3DEN-GB style=
=3D'mso-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p><span style=3D'text-decoration:no=
ne'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i style=3D'mso-bidi-font-sty=
le:normal'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:ye=
s'>Treatment
in women<o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Before starting treatment, the couples
infertility should be assessed as appropriate and putative contraindications
for pregnancy evaluated. In particular, patients should be evaluated for
hypothyroidism, adrenocortical deficiency, hyperprolactinemia and appropria=
te
specific treatment given.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Patients undergoing stimulation of
follicular growth, whether as treatment for anovulatory infertility or ART
procedures, may experience ovarian enlargement or develop hyperstimulation.
Adherence to recommended follitropin alfa dose and regimen of administration
and careful monitoring of therapy will minimise the incidence of such event=
s.
For accurate interpretation of the indices of follicle development and
maturation, the physician should be experienced in the interpretation of the
relevant tests.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>In clinical trials, an increase of the
ovarian sensitivity to follitropin alfa was shown when administered with
lutropin alfa. If an FSH dose increase is deemed appropriate, dose adaptati=
on
should preferably be at 7&#8209;14&nbsp;day intervals and preferably with 3=
7.5&#8209;75&nbsp;IU
increments.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>No direct comparison of follitropin
alfa/LH versus human menopausal gonadotropin (hMG) has been performed.
Comparison with historical data suggests that the ovulation rate obtained w=
ith
follitropin alfa/LH is similar to that obtained with hMG.<o:p></o:p></span>=
</p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i><span lang=3DEN-GB style=
=3D'mso-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i><span lang=3DEN-GB style=
=3D'mso-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Ovarian Hyperstimulation Syndrome (OHS=
S)<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>A certain degree of ovarian enlargemen=
t is
an expected effect of controlled ovarian stimulation. It is more commonly s=
een
in women with polycystic ovarian syndrome and usually regresses without
treatment.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>In distinction to uncomplicated ovarian
enlargement, OHSS is a condition that can manifest itself with<span
style=3D'mso-spacerun:yes'> </span>increasing degrees of severity. It comp=
rises
marked ovarian enlargement, high serum sex steroids and an increase in vasc=
ular
permeability which can result in an accumulation of fluid in the peritoneal,
pleural and, rarely, in the pericardial cavities.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>The following symptomatology may be
observed in severe cases of OHSS: abdominal pain, abdominal distension, sev=
ere
ovarian enlargement, weight gain, dyspnoea, oliguria and gastrointestinal s=
ymptoms
including nausea, vomiting and diarrhoea. Clinical evaluation may reveal
hypovolaemia, haemoconcentration, electrolyte imbalances, ascites,
haemoperitoneum, pleural effusions, hydrothorax, or acute pulmonary distres=
s.
Very rarely, severe OHSS may be complicated by ovarian torsion or
thromboembolic events such as pulmonary embolism, ischaemic stroke or
myocardial infarction.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Independent risk factors for developing
OHSS include polycystic ovarian syndrome high absolute or rapidly rising se=
rum
oestradiol levels (e.g. &gt;&nbsp;900&nbsp;pg/mL or &gt;&nbsp;3,300&nbsp;pm=
ol/L
in anovulation; &gt;&nbsp;3,000&nbsp;pg/mL or &gt;&nbsp;11,000&nbsp;pmol/L =
in
ART) and large number of developing ovarian follicles (e.g.
&gt;&nbsp;3&nbsp;follicles of &#8805;&nbsp;14&nbsp;mm in diameter in
anovulation; &#8805;&nbsp;20&nbsp;follicles of &#8805;&nbsp;12&nbsp;mm in
diameter in ART).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Adherence to recommended follitropin a=
lfa
dose and regimen of administration can minimise the risk of ovarian
hyperstimulation (see sections 4.2 and 4.8). Monitoring of stimulation cycl=
es
by ultrasound scans as well as oestradiol measurements are recommended to e=
arly
identify risk factors.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>There is evidence to suggest that hCG
plays a key role in triggering OHSS and that the syndrome may be more severe
and more protracted if pregnancy occurs. Therefore, if signs of ovarian
hyperstimulation occur such as serum oestradiol level &gt;&nbsp;5,500&nbsp;=
pg/mL
or &gt;&nbsp;20,200&nbsp;pmol/L and/or &#8805;&nbsp;40&nbsp;follicles in to=
tal,
it is recommended that hCG be withheld and the patient be advised to refrain
from coitus or to use barrier contraceptive methods for at least 4&nbsp;day=
s.
OHSS may progress rapidly (within 24&nbsp;hours) or over several days to be=
come
a serious medical event. It most often occurs after hormonal treatment has =
been
discontinued and reaches its maximum at about 7 to 10&nbsp;days following
treatment. Therefore, patients should be followed for at least 2&nbsp;weeks
after hCG administration.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>In ART, aspiration of all follicles pr=
ior
to ovulation may reduce the occurrence of hyperstimulation.<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Mild or moderate OHSS usually resolves
spontaneously. If severe OHSS occurs, it is recommended that gonadotropin
treatment be stopped if still ongoing and that the patient be hospitalised =
and
appropriate therapy be started.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><i><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Multiple pregnancy<o:p></o:p></span></=
i></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt;color:black;mso-no-proof:yes'>In patients undergoing ovulation
induction, the incidence of multiple pregnancy is increased compared with
natural conception. The majority of multiple conceptions are twins. Multiple
pregnancy, especially of high order, carries an increased risk of adverse
maternal and perinatal outcomes.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>To minimise the risk of multiple
pregnancy, careful monitoring of ovarian response is recommended.<o:p></o:p=
></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>In patients undergoing ART procedures =
the
risk of multiple pregnancy is related mainly to the number of embryos repla=
ced,
their quality and the patient age.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>The patients should be advised of the
potential risk of multiple births before starting treatment.<o:p></o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i><span lang=3DEN-GB style=
=3D'mso-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i><span lang=3DEN-GB style=
=3D'mso-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Pregnancy loss<o:p></o:p></span></i></=
p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>The incidence of pregnancy loss by
miscarriage or abortion is higher in patients undergoing stimulation of
follicular growth for ovulation induction or ART than following natural
conception.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i><span lang=3DEN-GB style=
=3D'mso-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i><span lang=3DEN-GB style=
=3D'mso-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Ectopic pregnancy<o:p></o:p></span></i=
></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Women with a history of tubal disease =
are
at risk of ectopic pregnancy, whether the pregnancy is obtained by spontane=
ous
conception or with fertility treatments. The prevalence of ectopic pregnancy
after ART, was reported to be higher than in the general population.<o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i><span lang=3DEN-GB style=
=3D'mso-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i><span lang=3DEN-GB style=
=3D'mso-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Reproductive system neoplasms<o:p></o:=
p></span></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>There have been reports of ovarian and
other reproductive system neoplasms, both benign and malignant, in women who
have undergone multiple treatment regimens for infertility treatment. It is=
 not
yet established whether or not treatment with gonadotropins increases the r=
isk
of these tumours in infertile women.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i><span lang=3DEN-GB style=
=3D'mso-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i><span lang=3DEN-GB style=
=3D'mso-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Congenital malformation<o:p></o:p></sp=
an></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>The prevalence of congenital malformat=
ions
after ART may be slightly higher than after spontaneous conceptions. This is
thought to be due to differences in parental characteristics (e.g. maternal
age, sperm characteristics) and multiple pregnancies.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i><span lang=3DEN-GB style=
=3D'mso-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i><span lang=3DEN-GB style=
=3D'mso-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Thromboembolic events<o:p></o:p></span=
></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>In women with recent or ongoing
thromboembolic disease or women with generally recognised risk factors for
thromboembolic events, such as personal or family history, treatment with
gonadotropins may further increase the risk for aggravation or occurrence of
such events. In these women, the benefits of gonadotropin administration ne=
ed
to be weighed against the risks. It should be noted however that pregnancy
itself as well as OHSS also carry an increased risk of thromboembolic event=
s.<o:p></o:p></span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:EN-=
GB;
mso-fareast-language:EN-US;mso-bidi-language:AR-SA;mso-no-proof:yes'><br
clear=3Dall style=3D'mso-special-character:line-break;page-break-before:alw=
ays'>
</span>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i style=3D'mso-bidi-font-sty=
le:normal'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:ye=
s'>Treatment
in men<o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Elevated endogenous FSH levels are
indicative of primary testicular failure. Such patients are unresponsive to
follitropin alfa/hCG therapy. Follitropin alfa should not be used when an
effective response cannot be obtained.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Semen analysis is recommended 4 to
6&nbsp;months after the beginning of treatment as part of the assessment of=
 the
response.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><i style=3D'mso-bidi-font-style:norm=
al'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold;
mso-no-proof:yes'>Benzalkonium chloride content</span></u></i><i
style=3D'mso-bidi-font-style:normal'><u><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt;color:black;mso-no-proof:yes'>Ovaleap contains 0.02 mg/mL of benzalk=
onium
chloride<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><i style=3D'mso-bidi-font-style:norm=
al'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold;
mso-no-proof:yes'><o:p><span style=3D'text-decoration:none'>&nbsp;</span></=
o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><i style=3D'mso-bidi-font-style:norm=
al'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold;
mso-no-proof:yes'>Benzyl alcohol content</span></u></i><i style=3D'mso-bidi=
-font-style:
normal'><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-pro=
of:yes'><o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt;mso-no-proof:yes'>Ovaleap contains </span><span lang=3DEN-GB>10.0 mg=
 per
mL benzyl alcohol</span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><u><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
11.0pt;mso-bidi-font-weight:bold;mso-no-proof:yes'>Benzyl alcohol may cause
allergic reactions.<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB>High volumes shou=
ld be
used with caution and only if necessary, especially in subjects with liver =
or
kidney impairment as well as in pregnant women or while breast-feeding, bec=
ause
of the risk of accumulation and toxicity (metabolic acidosis).</span><u><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold;
mso-no-proof:yes'><o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><u><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
11.0pt;mso-bidi-font-weight:bold;mso-no-proof:yes'><o:p><span style=3D'text=
-decoration:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><i style=3D'mso-bidi-font-style:norm=
al'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold;
mso-no-proof:yes'>Sodium content</span></u></i><i style=3D'mso-bidi-font-st=
yle:
normal'><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:blac=
k;
mso-no-proof:yes'><o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt;color:black;mso-no-proof:yes'>Ovaleap contains less than 1&nbsp;mmol
sodium (23&nbsp;mg) per dose, that is to say essentially sodiumfree.<o:p=
></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
pagination:
widow-orphan lines-together;page-break-after:avoid;mso-outline-level:1'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>4.5<span style=3D'mso-tab-count:1'> </span>Int=
eraction
with other medicinal products and other forms of interaction</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt;color:black;mso-no-proof:yes'>Concomitant use of follitropin alfa wi=
th
other medicinal products used to stimulate ovulation (e.g. hCG, clomifene
citrate) may potentiate the follicular response, whereas concurrent use of a
GnRH agonist or antagonist to induce pituitary desensitisation may increase=
 the
dose of follitropin alfa needed to elicit an adequate ovarian response. No
other clinically significant medicinal product interaction has been reported
during follitropin alfa therapy.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'>4.6<span style=3D'mso-tab-count:1'> </span></s=
pan></b><b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Fertility, p</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>regnancy and lactation</span></b><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i style=3D'mso-bidi-font-sty=
le:normal'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-fareast-lan=
guage:
DE'>Pregnancy<o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>There is no indication for use of Oval=
eap
during pregnancy. Data on a limited number of exposed pregnancies (less than
300 pregnancy outcomes) indicate no malformative or foeto/neonatal toxicity=
 of
follitropin alfa.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>No teratogenic effect has been observe=
d in
animal studies (see section 5.3). In case of exposure during pregnancy,
clinical data are not sufficient to exclude a teratogenic effect of follitr=
opin
alfa.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i style=3D'mso-bidi-font-sty=
le:normal'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:ye=
s'>Breast&#8209;feeding<o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><u><span lang=3DEN-GB style=
=3D'mso-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p><span style=3D'text-decoration:no=
ne'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Ovaleap is not indicated during breast=
&#8209;feeding.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i style=3D'mso-bidi-font-sty=
le:normal'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:ye=
s'>Fertility<o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><u><span lang=3DEN-GB style=
=3D'mso-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p><span style=3D'text-decoration:no=
ne'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Ovaleap is indicated for use in
infertility (see section 4.1).<o:p></o:p></span></p>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></i></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'>4.7<span style=3D'mso-tab-count:1'> </span>Eff=
ects
on ability to drive and use machines</span></b><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'>Ovaleap has no or negligible influence on the ability to
drive and use machines.<o:p></o:p></span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-farea=
st-language:
EN-US;mso-bidi-language:AR-SA;mso-no-proof:yes'><br clear=3Dall style=3D'ms=
o-special-character:
line-break;page-break-before:always'>
</span>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>4.8<span
style=3D'mso-tab-count:1'> </span>Undesirable effects<o:p></o:p></span>=
</b></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i style=3D'mso-bidi-font-sty=
le:normal'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:ye=
s'>Summary
of the safety profile<o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>The most commonly reported adverse rea=
ctions
are headache, ovarian cysts and local injection site reactions (e.g. pain,
erythema, haematoma, swelling and/or irritation at the site of injection).<=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Mild or moderate OHSS has been commonly
reported and should be considered as an intrinsic risk of the stimulation
procedure. Severe OHSS is uncommon (see section 4.4).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Thromboembolism may occur very rarely =
(see
section 4.4).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><i style=3D'mso-bidi-font-sty=
le:normal'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:ye=
s'>Tabulated
list of adverse reactions<o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'margin-left:85.05pt;text-indent:-85.05pt;tab-=
stops:
.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>The adverse re=
actions
are ranked under heading of frequency using the following convention: very<=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:85.05pt;text-indent:-85.05pt;tab-=
stops:
.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>common (&#8805=
;1/10),
common (&#8805;1/100 to &lt;1/10), uncommon (&#8805;1/1,000 to &lt;1/100), =
rare
(&#8805;1/10,000 to<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:85.05pt;text-indent:-85.05pt;tab-=
stops:
.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>&lt;1/1,000), =
very
rare (&lt;1/10,000) and not known (cannot be estimated from the available
data). Within<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:85.05pt;text-indent:-85.05pt;tab-=
stops:
.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>each frequency
grouping, adverse reactions are presented in order of decreasing seriousnes=
s.<span
style=3D'color:black;mso-no-proof:yes'><o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><i style=3D'mso-bidi-font-style:norm=
al'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:ye=
s'>Treatment
in women<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><i><span lang=3DEN-GB style=3D'mso-b=
idi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></i></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;border:none;mso-border-bottom-alt:solid =
windowtext .5pt;
 mso-yfti-tbllook:480;mso-padding-alt:0in 5.4pt 0in 5.4pt;mso-border-inside=
h:
 .5pt solid windowtext;mso-border-insidev:.5pt solid windowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=3D614 colspan=3D3 valign=3Dtop style=3D'width:460.6pt;border:no=
ne;
  border-bottom:solid windowtext 1.0pt;mso-border-bottom-alt:solid windowte=
xt .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB>Table 1: Adverse reactions in women<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1'>
  <td width=3D205 valign=3Dtop style=3D'width:153.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB>System organ class<o:p></o:p></span></b></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB>Frequency<o:p></o:p></span></b></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB>Adverse reaction<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2'>
  <td width=3D205 valign=3Dtop style=3D'width:153.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid;tab-stops:.5in'><i style=3D'mso-bidi-font-style:no=
rmal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Immune system disorders<=
/span><span
  lang=3DEN-GB><o:p></o:p></span></i></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-no-proof:yes'>Very rare</span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-no-proof:yes'>Mild to severe hypersensitivity reactions,
  including anaphylactic reactions and shock</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3'>
  <td width=3D205 valign=3Dtop style=3D'width:153.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid;tab-stops:.5in'><i style=3D'mso-bidi-font-style:no=
rmal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Nervous system disorders=
<o:p></o:p></span></i></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-no-proof:yes'>Very common</span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid;tab-stops:28.35pt center 71.35pt'><span lang=3DEN-=
GB
  style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Headache=
</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4'>
  <td width=3D205 valign=3Dtop style=3D'width:153.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid;tab-stops:.5in'><i><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
  11.0pt;color:black;mso-no-proof:yes'>Vascular disorders</span></i><i
  style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
  11.0pt'><o:p></o:p></span></i></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-no-proof:yes'>Very rare</span><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid;tab-stops:28.35pt center 71.35pt'><span lang=3DEN-=
GB
  style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Thromboe=
mbolism
  (both in association with and separate from OHSS)</span><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5'>
  <td width=3D205 valign=3Dtop style=3D'width:153.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid;tab-stops:.5in'><i><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
  11.0pt;color:black;mso-no-proof:yes'>Respiratory, thoracic and mediastinal
  disorders</span></i><i style=3D'mso-bidi-font-style:normal'><span lang=3D=
EN-GB
  style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></i></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-no-proof:yes'>Very rare</span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-no-proof:yes'>Exacerbation or aggravation of asthma</span=
></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:6'>
  <td width=3D205 valign=3Dtop style=3D'width:153.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><i><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt;
  color:black;mso-no-proof:yes'>Gastrointestinal disorders</span></i><i
  style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
  11.0pt'><o:p></o:p></span></i></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-no-proof:yes'>Common:</span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-no-proof:yes'>Abdominal pain, abdominal distension, abdom=
inal
  discomfort, nausea, vomiting, diarrhoea</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:7'>
  <td width=3D205 rowspan=3D4 valign=3Dtop style=3D'width:153.5pt;border:so=
lid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><i><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt;
  color:black;mso-no-proof:yes'>Reproductive system and breast disorders<o:=
p></o:p></span></i></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-no-proof:yes'>Very common</span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-no-proof:yes'>Ovarian cysts</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:8'>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB>Common</span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-no-proof:yes'>Mild or moderate OHSS (including associated
  symptomatology)</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:9'>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB>Uncommon</span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-no-proof:yes'>Severe OHSS (including associated
  symptomatology) (see section 4.4)</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:10'>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-no-proof:yes'>Rare</span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-no-proof:yes'>Complication of severe OHSS</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:11;mso-yfti-lastrow:yes'>
  <td width=3D205 valign=3Dtop style=3D'width:153.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><i style=3D'mso-bidi-font-style:normal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>General disorders and
  administration site conditions</span><span lang=3DEN-GB><o:p></o:p></span=
></i></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-no-proof:yes'>Very common</span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-no-proof:yes'>Injection site reactions (e.g. pain, erythe=
ma,
  haematoma, swelling and/or irritation at the site of injection)</span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'margin-left:85.05pt;text-indent:-85.05pt;tab-=
stops:
.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";color:black;mso-ansi-language:EN-=
GB;
mso-fareast-language:EN-US;mso-bidi-language:AR-SA;mso-no-proof:yes'><br
clear=3Dall style=3D'mso-special-character:line-break;page-break-before:alw=
ays'>
</span>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:85.05pt;text-indent:-85.05pt;tab-=
stops:
.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:85.05pt;text-indent:-85.05pt;tab-=
stops:
.5in'><i style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Treatment in men<o:p></o:p></span></i>=
</p>

<p class=3DMsoNormal style=3D'margin-left:85.05pt;text-indent:-85.05pt;tab-=
stops:
.5in'><i><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></i></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;border:none;mso-border-bottom-alt:solid =
windowtext .5pt;
 mso-yfti-tbllook:480;mso-padding-alt:0in 5.4pt 0in 5.4pt;mso-border-inside=
h:
 .5pt solid windowtext;mso-border-insidev:.5pt solid windowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=3D614 colspan=3D3 valign=3Dtop style=3D'width:460.6pt;border:no=
ne;
  border-bottom:solid windowtext 1.0pt;mso-border-bottom-alt:solid windowte=
xt .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB>Table 2: Adverse reactions in men<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1'>
  <td width=3D205 valign=3Dtop style=3D'width:153.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB>System organ class<o:p></o:p></span></b></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB>Frequency<o:p></o:p></span></b></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB>Adverse reaction<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2'>
  <td width=3D205 valign=3Dtop style=3D'width:153.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid;tab-stops:.5in'><i style=3D'mso-bidi-font-style:no=
rmal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Immune system disorders<=
/span><span
  lang=3DEN-GB><o:p></o:p></span></i></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-no-proof:yes'>Very rare</span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-no-proof:yes'>Mild to severe hypersensitivity reactions,
  including anaphylactic reactions and shock</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3'>
  <td width=3D205 valign=3Dtop style=3D'width:153.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid;tab-stops:.5in'><i><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
  11.0pt;color:black;mso-no-proof:yes'>Respiratory, thoracic and mediastinal
  disorders</span></i><i style=3D'mso-bidi-font-style:normal'><span lang=3D=
EN-GB
  style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></i></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-no-proof:yes'>Very rare</span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-no-proof:yes'>Exacerbation or aggravation of asthma</span=
></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4'>
  <td width=3D205 valign=3Dtop style=3D'width:153.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><i><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt;
  color:black;mso-no-proof:yes'>Skin and subcutaneous tissue disorders</spa=
n></i><i
  style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
  11.0pt'><o:p></o:p></span></i></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-no-proof:yes'>Common:</span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-no-proof:yes'>Acne</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5'>
  <td width=3D205 valign=3Dtop style=3D'width:153.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><i><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt;
  color:black;mso-no-proof:yes'>Reproductive system and breast disorders<o:=
p></o:p></span></i></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-no-proof:yes'>Common<o:p></o:p></span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-no-proof:yes'>Gynaecomastia, varicocele<o:p></o:p></span>=
</p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:6'>
  <td width=3D205 valign=3Dtop style=3D'width:153.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><i style=3D'mso-bidi-font-style:normal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>General disorders and
  administration site conditions</span><span lang=3DEN-GB><o:p></o:p></span=
></i></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-no-proof:yes'>Very common</span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-no-proof:yes'>Injection site reactions (e.g. pain, erythe=
ma,
  haematoma, swelling and/or irritation at the site of injection)</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:7;mso-yfti-lastrow:yes'>
  <td width=3D205 valign=3Dtop style=3D'width:153.5pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><i><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt;
  color:black;mso-no-proof:yes'>Investigations</span></i><i style=3D'mso-bi=
di-font-style:
  normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p=
></span></i></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-no-proof:yes'>Common<o:p></o:p></span></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.55pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11=
.0pt;
  color:black;mso-no-proof:yes'>Weight gain<o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-bidi-font-style:italic;mso-no-proof:yes'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><u><span lang=3DEN-GB style=
=3D'mso-bidi-font-size:
11.0pt;mso-no-proof:yes'>Reporting of suspected adverse reactions<o:p></o:p=
></span></u></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;mso-no-proof:yes'>Reporting suspected adverse reactions after
authorisation of the medicinal product is important. It allows continued
monitoring of the benefit/risk balance of the medicinal product. Healthcare
professionals are asked to report any suspected adverse reactions via <span
style=3D'background:lightgrey;mso-highlight:lightgrey'>the national reporti=
ng
system listed in </span></span><span lang=3DEN-GB><a
href=3D"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_fo=
rm/2013/03/WC500139752.doc"><span
style=3D'mso-bidi-font-size:11.0pt;mso-fareast-font-family:Verdana;backgrou=
nd:
lightgrey;mso-highlight:lightgrey'>Appendix V</span></a></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>.<o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'>4.9<span style=3D'mso-tab-count:1'> </span>Ove=
rdose</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>The effects of an overdose of follitro=
pin
alfa are unknown, nevertheless, there is a possibility that OHSS may occur =
(see
section 4.4).<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
pagination:
widow-orphan lines-together;page-break-after:avoid'><b style=3D'mso-bidi-fo=
nt-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>5.<span
style=3D'mso-tab-count:1'> </span>PHARMACOLOGICAL PROPERTIES</span></=
b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
pagination:
widow-orphan lines-together;page-break-after:avoid;mso-outline-level:1'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>5.1 <span style=3D'mso-tab-count:1'> </span>Pha=
rmacodynamic
properties</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic;mso-no-proof:=
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Pharmacotherapeutic group: Sex hormones
and modulators of the genital systems, gonadotropins, ATC code: G03GA05.<o:=
p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Ovaleap</span><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black'> is a biosimilar medicinal
product. Detailed information is available on the website of the European
Medicines Agency </span><span lang=3DEN-GB><a href=3D"http://www.ema.europa=
.eu"><span
style=3D'color:black;text-decoration:none;text-underline:none'>http://www.e=
ma.europa.eu</span></a><span
style=3D'color:black'>.</span></span><span lang=3DEN-GB style=3D'mso-bidi-f=
ont-size:
11.0pt;color:black;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><i style=3D'mso-bidi-font-s=
tyle:
normal'><u><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:blac=
k;
mso-no-proof:yes'>Pharmacodynamic effects<o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>In women, =
the
most important effect resulting from parenteral administration of FSH is the
development of mature Graafian follicles. In women with anovulation, the ob=
ject
of follitropin alfa<span style=3D'background:yellow;mso-highlight:yellow'> =
</span>therapy
is to develop a single mature Graafian follicle from which the ovum will be=
 liberated
after the administration of hCG.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><i><u><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:ye=
s'>Clinical
efficacy and safety in women<o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>In clinical
trials, patients with severe FSH and LH deficiency were defined by an
endogenous serum LH level &lt;&nbsp;1.2&nbsp;IU/L as measured in a central
laboratory. However, it should be taken into account that there are variati=
ons
between LH measurements performed in different laboratories.<o:p></o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>In clinical
studies comparing r-hFSH (follitropin alfa) and urinary FSH in ART (see tab=
le 3
below) and in ovulation induction, follitropin alfa was more potent than
urinary FSH in terms of a lower total dose and a shorter treatment period
needed to trigger follicular maturation.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>In ART,
follitropin alfa at a lower total dose and shorter treatment period than
urinary FSH, resulted in a higher number of oocytes retrieved when compared=
 to
urinary FSH.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Table 3: R=
esults
of study GF 8407 (randomised parallel group study comparing efficacy and sa=
fety
of follitropin alfa with urinary FSH in ART)<o:p></o:p></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D536
 style=3D'width:402.3pt;margin-left:5.4pt;border-collapse:collapse;border:n=
one;
 mso-border-alt:solid windowtext .5pt;mso-yfti-tbllook:480;mso-padding-alt:
 0in 5.4pt 0in 5.4pt;mso-border-insideh:.5pt solid windowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=3D243 valign=3Dtop style=3D'width:182.6pt;border:solid windowte=
xt 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid;mso-outline-level:1;tab-stops:.5in'><span lang=3DE=
N-GB
  style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nb=
sp;</o:p></span></p>
  </td>
  <td width=3D142 valign=3Dtop style=3D'width:106.3pt;border:solid windowte=
xt 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-pagina=
tion:widow-orphan lines-together;
  page-break-after:avoid;tab-stops:.5in;mso-layout-grid-align:none;text-aut=
ospace:
  none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;
  mso-fareast-language:DE;mso-bidi-font-weight:bold'>follitropin alfa<o:p><=
/o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-pagina=
tion:widow-orphan lines-together;
  page-break-after:avoid;mso-outline-level:1;tab-stops:.5in'><span lang=3DE=
N-GB
  style=3D'mso-bidi-font-size:11.0pt;color:black;mso-fareast-language:DE;
  mso-bidi-font-weight:bold'>(n =3D 130)</span><span lang=3DEN-GB style=3D'=
mso-bidi-font-size:
  11.0pt;color:black;mso-no-proof:yes'><o:p></o:p></span></p>
  </td>
  <td width=3D151 valign=3Dtop style=3D'width:113.4pt;border:solid windowte=
xt 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-pagina=
tion:widow-orphan lines-together;
  page-break-after:avoid;tab-stops:.5in;mso-layout-grid-align:none;text-aut=
ospace:
  none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;
  mso-fareast-language:DE;mso-bidi-font-weight:bold'>urinary FSH<o:p></o:p>=
</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-pagina=
tion:widow-orphan lines-together;
  page-break-after:avoid;mso-outline-level:1;tab-stops:.5in'><span lang=3DE=
N-GB
  style=3D'mso-bidi-font-size:11.0pt;color:black;mso-fareast-language:DE;
  mso-bidi-font-weight:bold'>(n =3D 116)</span><span lang=3DEN-GB style=3D'=
mso-bidi-font-size:
  11.0pt;color:black;mso-no-proof:yes'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1'>
  <td width=3D243 valign=3Dtop style=3D'width:182.6pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid;mso-outline-level:1;tab-stops:.5in'><span lang=3DE=
N-GB
  style=3D'mso-bidi-font-size:11.0pt;color:black;mso-fareast-language:DE'>N=
umber
  of oocytes retrieved</span><span lang=3DEN-GB style=3D'mso-bidi-font-size=
:11.0pt;
  color:black;mso-no-proof:yes'><o:p></o:p></span></p>
  </td>
  <td width=3D142 valign=3Dtop style=3D'width:106.3pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-pagina=
tion:widow-orphan lines-together;
  page-break-after:avoid;mso-outline-level:1;tab-stops:.5in'><span lang=3DE=
N-GB
  style=3D'mso-bidi-font-size:11.0pt;color:black;mso-fareast-language:DE'>1=
1.0 
  5.9</span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:bla=
ck;
  mso-no-proof:yes'><o:p></o:p></span></p>
  </td>
  <td width=3D151 valign=3Dtop style=3D'width:113.4pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-pagina=
tion:widow-orphan lines-together;
  page-break-after:avoid;mso-outline-level:1;tab-stops:.5in'><span lang=3DE=
N-GB
  style=3D'mso-bidi-font-size:11.0pt;color:black;mso-fareast-language:DE'>8=
.8 
  4.8</span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:bla=
ck;
  mso-no-proof:yes'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2'>
  <td width=3D243 valign=3Dtop style=3D'width:182.6pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid;mso-outline-level:1;tab-stops:.5in'><span lang=3DE=
N-GB
  style=3D'mso-bidi-font-size:11.0pt;color:black;mso-fareast-language:DE'>D=
ays of
  FSH stimulation required</span><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:
  11.0pt;color:black;mso-no-proof:yes'><o:p></o:p></span></p>
  </td>
  <td width=3D142 valign=3Dtop style=3D'width:106.3pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-pagina=
tion:widow-orphan lines-together;
  page-break-after:avoid;mso-outline-level:1;tab-stops:.5in'><span lang=3DE=
N-GB
  style=3D'mso-bidi-font-size:11.0pt;color:black;mso-fareast-language:DE'>1=
1.7 
  1.9</span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:bla=
ck;
  mso-no-proof:yes'><o:p></o:p></span></p>
  </td>
  <td width=3D151 valign=3Dtop style=3D'width:113.4pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-pagina=
tion:widow-orphan lines-together;
  page-break-after:avoid;mso-outline-level:1;tab-stops:.5in'><span lang=3DE=
N-GB
  style=3D'mso-bidi-font-size:11.0pt;color:black;mso-fareast-language:DE'>1=
4.5 
  3.3</span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:bla=
ck;
  mso-no-proof:yes'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3'>
  <td width=3D243 valign=3Dtop style=3D'width:182.6pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid;mso-outline-level:1;tab-stops:.5in'><span lang=3DE=
N-GB
  style=3D'mso-bidi-font-size:11.0pt;color:black;mso-fareast-language:DE'>T=
otal
  dose of FSH required (number of FSH 75&nbsp;IU ampoules)</span><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:=
yes'><o:p></o:p></span></p>
  </td>
  <td width=3D142 valign=3Dtop style=3D'width:106.3pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-pagina=
tion:widow-orphan lines-together;
  page-break-after:avoid;mso-outline-level:1;tab-stops:.5in'><span lang=3DE=
N-GB
  style=3D'mso-bidi-font-size:11.0pt;color:black;mso-fareast-language:DE'>2=
7.6 
  10.2</span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:bl=
ack;
  mso-no-proof:yes'><o:p></o:p></span></p>
  </td>
  <td width=3D151 valign=3Dtop style=3D'width:113.4pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-pagina=
tion:widow-orphan lines-together;
  page-break-after:avoid;mso-outline-level:1;tab-stops:.5in'><span lang=3DE=
N-GB
  style=3D'mso-bidi-font-size:11.0pt;color:black;mso-fareast-language:DE'>4=
0.7 
  13.6</span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:bl=
ack;
  mso-no-proof:yes'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;mso-yfti-lastrow:yes'>
  <td width=3D243 valign=3Dtop style=3D'width:182.6pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid;mso-outline-level:1;tab-stops:.5in'><span lang=3DE=
N-GB
  style=3D'mso-bidi-font-size:11.0pt;color:black;mso-fareast-language:DE'>N=
eed to
  increase the dose (%)</span><span lang=3DEN-GB style=3D'mso-bidi-font-siz=
e:11.0pt;
  color:black;mso-no-proof:yes'><o:p></o:p></span></p>
  </td>
  <td width=3D142 valign=3Dtop style=3D'width:106.3pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-pagina=
tion:widow-orphan lines-together;
  page-break-after:avoid;mso-outline-level:1;tab-stops:.5in'><span lang=3DE=
N-GB
  style=3D'mso-bidi-font-size:11.0pt;color:black;mso-fareast-language:DE'>5=
6.2</span><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:=
yes'><o:p></o:p></span></p>
  </td>
  <td width=3D151 valign=3Dtop style=3D'width:113.4pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-pagina=
tion:widow-orphan lines-together;
  page-break-after:avoid;mso-outline-level:1;tab-stops:.5in'><span lang=3DE=
N-GB
  style=3D'mso-bidi-font-size:11.0pt;color:black;mso-fareast-language:DE'>8=
5.3</span><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:=
yes'><o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-fareast-language:DE'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-fareast-language:DE'>Dif=
ferences
between the 2 groups were statistically significant (p&nbsp;&lt;&nbsp;0.05)=
 for
all criteria listed.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-fareast-language:DE'><o:=
p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><i><u><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:ye=
s'>Clinical
efficacy and safety in men<o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>In men def=
icient
in FSH, follitropin alfa administered concomitantly with hCG for at least
4&nbsp;months induces spermatogenesis.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic;mso-no-proof:=
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
pagination:
widow-orphan lines-together;page-break-after:avoid;mso-outline-level:1'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>5.2<span style=3D'mso-tab-count:1'> </span>Pha=
rmacokinetic
properties<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-bidi-font-style:italic;mso-no-proof:yes'><o:p>&nbsp;</o:p></span=
></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;color:black;mso-fareast-language:DE'>Following intravenous
administration, follitropin alfa is distributed to the extracellular fluid
space with </span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;col=
or:black;
mso-bidi-font-style:italic;mso-no-proof:yes'>an initial half-life of around
2&nbsp;hours and eliminated from the body with a terminal half-life of about
one day. The steady state volume of distribution and total clearance are
10&nbsp;L and 0.6&nbsp;L/h, respectively. One&#8209;eighth of the follitrop=
in
alfa dose is excreted in the urine.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-bidi-font-style:italic;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-bidi-font-style:italic;
mso-no-proof:yes'>Following subcutaneous administration, the absolute
bioavailability is about 70&nbsp;%. Following repeated administration,
follitropin alfa accumulates 3&#8209;fold achieving a steady-state within 3=
&#8209;4&nbsp;days.
In women whose endogenous gonadotropin secretion is suppressed, follitropin
alfa has nevertheless been shown to effectively stimulate follicular
development and steroidogenesis, despite unmeasurable LH levels. <o:p></o:p=
></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic;mso-no-proof:=
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
pagination:
widow-orphan lines-together;page-break-after:avoid;mso-outline-level:1'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>5.3<span style=3D'mso-tab-count:1'> </span>Pre=
clinical
safety data</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt;color:black;mso-no-proof:yes'>Non-clinical data reveal no special ha=
zard
for humans based on conventional studies of single and repeated dose toxici=
ty
and genotoxicity additional to that already stated in other sections of thi=
s SmPC.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Impaired fertility has been reported in
rats exposed to pharmacological doses of follitropin alfa
(&#8805;&nbsp;40&nbsp;IU/kg/day) for extended periods, through reduced
fecundity.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Given in high doses
(&#8805;&nbsp;5&nbsp;IU/kg/day) follitropin alfa caused a decrease in the
number of viable foetuses without being a teratogen and dystocia similar to
that observed with urinary Menopausal Gonadotropin (hMG). However, since Ov=
aleap
is not indicated in pregnancy, these data are of limited clinical relevance=
.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
pagination:
widow-orphan lines-together;page-break-after:avoid'><b style=3D'mso-bidi-fo=
nt-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>6.<span
style=3D'mso-tab-count:1'> </span>PHARMACEUTICAL PARTICULARS<o:p></o:=
p></span></b></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
pagination:
widow-orphan lines-together;page-break-after:avoid;mso-outline-level:1'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>6.1<span style=3D'mso-tab-count:1'> </span>Lis=
t of
excipients</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'c=
olor:black'>Sodium
dihydrogen phosphate dihydrate</span><span lang=3DEN-GB style=3D'mso-bidi-f=
ont-size:
11.0pt;color:black;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'c=
olor:black'>Sodium
hydroxide (2&nbsp;M) (for pH adjustment)<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Mannitol<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Methionine<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Polysorbate 20<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Benzyl alcohol<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Benzalkonium chloride<o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'c=
olor:black'>Water
for injections</span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'>6.2<span style=3D'mso-tab-count:1'> </span>Inc=
ompatibilities</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>In the absence of compatibility studie=
s,
this medicinal product must not be mixed with other medicinal products.<o:p=
></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'>6.3<span style=3D'mso-tab-count:1'> </span>She=
lf
life</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no=
-proof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:red;mso-no-proof:yes'>3</span><span lang=3DEN-GB style=3D'mso-=
bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'> years.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><u><span lang=3DEN-GB style=
=3D'mso-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Shelf life</span></u><u><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'> and storage condition=
s after
first opening<span style=3D'color:black'><o:p></o:p></span></span></u></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>The cartridge in&#8209;use in the pen =
may
be stored for a maximum of 28&nbsp;days. Do not store above 25&nbsp;C. The
patient should write down in the patient diary provided with the Ovaleap Pen
the date of first use.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>The pen cap must be put back on the pen
after each injection in order to protect from light.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'>6.4<span style=3D'mso-tab-count:1'> </span>Spe=
cial precautions
for storage<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>=
<o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Store in a refrigerator (2&nbsp;C&nbs=
p;&#8209;&nbsp;8&nbsp;C).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Do not freeze.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Keep the cartridge in the outer carton=
 in
order to protect from light.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Before opening and within its shelf li=
fe,
the medicinal product may be removed from the refrigerator, without being
refrigerated again, for up to 3&nbsp;months. Do not store above 25&nbsp;C.=
 The
medicinal product must be discarded if it has not been used after
3&nbsp;months.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'>For storage conditions after first opening of the medicin=
al
product, see section 6.3.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>6.5<span
style=3D'mso-tab-count:1'> </span>Nature and contents of container<o:p>=
</o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Ovaleap
300&nbsp;IU/0.5&nbsp;mL solution for injection<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-layout-grid-align:none;text-autospace:non=
e'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:ye=
s'>Cartridge
(type I glass) with a rubber piston (bromobutyl rubber) and a crimp&#8209;c=
ap
(aluminium) with a septum (bromobutyl rubber), containing 0.5&nbsp;mL of
solution.<br>
Injection needles (stainless steel; 0.33&nbsp;mm&nbsp;x&nbsp;12&nbsp;mm,
29&nbsp;G&nbsp;x&nbsp;&quot;)<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;background:lightgrey;mso-hig=
hlight:
lightgrey;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Pack size of 1&nbsp;cartridge and 10&n=
bsp;injection
needles.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;background:lightgrey;mso-hig=
hlight:
lightgrey;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'>Not all pack sizes may be marketed.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Ovaleap
450&nbsp;IU/0.75&nbsp;mL solution for injection<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-layout-grid-align:none;text-autospace:non=
e'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:ye=
s'>Cartridge
(type I glass) with a rubber piston (bromobutyl rubber) and a crimp&#8209;c=
ap
(aluminium) with a septum (bromobutyl rubber), containing 0.75&nbsp;mL of
solution..<br>
Injection needles (stainless steel; 0.33&nbsp;mm&nbsp;x&nbsp;12&nbsp;mm,
29&nbsp;G&nbsp;x&nbsp;&quot;)<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Pack size of 1&nbsp;cartridge and
10&nbsp;injection needles.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;background:lightgrey;mso-hig=
hlight:
lightgrey;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'>Not all pack sizes may be marketed.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Ovaleap
900&nbsp;IU/1.5&nbsp;mL solution for injection<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-layout-grid-align:none;text-autospace:non=
e'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:ye=
s'>Cartridge
(type I glass) with a rubber piston (bromobutyl rubber) and a crimp&#8209;c=
ap
(aluminium) with a septum (bromobutyl rubber), containing 1.5&nbsp;mL of
solution..<br>
Injection needles (stainless steel; 0.33&nbsp;mm&nbsp;x&nbsp;12&nbsp;mm,
29&nbsp;G&nbsp;x&nbsp;&quot;)<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Pack size of 1&nbsp;cartridge and
20&nbsp;injection needles.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'>Not all pack sizes may be marketed.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1'><a name=3D"OLE_LINK1"><b style=3D'mso-bidi-font-weight:normal'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>6.6<span style=3D'mso-=
tab-count:
1'> </span>Special precautions for disposal and other handling</span></=
b></a><span
style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:11.0pt;
mso-no-proof:yes'><o:p></o:p></span></span></p>

<span style=3D'mso-bookmark:OLE_LINK1'></span>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;mso-no-proof:yes'>No special requirements for disposal.<span
style=3D'color:black'><o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>The solution must not be used if it co=
ntains
particles or if the solution is not clear.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Ovaleap is designed for use in conjunc=
tion
with the Ovaleap Pen only. The instructions for use of the pen must be foll=
owed
carefully.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Each cartridge must be used by a single
patient only.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Empty cartridges must not be refilled.=
 Ovaleap
cartridges are not designed to allow any other medicinal product to be mixe=
d in
the cartridges. Discard used needles immediately after injection.<o:p></o:p=
></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>7.<span style=3D'mso-tab-count:1'> </span>MA=
RKETING
AUTHORISATION HOLDER</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Theramex Ireland Limited<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-family:
Verdana;color:black'>3<sup>rd</sup> Floor, </span><span lang=3DNL
style=3D'mso-ansi-language:NL'>Kilmore House,<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Park Lane, Spencer Dock,<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Dublin 1<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>D01 YE64<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Ireland</span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;col=
or:black;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>8.<span style=3D'mso-tab-count:1'> </span>MA=
RKETING
AUTHORISATION NUMBER(S) <o:p></o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Ovaleap
300&nbsp;IU/0.5&nbsp;mL solution for injection<o:p></o:p></span></u></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'>EU/1/13/871/001<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Ovaleap
450&nbsp;IU/0.75&nbsp;mL solution for injection<o:p></o:p></span></u></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'>EU/1/13/871/002<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><u><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Ovaleap 90=
0&nbsp;IU/1.5&nbsp;mL
solution for injection<o:p></o:p></span></u></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'>EU/1/13/871/003<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>9.<span style=3D'mso-tab-count:1'> </span>DA=
TE OF
FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION</span></b><span lang=3DEN-=
GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Date of first authorisation: 27 Septem=
ber
2013.<i style=3D'mso-bidi-font-style:normal'><o:p></o:p></i></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'>Date of latest renewal: 16 May 2018.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>10.<span style=3D'mso-tab-count:1'> </span>DAT=
E OF
REVISION OF THE TEXT<o:p></o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic;mso-no-proof:=
yes'>Detailed
information on this medicinal product </span><span lang=3DEN-GB style=3D'ms=
o-bidi-font-size:
11.0pt;mso-no-proof:yes'>is available on the website of the European Medici=
nes
Agency </span><span lang=3DEN-GB><a href=3D"http://www.ema.europa.eu"><span
style=3D'color:windowtext;text-decoration:none;text-underline:none'>http://=
www.ema.europa.eu</span></a></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>. <o:p></=
o:p></span></p>

<b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-ansi-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA;
mso-no-proof:yes'><br clear=3Dall style=3D'mso-special-character:line-break;
page-break-before:always'>
</span></b>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>ANNEX
II</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-p=
roof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:70.8pt;margin-bot=
tom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:42.45pt;margin-bo=
ttom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.4pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>A.<span style=3D'mso-tab-count:1'> </span>M=
ANUFACTURER
OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURERS RESPONSIBLE FOR BATCH
RELEASE<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:42.45pt;margin-bo=
ttom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.4pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>B.<span style=3D'mso-tab-count:1'> </span>C=
ONDITIONS
OR RESTRICTIONS REGARDING SUPPLY AND USE<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:42.45pt;margin-bo=
ttom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.4pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>C.<span style=3D'mso-tab-count:1'> </span>O=
THER
CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION<o:p></o:p></span=
></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:77.9pt;margin-bot=
tom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.4pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:42.45pt;margin-bo=
ttom:
0in;margin-left:85.05pt;margin-bottom:.0001pt;text-indent:-35.4pt;mso-pagin=
ation:
widow-orphan no-line-numbers'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>D.<span style=3D'mso-tab-c=
ount:1'> </span><span
style=3D'text-transform:uppercase'>conditions or restrictions with regard t=
o the
safe and effective use of the medicinal product</span><span style=3D'mso-no=
-proof:
yes'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.05pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-ansi-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA;
mso-no-proof:yes'><br clear=3Dall style=3D'page-break-before:always'>
</span></b>

<p class=3DTitleB><span lang=3DEN-GB>A.<span style=3D'mso-tab-count:1'>=
 </span>MANUFACTURER
OF THE BIOLOGICAL ACTIVE SUBSTANCE AND MANUFACTURERS RESPONSIBLE FOR BATCH
RELEASE</span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt;mso-outline-level:1'><u>=
<span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Name and =
address
of the manufacturer of the biological active substance<o:p></o:p></span></u=
></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt;mso-list:skip;tab-stops:=
.5in'><span
lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE;mso-bidi-=
font-weight:
bold'>Teva Biotech GmbH<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt;mso-list:skip;tab-stops:=
.5in'><span
lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE;mso-bidi-=
font-weight:
bold'>Dornierstrae 10<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt;mso-list:skip;tab-stops:=
.5in'><span
lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE;mso-bidi-=
font-weight:
bold'>D-89079 Ulm<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt;tab-stops:.5in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Germany<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt;mso-outline-level:1'><u>=
<span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Name and =
address
of the manufacturers responsible for batch release</span></u><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt;mso-list:skip;tab-stops:=
.5in'><span
lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE;mso-bidi-=
font-weight:
bold'>Teva Biotech GmbH<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt;mso-list:skip;tab-stops:=
.5in'><span
lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE;mso-bidi-=
font-weight:
bold'>Dornierstrae 10<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt;mso-list:skip;tab-stops:=
.5in'><span
lang=3DDE style=3D'mso-bidi-font-size:11.0pt;mso-ansi-language:DE;mso-bidi-=
font-weight:
bold'>D-89079 Ulm<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt;tab-stops:.5in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Germany<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Teva Pharmaceuticals E=
urope
B.V.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Swensweg 5<o:p></o:p><=
/span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>NL-2031 GA Haarlem<o:p=
></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>The Netherlands<o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Merckle GmbH<o:p></o:p=
></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Graf-Arco-Strae 3<o:p=
></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>89079 Ulm, <o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Germany<o:p></o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:-.05pt'><span lang=3DEN-GB
style=3D'mso-no-proof:yes'>The printed package leaflet of the medicinal pro=
duct
must state the name and address of the manufacturer responsible for the rel=
ease
of the concerned batch.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DTitleB><a name=3D"OLE_LINK2"><span lang=3DEN-GB>B.</span></a><sp=
an
lang=3DEN-GB><span style=3D'mso-tab-count:1'> </span>CONDITIONS OR
RESTRICTIONS REGARDING SUPPLY AND USE</span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt;mso-list:skip'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Medicinal product subj=
ect to
restricted medical prescription (see Annex I: Summary of Product
Characteristics, section 4.2).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt;mso-list:skip'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt;mso-list:skip'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DTitleB><span lang=3DEN-GB>C.<span style=3D'mso-tab-count:1'>=
 </span>OTHER
CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORISATION</span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic'>&#9679;<span
style=3D'mso-tab-count:1'> </span></span><b style=3D'mso-bidi-font-we=
ight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Periodic Saf=
ety
Update Reports</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.=
0pt;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>The requirements for
submission of periodic safety update reports for this medicinal product are=
 set
out in the list of Union reference dates (EURD list) provided for under Art=
icle
107c(7) of Directive 2001/83/EC and any subsequent updates published on the=
 European
medicines web-portal.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DTitleB><span lang=3DEN-GB>D.<span style=3D'mso-tab-count:1'>=
 </span>CONDITIONS
OR RESTRICTIONS WITH REGARD TO THE SAFE AND EFFECTIVE USE OF THE MEDICINAL
PRODUCT</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-28.4pt;margin-bo=
ttom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-pagi=
nation:
widow-orphan no-line-numbers'><b><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:
11.0pt'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.05pt;line-height:13.0pt;mso-li=
ne-height-rule:
exactly;mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic'>&#9679;<span
style=3D'mso-tab-count:1'> </span></span><b style=3D'mso-bidi-font-we=
ight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Risk Managem=
ent Plan
(RMP)<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:28.35pt;tab-stops:0in'><span lan=
g=3DEN-GB
style=3D'mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.05pt;tab-stops:0in'><span lang=
=3DEN-GB
style=3D'mso-no-proof:yes'>The MAH shall perform the required pharmacovigil=
ance
activities and interventions detailed in the agreed RMP presented in Module
1.8.2 of the Marketing Authorisation and any agreed subsequent updates of t=
he
RMP.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:28.35pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:-.05pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>An updated RMP should =
be
submitted:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.05pt;text-indent:14.2pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic'=
>&#9679;<span
style=3D'mso-tab-count:1'> </span></span><span lang=3DEN-GB style=3D'mso-=
bidi-font-size:
11.0pt;mso-no-proof:yes'>At the request of the European Medicines Agency;<o=
:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.05pt;margin-bot=
tom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-14.15pt'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic'=
>&#9679;<span
style=3D'mso-tab-count:1'> </span></span><span lang=3DEN-GB style=3D'mso-=
bidi-font-size:
11.0pt;mso-no-proof:yes'>Whenever the risk management system is modified,
especially as the result of new information being received that may lead to=
 a
significant change to the benefit/risk profile or as the result of an impor=
tant
(pharmacovigilance or risk minimisation) milestone being reached.<o:p></o:p=
></span></p>

<b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:"Times New Roma=
n";
mso-ansi-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA;
mso-no-proof:yes'><br clear=3Dall style=3D'mso-special-character:line-break;
page-break-before:always'>
</span></b>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-right:-.05pt;text-align=
:center'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'>ANNEX III<o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'>LABELLING AND PACKAGE LEAFLET<o:p></o:p></span></b=
></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'><o:p>&nbsp;</o:p></span></b></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-farea=
st-language:
EN-US;mso-bidi-language:AR-SA;mso-no-proof:yes'><br clear=3Dall style=3D'ms=
o-special-character:
line-break;page-break-before:always'>
</span>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DTitleA><span lang=3DEN-GB>A. LABELLING</span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";color:black;mso-color-alt:windowt=
ext;
mso-ansi-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA;
mso-no-proof:yes'><br clear=3Dall style=3D'page-break-before:always'>
</span>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=3DMsoNormal style=3D'background:white;border:none;mso-border-alt:s=
olid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;
mso-color-alt:windowtext;mso-no-proof:yes'>PARTICULARS TO APPEAR ON THE OUT=
ER
PACKAGING</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;back=
ground:
white;mso-shading:transparent;border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold;mso-no-proof:y=
es'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'background:white;mso-shading:transparent;bord=
er:none;
mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0p=
t 1.0pt 4.0pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>OUTER CARTON</span></b><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold;mso-no-proof:y=
es'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>1.<span
style=3D'mso-tab-count:1'> </span>NAME OF THE MEDICINAL PRODUCT</span=
></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Ovaleap
300&nbsp;IU/0.5&nbsp;mL solution for injection<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-no-proof:yes'>follitropin&nbsp;alfa</span><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>2.<span
style=3D'mso-tab-count:1'> </span>STATEMENT OF ACTIVE SUBSTANCE(S)<o:=
p></o:p></span></b></p>

</div>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Each cartridge contains 300&nbsp;IU
(equivalent to 22&nbsp;micrograms) follitropin alfa in 0.5&nbsp;mL solution.
Each mL of the solution contains 600&nbsp;IU (equivalent to 44&nbsp;microgr=
ams)
follitropin alfa.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>3.<span
style=3D'mso-tab-count:1'> </span>LIST OF EXCIPIENTS</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'>Excipients: sodium dihydrogen phosphate dihydrate, sodium
hydroxide (2&nbsp;M) (for pH adjustment), mannitol, methionine, polysorbate=
 20,
benzyl alcohol, benzalkonium chloride, water for injections.<o:p></o:p></sp=
an></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>4.<span
style=3D'mso-tab-count:1'> </span>PHARMACEUTICAL FORM AND CONTENTS</s=
pan></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;background:lightgrey;mso-highlight:lightgrey;mso-no-proof:yes'>=
Solution
for injection</span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>1&nbsp;cartridge with 0.5&nbsp;mL solu=
tion
and 10&nbsp;injection needles<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>5.<span
style=3D'mso-tab-count:1'> </span>METHOD AND ROUTE(S) OF ADMINISTRATI=
ON</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>For use on=
ly
with the Ovaleap Pen.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'>Read the package leaflet before use.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:DE'>Subcutaneous us=
e<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>6.<span
style=3D'mso-tab-count:1'> </span>SPECIAL WARNING THAT THE MEDICINAL
PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Keep out of the sight =
and
reach of children.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>7.<span
style=3D'mso-tab-count:1'> </span>OTHER SPECIAL WARNING(S), IF NECESS=
ARY</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
pagination:
widow-orphan lines-together;page-break-after:avoid;mso-outline-level:1;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>8.<span
style=3D'mso-tab-count:1'> </span>EXPIRY DATE</span></b><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt;
mso-no-proof:yes'>EXP<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>The cartridge in&#8209;use in the pen =
may
be stored for a maximum of 28&nbsp;days not above 25&nbsp;C.<o:p></o:p></s=
pan></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;page=
-break-after:
avoid;mso-outline-level:1;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>9.<span
style=3D'mso-tab-count:1'> </span>SPECIAL STORAGE CONDITIONS</span></=
b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Store in a refrigerator.<o:p></o:p></s=
pan></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Do not freeze.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Keep the cartridge in the outer carton=
 in
order to protect from light.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'>May be stored <span style=3D'color:black'>before opening =
not
above 25&nbsp;C for up to 3&nbsp;months. Must be discarded if it has not b=
een
used after 3&nbsp;months.<o:p></o:p></span></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>10.<span
style=3D'mso-tab-count:1'> </span>SPECIAL PRECAUTIONS FOR DISPOSAL OF U=
NUSED
MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS,=
 IF
APPROPRIATE<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>11.<span
style=3D'mso-tab-count:1'> </span>NAME AND ADDRESS OF THE MARKETING
AUTHORISATION HOLDER<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Theramex Ireland Limited<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-family:
Verdana;color:black'>3<sup>rd</sup> Floor, </span><span lang=3DNL
style=3D'mso-ansi-language:NL'>Kilmore House,<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Park Lane, Spencer Dock,<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Dublin 1<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>D01 YE64<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Ireland</span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;col=
or:black;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>12.<span
style=3D'mso-tab-count:1'> </span>MARKETING AUTHORISATION NUMBER(S) </s=
pan></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>EU/1/13/871/001<o:p></=
o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>13.<span
style=3D'mso-tab-count:1'> </span>BATCH NUMBER</span></b><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'>Batch<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>14.<span
style=3D'mso-tab-count:1'> </span>GENERAL CLASSIFICATION FOR SUPPLY</sp=
an></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:2.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:2.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>15.<span
style=3D'mso-tab-count:1'> </span>INSTRUCTIONS ON USE</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 0in 4.0pt'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>16.<span
style=3D'mso-tab-count:1'> </span>INFORMATION IN BRAILLE</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Ovaleap
300&nbsp;IU/0.5&nbsp;mL<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:#CCCCCC;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:#CCCCCC;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 0in 4.0pt'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DEN-GB style=3D'mso-no-proof:yes'>17.<span style=3D'mso=
-tab-count:
1'> </span>UNIQUE IDENTIFIER  2D BARCODE</span></b><i style=3D'mso-bid=
i-font-style:
normal'><span lang=3DEN-GB style=3D'mso-no-proof:yes'><o:p></o:p></span></i=
></p>

</div>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-no-proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'background:lightgrey;mso-h=
ighlight:
lightgrey;mso-no-proof:yes'>2D barcode carrying the unique identifier inclu=
ded.</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;background:#CCCCCC;mso-no-p=
roof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:#CCCCCC;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-no-proof:
yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'page-break-after:avoid;border:none;mso-border=
-alt:
solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0pt 0in 4.0pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-no-pr=
oof:yes'>18.<span
style=3D'mso-tab-count:1'> </span>UNIQUE IDENTIFIER - HUMAN READABLE DA=
TA</span></b><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-no-pro=
of:yes'><o:p></o:p></span></i></p>

</div>

<p class=3DMsoNormal style=3D'page-break-after:avoid;tab-stops:.5in'><span
lang=3DEN-GB style=3D'mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>PC:<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>SN:<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>NN:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";color:black;mso-color-alt:windowt=
ext;
background:#CCCCCC;mso-ansi-language:EN-GB;mso-fareast-language:EN-US;
mso-bidi-language:AR-SA;mso-no-proof:yes'><br clear=3Dall style=3D'page-bre=
ak-before:
always'>
</span>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=3DMsoNormal style=3D'background:white;border:none;mso-border-alt:s=
olid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;
mso-color-alt:windowtext;mso-no-proof:yes'>PARTICULARS TO APPEAR ON THE OUT=
ER
PACKAGING</span></b><b style=3D'mso-bidi-font-weight:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></b>=
</p>

<p class=3DMsoNormal style=3D'background:white;border:none;mso-border-alt:s=
olid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'background:white;mso-shading:transparent;bord=
er:none;
mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0p=
t 1.0pt 4.0pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>OUTER CARTON</span></b><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold;mso-no-proof:y=
es'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>1.<span
style=3D'mso-tab-count:1'> </span>NAME OF THE MEDICINAL PRODUCT</span=
></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Ovaleap
450&nbsp;IU/0.75&nbsp;mL solution for injection<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-no-proof:yes'>follitropin&nbsp;alfa</span><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>2.<span
style=3D'mso-tab-count:1'> </span>STATEMENT OF ACTIVE SUBSTANCE(S)<o:=
p></o:p></span></b></p>

</div>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Each cartridge contains 450&nbsp;IU
(equivalent to 33&nbsp;micrograms) follitropin alfa in 0.75&nbsp;mL solutio=
n.
Each mL of the solution contains 600&nbsp;IU (equivalent to 44&nbsp;microgr=
ams)
follitropin alfa.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>3.<span
style=3D'mso-tab-count:1'> </span>LIST OF EXCIPIENTS</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'>Excipients: sodium dihydrogen phosphate dihydrate, sodium
hydroxide (2&nbsp;M) (for pH adjustment), mannitol, methionine, polysorbate=
 20,
benzyl alcohol, benzalkonium chloride, water for injections.<o:p></o:p></sp=
an></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>4.<span
style=3D'mso-tab-count:1'> </span>PHARMACEUTICAL FORM AND CONTENTS</s=
pan></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;background:lightgrey;mso-highlight:lightgrey;mso-no-proof:yes'>=
Solution
for injection</span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>1&nbsp;cartridge with 0.75&nbsp;mL
solution and 10&nbsp;injection needles<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>5.<span
style=3D'mso-tab-count:1'> </span>METHOD AND ROUTE(S) OF ADMINISTRATI=
ON</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>For use on=
ly
with the Ovaleap Pen.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:lightgrey;mso-highlight:lightgrey;mso-no-proof:yes'><o:p>&nbsp;<=
/o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'>Read the package leaflet before use.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:DE'>Subcutaneous us=
e<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>6.<span
style=3D'mso-tab-count:1'> </span>SPECIAL WARNING THAT THE MEDICINAL
PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Keep out of the sight =
and reach
of children.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>7.<span
style=3D'mso-tab-count:1'> </span>OTHER SPECIAL WARNING(S), IF NECESS=
ARY</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
pagination:
widow-orphan lines-together;page-break-after:avoid;mso-outline-level:1;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>8.<span
style=3D'mso-tab-count:1'> </span>EXPIRY DATE</span></b><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt;
mso-no-proof:yes'>EXP<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>The cartridge in&#8209;use in the pen =
may
be stored for a maximum of 28&nbsp;days not above 25&nbsp;C.<o:p></o:p></s=
pan></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;page=
-break-after:
avoid;mso-outline-level:1;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>9.<span
style=3D'mso-tab-count:1'> </span>SPECIAL STORAGE CONDITIONS</span></=
b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Store in a refrigerator.<o:p></o:p></s=
pan></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Do not freeze.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Keep the cartridge in the outer carton=
 in
order to protect from light.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'>May be stored <span style=3D'color:black'>before opening =
not
above 25&nbsp;C for up to 3&nbsp;months. Must be discarded if it has not b=
een
used after 3&nbsp;months.<o:p></o:p></span></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>10.<span
style=3D'mso-tab-count:1'> </span>SPECIAL PRECAUTIONS FOR DISPOSAL OF U=
NUSED
MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS,=
 IF
APPROPRIATE<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>11.<span
style=3D'mso-tab-count:1'> </span>NAME AND ADDRESS OF THE MARKETING
AUTHORISATION HOLDER<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Theramex Ireland Limited<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-family:
Verdana;color:black'>3<sup>rd</sup> Floor, </span><span lang=3DNL
style=3D'mso-ansi-language:NL'>Kilmore House,<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Park Lane, Spencer Dock,<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Dublin 1<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>D01 YE64<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DNL style=3D'mso-ansi-language:NL'>Ireland=
</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>12.<span
style=3D'mso-tab-count:1'> </span>MARKETING AUTHORISATION NUMBER(S) </s=
pan></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>EU/1/13/871/002<o:p></=
o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>13.<span
style=3D'mso-tab-count:1'> </span>BATCH NUMBER</span></b><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'>Batch<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>14.<span
style=3D'mso-tab-count:1'> </span>GENERAL CLASSIFICATION FOR SUPPLY</sp=
an></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:2.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:2.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>15.<span
style=3D'mso-tab-count:1'> </span>INSTRUCTIONS ON USE</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 0in 4.0pt'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>16.<span
style=3D'mso-tab-count:1'> </span>INFORMATION IN BRAILLE</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Ovaleap
450&nbsp;IU/0.75&nbsp;mL<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:#CCCCCC;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:#CCCCCC;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 0in 4.0pt'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DEN-GB style=3D'mso-no-proof:yes'>17.<span style=3D'mso=
-tab-count:
1'> </span>UNIQUE IDENTIFIER  2D BARCODE</span></b><i style=3D'mso-bid=
i-font-style:
normal'><span lang=3DEN-GB style=3D'mso-no-proof:yes'><o:p></o:p></span></i=
></p>

</div>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-no-proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'background:lightgrey;mso-h=
ighlight:
lightgrey;mso-no-proof:yes'>2D barcode carrying the unique identifier inclu=
ded.</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;background:#CCCCCC;mso-no-p=
roof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:#CCCCCC;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-no-proof:
yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'page-break-after:avoid;border:none;mso-border=
-alt:
solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0pt 0in 4.0pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-no-pr=
oof:yes'>18.<span
style=3D'mso-tab-count:1'> </span>UNIQUE IDENTIFIER - HUMAN READABLE DA=
TA</span></b><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-no-pro=
of:yes'><o:p></o:p></span></i></p>

</div>

<p class=3DMsoNormal style=3D'page-break-after:avoid;tab-stops:.5in'><span
lang=3DEN-GB style=3D'mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>PC:<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>SN:<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>NN:<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:#CCCCCC;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";color:black;mso-color-alt:windowt=
ext;
background:#CCCCCC;mso-ansi-language:EN-GB;mso-fareast-language:EN-US;
mso-bidi-language:AR-SA;mso-no-proof:yes'><br clear=3Dall style=3D'page-bre=
ak-before:
always'>
</span>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt;
background:white'>

<p class=3DMsoNormal style=3D'background:white;border:none;mso-border-alt:s=
olid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;
mso-color-alt:windowtext;mso-no-proof:yes'>PARTICULARS TO APPEAR ON THE OUT=
ER
PACKAGING</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;back=
ground:
white;mso-shading:transparent;border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold;mso-no-proof:y=
es'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'background:white;mso-shading:transparent;bord=
er:none;
mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0p=
t 1.0pt 4.0pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>OUTER CARTON</span></b><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold;mso-no-proof:y=
es'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>1.<span
style=3D'mso-tab-count:1'> </span>NAME OF THE MEDICINAL PRODUCT</span=
></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Ovaleap
900&nbsp;IU/1.5&nbsp;mL solution for injection<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-no-proof:yes'>follitropin&nbsp;alfa</span><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>2.<span
style=3D'mso-tab-count:1'> </span>STATEMENT OF ACTIVE SUBSTANCE(S)<o:=
p></o:p></span></b></p>

</div>

<p class=3DMsoNormal><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></i></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Each cartridge contains 900&nbsp;IU
(equivalent to 66&nbsp;micrograms) follitropin alfa in 1.5&nbsp;mL solution.
Each mL of the solution contains 600&nbsp;IU (equivalent to 44&nbsp;microgr=
ams)
follitropin alfa.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>3.<span
style=3D'mso-tab-count:1'> </span>LIST OF EXCIPIENTS</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'>Excipients: sodium dihydrogen phosphate dihydrate, sodium
hydroxide (2&nbsp;M) (for pH adjustment), mannitol, methionine, polysorbate=
 20,
benzyl alcohol, benzalkonium chloride, water for injections.<o:p></o:p></sp=
an></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>4.<span
style=3D'mso-tab-count:1'> </span>PHARMACEUTICAL FORM AND CONTENTS</s=
pan></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;background:lightgrey;mso-highlight:lightgrey;mso-no-proof:yes'>=
Solution
for injection</span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>1&nbsp;cartridge with 1.5&nbsp;mL solu=
tion
and 20&nbsp;injection needles<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>5.<span
style=3D'mso-tab-count:1'> </span>METHOD AND ROUTE(S) OF ADMINISTRATI=
ON</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>For use on=
ly
with the Ovaleap Pen.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:lightgrey;mso-highlight:lightgrey;mso-no-proof:yes'><o:p>&nbsp;<=
/o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'>Read the package leaflet before use.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-fareast-language:DE'>Subcutaneous us=
e<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>6.<span
style=3D'mso-tab-count:1'> </span>SPECIAL WARNING THAT THE MEDICINAL
PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Keep out of the sight =
and
reach of children.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
outline-level:
1;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>7.<span
style=3D'mso-tab-count:1'> </span>OTHER SPECIAL WARNING(S), IF NECESS=
ARY</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'tab-stops:28.35pt 37.45pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
pagination:
widow-orphan lines-together;page-break-after:avoid;mso-outline-level:1;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>8.<span
style=3D'mso-tab-count:1'> </span>EXPIRY DATE</span></b><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0=
pt;
mso-no-proof:yes'>EXP<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>The cartridge in&#8209;use in the pen =
may
be stored for a maximum of 28&nbsp;days not above 25&nbsp;C.<o:p></o:p></s=
pan></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;page=
-break-after:
avoid;mso-outline-level:1;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>9.<span
style=3D'mso-tab-count:1'> </span>SPECIAL STORAGE CONDITIONS</span></=
b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Store in a refrigerator.<o:p></o:p></s=
pan></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Do not freeze.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Keep the cartridge in the outer carton=
 in
order to protect from light.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'>May be stored <span style=3D'color:black'>before opening =
not
above 25&nbsp;C for up to 3&nbsp;months. Must be discarded if it has not b=
een
used after 3&nbsp;months.<o:p></o:p></span></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>10.<span
style=3D'mso-tab-count:1'> </span>SPECIAL PRECAUTIONS FOR DISPOSAL OF U=
NUSED
MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS,=
 IF
APPROPRIATE<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>11.<span
style=3D'mso-tab-count:1'> </span>NAME AND ADDRESS OF THE MARKETING AUT=
HORISATION
HOLDER<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Theramex Ireland Limited<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-family:
Verdana;color:black'>3<sup>rd</sup> Floor, </span><span lang=3DNL
style=3D'mso-ansi-language:NL'>Kilmore House,<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Park Lane, Spencer Dock,<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Dublin 1<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>D01 YE64<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DNL style=3D'mso-ansi-language:NL'>Ireland=
</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:ye=
s'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>12.<span
style=3D'mso-tab-count:1'> </span>MARKETING AUTHORISATION NUMBER(S) </s=
pan></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>EU/1/13/871/003<o:p></=
o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>13.<span
style=3D'mso-tab-count:1'> </span>BATCH NUMBER</span></b><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'>Batch<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>14.<span
style=3D'mso-tab-count:1'> </span>GENERAL CLASSIFICATION FOR SUPPLY</sp=
an></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:2.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:2.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>15.<span
style=3D'mso-tab-count:1'> </span>INSTRUCTIONS ON USE</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 0in 4.0pt'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>16.<span
style=3D'mso-tab-count:1'> </span>INFORMATION IN BRAILLE</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Ovaleap
900&nbsp;IU/1.5&nbsp;mL<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:#CCCCCC;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 0in 4.0pt'><b style=3D'mso-bidi-fon=
t-weight:
normal'><span lang=3DEN-GB style=3D'mso-no-proof:yes'>17.<span style=3D'mso=
-tab-count:
1'> </span>UNIQUE IDENTIFIER  2D BARCODE</span></b><i style=3D'mso-bid=
i-font-style:
normal'><span lang=3DEN-GB style=3D'mso-no-proof:yes'><o:p></o:p></span></i=
></p>

</div>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-no-proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'background:lightgrey;mso-h=
ighlight:
lightgrey;mso-no-proof:yes'>2D barcode carrying the unique identifier inclu=
ded.</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;background:#CCCCCC;mso-no-p=
roof:
yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
background:#CCCCCC;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-no-proof:
yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'page-break-after:avoid;border:none;mso-border=
-alt:
solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0pt 0in 4.0pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-no-pr=
oof:yes'>18.<span
style=3D'mso-tab-count:1'> </span>UNIQUE IDENTIFIER - HUMAN READABLE DA=
TA</span></b><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-no-pro=
of:yes'><o:p></o:p></span></i></p>

</div>

<p class=3DMsoNormal style=3D'page-break-after:avoid;tab-stops:.5in'><span
lang=3DEN-GB style=3D'mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt'>PC:<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>SN:<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'=
>NN:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp=
;</o:p></span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";color:black;mso-color-alt:windowt=
ext;
background:#CCCCCC;mso-ansi-language:EN-GB;mso-fareast-language:EN-US;
mso-bidi-language:AR-SA;mso-no-proof:yes'><br clear=3Dall style=3D'page-bre=
ak-before:
always'>
</span>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>MINIMUM
PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS<o:p></o:p></span><=
/b></p>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>CARTRIDGE<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>1.<span
style=3D'mso-tab-count:1'> </span>NAME OF THE MEDICINAL PRODUCT AND
ROUTE(S) OF ADMINISTRATION<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Ovaleap
300&nbsp;IU/0.5&nbsp;mL injection<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-no-proof:yes'>follitropin&nbsp;alfa</span><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'>SC<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>2.<span
style=3D'mso-tab-count:1'> </span>METHOD OF ADMINISTRATION<o:p></o:p>=
</span></b></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>3.<span
style=3D'mso-tab-count:1'> </span>EXPIRY DATE<o:p></o:p></span></b></=
p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'>EXP<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>4.<span
style=3D'mso-tab-count:1'> </span>BATCH NUMBER<o:p></o:p></span></b><=
/p>

</div>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Batch<o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>5.<span
style=3D'mso-tab-count:1'> </span>CONTENTS BY WEIGHT, BY VOLUME OR BY=
 UNIT<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>0.5&nbsp;mL<o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>6.<span
style=3D'mso-tab-count:1'> </span>OTHER<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-farea=
st-language:
EN-US;mso-bidi-language:AR-SA;mso-no-proof:yes'><br clear=3Dall style=3D'pa=
ge-break-before:
always'>
</span>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>MINIMUM
PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS<o:p></o:p></span><=
/b></p>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>CARTRIDGE<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>1.<span
style=3D'mso-tab-count:1'> </span>NAME OF THE MEDICINAL PRODUCT AND
ROUTE(S) OF ADMINISTRATION<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Ovaleap
450&nbsp;IU/0.75&nbsp;mL injection<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-no-proof:yes'>follitropin&nbsp;alfa</span><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'>SC<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>2.<span
style=3D'mso-tab-count:1'> </span>METHOD OF ADMINISTRATION<o:p></o:p>=
</span></b></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>3.<span
style=3D'mso-tab-count:1'> </span>EXPIRY DATE<o:p></o:p></span></b></=
p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'>EXP<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>4.<span
style=3D'mso-tab-count:1'> </span>BATCH NUMBER<o:p></o:p></span></b><=
/p>

</div>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Batch<o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>5.<span
style=3D'mso-tab-count:1'> </span>CONTENTS BY WEIGHT, BY VOLUME OR BY=
 UNIT<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>0.75&nbsp;mL<o:p></o:p=
></span></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>6.<span
style=3D'mso-tab-count:1'> </span>OTHER<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-farea=
st-language:
EN-US;mso-bidi-language:AR-SA;mso-no-proof:yes'><br clear=3Dall style=3D'pa=
ge-break-before:
always'>
</span>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>MINIMUM
PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS<o:p></o:p></span><=
/b></p>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'border:none;mso-border-alt:solid windowtext .=
5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>CARTRIDGE<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>1.<span
style=3D'mso-tab-count:1'> </span>NAME OF THE MEDICINAL PRODUCT AND
ROUTE(S) OF ADMINISTRATION<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'>Ovaleap
900&nbsp;IU/1.5&nbsp;mL injection<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
color:black;mso-no-proof:yes'>follitropin&nbsp;alfa</span><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'>SC<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>2.<span
style=3D'mso-tab-count:1'> </span>METHOD OF ADMINISTRATION<o:p></o:p>=
</span></b></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>3.<span
style=3D'mso-tab-count:1'> </span>EXPIRY DATE<o:p></o:p></span></b></=
p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'>EXP<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>4.<span
style=3D'mso-tab-count:1'> </span>BATCH NUMBER<o:p></o:p></span></b><=
/p>

</div>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Batch<o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>5.<span
style=3D'mso-tab-count:1'> </span>CONTENTS BY WEIGHT, BY VOLUME OR BY=
 UNIT<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>1.5&nbsp;mL<o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'mso-outline-level:1;border:none;mso-border-al=
t:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>6.<span
style=3D'mso-tab-count:1'> </span>OTHER<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-right:5.65pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-farea=
st-language:
EN-US;mso-bidi-language:AR-SA;mso-no-proof:yes'><br clear=3Dall style=3D'ms=
o-special-character:
line-break;page-break-before:always'>
</span>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b style=3D=
'mso-bidi-font-weight:
normal'><span lang=3DEN-GB style=3D'mso-no-proof:yes'><o:p>&nbsp;</o:p></sp=
an></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DTitleA><span lang=3DEN-GB>B. PACKAGE LEAFLET</span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso=
-no-proof:
yes'><o:p>&nbsp;</o:p></span></b></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-farea=
st-language:
EN-US;mso-bidi-language:AR-SA;mso-no-proof:yes'><br clear=3Dall style=3D'pa=
ge-break-before:
always'>
</span>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1;tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-=
GB
style=3D'mso-no-proof:yes'>Package leaflet: Information for the user</span>=
</b><span
lang=3DEN-GB style=3D'mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-list:ski=
p;
tab-stops:.5in;background:white'><span lang=3DEN-GB style=3D'mso-no-proof:y=
es'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1;tab-stops:28.35pt 49.65pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-no-proof:yes'>Ovaleap 300&nbsp;IU/0.5&nbsp;mL sol=
ution
for injection<o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1;tab-stops:28.35pt 49.65pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-no-proof:yes'>Ovaleap 450&nbsp;IU/0.75&nbsp;mL so=
lution
for injection<o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-outline-=
level:
1;tab-stops:28.35pt 49.65pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-no-proof:yes'>Ovaleap 900&nbsp;IU/1.5&nbsp;mL sol=
ution
for injection<o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-list:ski=
p;
tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-no-proof:yes'><o:p>&nbsp;</=
o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;mso-list:ski=
p;
tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-no-proof:yes'>follitropin a=
lfa<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-no-proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-no-proof:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-hyphenate:none;tab-stops:.5in'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-no-pr=
oof:yes'>Read
all of this leaflet carefully before you start using this medicine because =
it
contains important information for you.</span></b><span lang=3DEN-GB
style=3D'mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l10=
 level1 lfo3;
tab-stops:.5in'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-no-pro=
of:yes'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-no-proof:yes=
'>Keep
this leaflet. You may need to read it again. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:l10=
 level1 lfo3;
tab-stops:.5in'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-no-pro=
of:yes'><span
style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-no-proof:yes=
'>If you
have any further questions, ask your doctor, pharmacist or nurse.<o:p></o:p=
></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=3DEN-GB style=3D'mso-no-proof:yes'>-<span style=3D'mso-tab-count:1'>=
 </span>This
medicine has been prescribed for you only. Do not pass it on to others. It =
may
harm them, even if their signs of illness are the same as yours.<o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l10 level1 lfo3'><![if !supportLists]><span lang=3DEN-GB style=3D'mso-no-pr=
oof:
yes'><span style=3D'mso-list:Ignore'>-<span style=3D'font:7.0pt "Times New =
Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&=
nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-no-proof:yes=
'>If you
get any side effects, talk to your doctor, pharmacist or nurse.</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'> </span><span lang=3DEN-GB
style=3D'mso-no-proof:yes'>This includes any possible side effects not list=
ed in
this leaflet.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;tab-stops:.5in'><span lang=
=3DEN-GB
style=3D'mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;tab-stops:.5in'><span lang=
=3DEN-GB
style=3D'mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;mso-list:skip;tab-stops:.=
5in'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>What is in this le=
aflet<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;mso-list:skip;tab-stops:.=
5in'><span
lang=3DEN-GB style=3D'mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:
skip'><span lang=3DEN-GB style=3D'mso-no-proof:yes'>1.<span style=3D'mso-ta=
b-count:
1'> </span>What Ovaleap is and what it is used for<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:
skip'><span lang=3DEN-GB style=3D'mso-no-proof:yes'>2.<span style=3D'mso-ta=
b-count:
1'> </span>What you need to know before you use Ovaleap <o:p></o:p></=
span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:
skip'><span lang=3DEN-GB style=3D'mso-no-proof:yes'>3.<span style=3D'mso-ta=
b-count:
1'> </span>How to use Ovaleap<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:
skip'><span lang=3DEN-GB style=3D'mso-no-proof:yes'>4.<span style=3D'mso-ta=
b-count:
1'> </span>Possible side effects<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=3DEN-GB style=3D'mso-no-proof:yes'>5.<span style=3D'mso-tab-count:1'>=
 </span>How
to store Ovaleap<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt'><span
lang=3DEN-GB style=3D'mso-no-proof:yes'>6.<span style=3D'mso-tab-count:1'>=
 </span>Contents
of the pack and other information<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>1.<span
style=3D'mso-tab-count:1'> </span>What Ovaleap is and what it is used=
 for<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;tab-stops:.5in'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>What Ovaleap is<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;tab-stops:.5in'><span lang=
=3DEN-GB>This
medicine</span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no=
-proof:
yes'> contains </span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt=
'>the
active substance follitropin alfa, which is almost identical to a natural
hormone produced by your body called f<span style=3D'mso-no-proof:yes'>oll=
icle&#8209;stimulating
hormone (FSH)</span>. <span style=3D'mso-no-proof:yes'>FSH is a gonadotrop=
in, a
type of hormone that plays an important role in human fertility and
reproduction. In women, FSH is needed for the growth and development of the
sacs (follicles) in the ovaries that contain the egg cells. In men, FSH is
needed for the production of sperm.<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;tab-stops:.5in'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;tab-stops:.5in'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>What Ovaleap is used for<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;tab-stops:.5in'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;tab-stops:.5in'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>In adult =
women, Ovaleap
is used:<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><span
style=3D'mso-tab-count:1'> </span>to help ovulation (release of a ma=
ture
egg cell from the follicle) in women that cannot ovulate and that have not
responded to treatment with a medicine called clomifene citrate.<o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DEN-GB style=3D'mso-no-proof:yes'><span style=3D'mso-tab-count:1'>=
 </span>to
help follicles develop in women undergoing assisted reproductive technology
procedures (procedures that may help you to become pregnant) such as <i
style=3D'mso-bidi-font-style:normal'>in vitro </i>fertilisation, gamete i=
ntra&#8209;fallopian
transfer or zygote intra&#8209;fallopian transfer.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DEN-GB style=3D'mso-no-proof:yes'><span style=3D'mso-tab-count:1'>=
 </span>in
combination with a medicine called lutropin alfa (a version of another
gonadotropin, luteinising hormone or LH) to help ovulation in women that =
are
not ovulating because their body is producing too little FSH and LH.<o:p></=
o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-no-proof:yes'><o:p>&nb=
sp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB style=3D'mso-no-proof:yes'>In ad=
ult men, Ovaleap
is used:<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DEN-GB style=3D'mso-no-proof:yes'><span style=3D'mso-tab-count:1'>=
 </span>in
combination with a medicine called human chorionic gonadotropin (hCG) to =
help
produce sperm in men that are infertile due to low levels of certain hormon=
es.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;tab-stops:.5in'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;background:yellow;mso-highlight:yellow;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-no-proof:yes'>2.<span style=3D'mso-tab-count:1'>=
 </span>What
you need to know before you use Ovaleap</span></b><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;mso-outline-level:1;mso-list:skip;tab-stops:.5in'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-bidi-f=
ont-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;mso-outline-level:1;mso-list:skip;tab-stops:.5in'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>Do not use Ovaleap:</span></b><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
skip;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><span style=3D'mso-tab-count:1'> </span>if you ar=
e allergic
to follitropin alfa, Follicle Stimulating Hormone (FSH) or any of the other
ingredients of </span><span lang=3DEN-GB style=3D'mso-no-proof:yes'>this me=
dicine
(listed in section 6)</span><span lang=3DEN-GB style=3D'mso-bidi-font-size:=
11.0pt;
mso-no-proof:yes'>.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
skip;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><span style=3D'mso-tab-count:1'> </span>if you ha=
ve a
tumour in your hypothalamus or pituitary gland (parts of the brain).<o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
skip;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><span style=3D'mso-tab-count:1'> </span>if you ar=
e a <b
style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-style:norma=
l'>woman
</i></b>with:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:56.7pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>- large o=
varies
or sacs of fluids within the ovaries (ovarian cysts) of unknown origin.<o:p=
></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:56.7pt'><span lang=3DEN-GB
style=3D'mso-no-proof:yes'>- unexplained vaginal bleeding.<o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'margin-left:56.7pt'><span lang=3DEN-GB
style=3D'mso-no-proof:yes'>- cancer in your ovaries, womb or breasts.<o:p><=
/o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:56.7pt;tab-stops:.5in'><span lang=
=3DEN-GB
style=3D'mso-no-proof:yes'>- any condition that usually makes normal pregna=
ncy
impossible, such as ovarian failure (early menopause), fibroid tumours of t=
he
womb or malformed reproductive organs.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-no-proof:yes'><span
style=3D'mso-tab-count:1'> </span>if you are a <b style=3D'mso-bidi-=
font-weight:
normal'><i style=3D'mso-bidi-font-style:normal'>man</i></b> with:<o:p></o:p=
></span></p>

<p class=3DMsoNormal style=3D'margin-left:56.7pt'><span lang=3DEN-GB
style=3D'mso-no-proof:yes'>- testicular failure that is not treatable.<o:p>=
</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-no-proof:yes'><o:p>&nb=
sp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-no-proof:yes'>Do not u=
se </span><span
lang=3DEN-GB>this medicine <span style=3D'mso-no-proof:yes'>if any of the a=
bove
applies to you. If you are not sure, talk to your doctor or pharmacist befo=
re
using this medicine.<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'mso-outline-level:1;mso-list:skip;tab-stops:.=
5in'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-no-pr=
oof:yes'>Warnings
and precautions</span></b><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Before the
treatment is started you and your partners fertility should be evaluated b=
y a
doctor experienced in treating fertility disorders.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><u><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Porphyria<o:p></o:p></=
span></u></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Tell your doctor befor=
e you
start treatment, if you or any member of your family have porphyria. This i=
s a
condition that may be passed on from parents to children which means that y=
ou
have an inability to break down porphyrins (organic compounds).<o:p></o:p><=
/span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Tell your doctor strai=
ght
away if:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
skip;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><span style=3D'mso-tab-count:1'> </span>your skin
becomes fragile and easily blistered, especially skin that has been frequen=
tly
in the sun, and/or<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-no-proof:yes'><span
style=3D'mso-tab-count:1'> </span>you have stomach, arm or leg pain.=
<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>If you experience the =
above
symptoms your doctor may recommend that you stop treatment.<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><u><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Ovarian Hyper&#8209;St=
imulation
Syndrome (OHSS)<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>If you are a woman, th=
is
medicine increases your risk of developing OHSS. This is when your follicle=
s develop
too much and become large cysts.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Talk to your doctor st=
raight
away if:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
skip;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><span style=3D'mso-tab-count:1'> </span>you get p=
ain in
the lower part of the abdomen (belly),<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
skip;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><span style=3D'mso-tab-count:1'> </span>you gain =
any
weight rapidly,<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
skip;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><span style=3D'mso-tab-count:1'> </span>you feel =
sick
or are vomiting,<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
skip;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><span style=3D'mso-tab-count:1'> </span>you have
difficulty in breathing.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>If you experience the =
above
symptoms your doctor might ask you to stop using this medicine (see also se=
ction
4</span><span lang=3DEN-GB> under </span><span lang=3DEN-GB style=3D'mso-bi=
di-font-size:
11.0pt;mso-no-proof:yes'>Serious side effects in women&quot;).<o:p></o:p><=
/span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>If you are not ovulati=
ng and
if the recommended dose and timing are followed, the occurrence of OHSS is =
less
likely. Ovaleap treatment seldom causes severe OHSS unless the medicine tha=
t is
used for final follicular maturation (containing human chorionic gonadotrop=
in,
hCG) is given. If you are developing OHSS your doctor may not give you any =
hCG
in this treatment cycle. You may be told not to have sex or to use a barrier
contraceptive method for at least 4&nbsp;days.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><u><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Multiple pregnancy<o:p=
></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>When using </span><span
lang=3DEN-GB>this medicine</span><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:11.0pt;
mso-no-proof:yes'>, you have a higher risk of being pregnant with more than=
 one
child (i.e. multiple pregnancy, typically twins) than if you conceived na=
turally.
Multiple pregnancy may lead to medical complications for you and your babie=
s. You
can reduce the risk of multiple pregnancy by using the right dose of </span=
><span
lang=3DEN-GB>this medicine</span><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:11.0pt;
mso-no-proof:yes'> at the right times. When undergoing assisted reproductiv=
e technology
the risk of having a multiple pregnancy is related to your age, the quality=
 and
number of fertilised eggs or embryos placed inside you.<o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><u><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Miscarriage<o:p></o:p>=
</span></u></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>You are more likely to=
 have
a miscarriage than the average woman when undergoing assisted reproductive
technology or stimulation of your ovaries to produce eggs.<o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><u><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Ectopic pregnancy<o:p>=
</o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>You are more likely to=
 have
a pregnancy outside the womb (an ectopic pregnancy) than the average woman =
when
undergoing assisted reproductive technology and if you have damaged fallopi=
an
tubes.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-bidi-font-style:italic;mso-no-proof:yes'><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><u><span lang=3DEN-GB style=
=3D'mso-bidi-font-size:
11.0pt;color:black;mso-bidi-font-style:italic;mso-no-proof:yes'>Birth defec=
ts<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>When being conceived by assisted
reproductive technology, a baby may have a slightly higher risk of birth
defects <span style=3D'mso-spacerun:yes'></span>than after natural concept=
ion.
This could be related to multiple pregnancies or to parent characteristics =
such
as maternal age and sperm characteristics.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><u><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Blood clotting problems
(thromboembolic events)<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>If you have ever had b=
lood
clots in your leg or lung, or a heart attack or stroke, or if your family h=
ave
experienced these, inform your doctor. You might have a higher risk of these
problems occurring or becoming worse with Ovaleap treatment.<o:p></o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><u><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Men with too much FSH =
in
their blood<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>If you are a man, havi=
ng too
much natural FSH in your blood can be a sign of damaged testicles. </span><=
span
lang=3DEN-GB>This medicine</span><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:11.0pt;
mso-no-proof:yes'> usually does not work if you have this problem. If your
doctor decides to try Ovaleap treatment, they may monitor it by asking you =
to
provide semen for analysis 4 to 6&nbsp;months after starting treatment.<o:p=
></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><b><span lang=
=3DEN-GB
style=3D'mso-no-proof:yes'>Children and adolescents<o:p></o:p></span></b></=
p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>T</span><span lang=3DE=
N-GB>his
medicine</span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no=
-proof:
yes'> is not indicated for use in children and adolescents </span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>less than 18&nbsp;years of=
 age<span
style=3D'mso-no-proof:yes'>.<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><b><span lang=
=3DEN-GB
style=3D'mso-no-proof:yes'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>Other medicines and Ovaleap</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Tell your=
 doctor
or pharmacist if you are </span><span lang=3DEN-GB style=3D'mso-no-proof:ye=
s'>using</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>, have re=
cently used
</span><span lang=3DEN-GB style=3D'mso-no-proof:yes'>or might use </span><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>any other
medicines.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
skip;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><span style=3D'mso-tab-count:1'> </span>If you us=
e Ovaleap
with other medicines which help ovulation such as human chorionic gonadotro=
pin
(hCG) or clomifene citrate, this may increase the response of your follicle=
s.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
skip;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><span style=3D'mso-tab-count:1'> </span>If you us=
e Ovaleap
at the same time as a gonadotropin-releasing hormone (GnRH) agonist or
antagonist (these medicines reduce your sex hormone levels and stop you
ovulating) you may need a higher dose of Ovaleap to produce follicles.<o:p>=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;background:yellow;mso-highl=
ight:
yellow;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-outline-level:1;mso-li=
st:skip;
tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Pregnancy and breast&#=
8209;feeding<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>You should not use </s=
pan><span
lang=3DEN-GB>this medicine</span><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:11.0pt;
mso-no-proof:yes'> if you are pregnant or breast&#8209;feeding.<o:p></o:p><=
/span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-outline-level:1;mso-li=
st:skip;
tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-outline-level:1;mso-li=
st:skip;
tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Driving and using mach=
ines</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>This medi=
cine
does not affect your ability to drive and use machines.<o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-outline-level:1;mso-li=
st:skip;
tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Ovaleap contains sodiu=
m,
benzalkonium chloride and benzyl alcohol<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt'>This medicine contains less than 1&nbsp;mmol sodium (23&nbsp;mg) pe=
r dose,
that is to say essentially sodium-free.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt;mso-no-proof:yes'>This medicine also contains 0.02 mg per mL of benz=
alkonium
chloride and </span><span lang=3DEN-GB>10.0 mg per mL of benzyl alcohol. As=
k your
doctor or pharmacist for advice if you have a liver or kidney disease, and =
if
you are pregnant or breast-feeding. This is because large amounts of benzyl
alcohol can build-up in your body and may cause side effects (called metab=
olic
acidosis).</span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'>3.<span
style=3D'mso-tab-count:1'> </span>H</span><span lang=3DEN-GB
style=3D'mso-no-proof:yes'>ow to use Ovaleap</span></b><b style=3D'mso-bidi=
-font-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:=
yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-bidi-f=
ont-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Always us=
e </span><span
lang=3DEN-GB style=3D'mso-no-proof:yes'>this medicine</span><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'> exactly as your docto=
r </span><span
lang=3DEN-GB style=3D'mso-no-proof:yes'>or pharmacist </span><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>has told you. Check wi=
th
your doctor or pharmacist if you are not sure.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in;mso-layout-grid-align:none;tex=
t-autospace:
none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>This medicine =
is given
<span style=3D'mso-no-proof:yes'>as an injection </span>into the tissue just
under the skin (subcutaneous injection)<span style=3D'mso-no-proof:yes'>. <=
/span></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-fareast-font-family:Sim=
Sun;
mso-fareast-language:EN-GB'>Your doctor or nurse will show you how to inject
the medicine. If you administer this medicine to yourself, please carefully
read and follow the Instructions for Use of the pen.</span><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;font-family:"TimesNewRoman",serif;mso-fa=
reast-font-family:
SimSun;mso-bidi-font-family:TimesNewRoman;mso-fareast-language:EN-GB'> </sp=
an><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>What the </span><span lang=3DEN-GB style=3D'mso-no=
-proof:
yes'>recommended</span></b><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'> dose is<=
o:p></o:p></span></b></p>

<p class=3DMsoNormal><span lang=3DEN-GB>Your doctor will decide how much me=
dicine
you will take and how often. The doses described below are stated in
International Units (IU).</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB>Women<o:p></o:p></span></u></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><u><span lang=3DEN-GB>If you are not ovulating and =
have
irregular or no periods<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><span lang=3DEN-GB><span style=3D'mso-tab-count:1'=
> </span>This
medicine is usually given every day.</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DEN-GB><span style=3D'mso-tab-count:1'> </span>If you have ir=
regular
periods, start using this medicine within the first 7&nbsp;days of your
menstrual cycle. If you do not have periods, you can start using the medici=
ne
on any convenient day.</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><span style=3D'mso-tab-count:1'>=
 </span>The
usual starting dose of this medicine is 75 to 150&nbsp;IU each day.</span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DEN-GB><span style=3D'mso-tab-count:1'> </span>Your dose of t=
his
medicine may be increased every 7 or every 14&nbsp;days by 37.5 to 75&nbsp;=
IU,
until you get the desired response.</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><span style=3D'mso-tab-count:1'>=
 </span>The
maximum daily dose of this medicine is usually not higher than 225&nbsp;IU.=
</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DEN-GB><span style=3D'mso-tab-count:1'> </span>When you get t=
he
desired response, you will be given hCG or recombinant hCG (r&#8209;hCG, =
an
hCG made in a laboratory by a special DNA technique). The single injection =
will
be 250&nbsp;micrograms of r&#8209;hCG or 5,000 to 10,000&nbsp;IU of hCG, 24=
 to
48&nbsp;hours after your last Ovaleap injection. The best time to have sex =
is
on the day of the hCG injection and the day after. Alternatively, intrauter=
ine
insemination may be performed by placing the sperm into the womb cavity.</s=
pan></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>If your doctor cannot see a desired
response after 4&nbsp;weeks, that treatment cycle with Ovaleap should be
stopped. For the following treatment cycle, your doctor will give you a hig=
her
starting dose of this medicine than before.</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>If your body responds too strongly,=
 your
treatment will be stopped and you will not be given any hCG [</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>see also =
section
2 under Ovarian Hyper&#8209;Stimulation Syndrome (OHSS)</span><span
lang=3DEN-GB>]. For the following cycle, your doctor will give you a lower =
dose
of Ovaleap than before.</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'background:yellow;mso-high=
light:
yellow'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB>If you need to develop several e=
ggs for
collection prior to any assisted reproductive technology<o:p></o:p></span><=
/u></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DEN-GB><span style=3D'mso-tab-count:1'> </span>The usual star=
ting
dose of this medicine is 150 to 225&nbsp;IU each day, from day&nbsp;2 or 3 =
of
your menstrual cycle.</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DEN-GB><span style=3D'mso-tab-count:1'> </span>The dose may be
increased, depending on your response. The maximum daily dose is 450&nbsp;I=
U.</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DEN-GB><span style=3D'mso-tab-count:1'> </span>Treatment is c=
ontinued
until your eggs have developed to a desired point. This usually takes about
10&nbsp;days but can take any time between 5 and 20&nbsp;days. Your doctor =
will
use blood tests and/or an ultrasound machine to check when this is.</span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DEN-GB><span style=3D'mso-tab-count:1'> </span>When your eggs=
 are
ready, you will be given hCG or r&#8209;hCG. The single injection will be
250&nbsp;micrograms of r&#8209;hCG or 5,000 to 10,000&nbsp;IU of hCG, 24 to
48&nbsp;hours after the last Ovaleap injection. This gets your eggs ready f=
or
collection.</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>In other cases, your doctor may fir=
st stop
you from ovulating by using a gonadotropin&#8209;releasing hormone (GnRH)
agonist or antagonist. Then Ovaleap is given approximately 2&nbsp;weeks aft=
er
the start of agonist treatment. The Ovaleap and GnRH agonist are then both
given until your follicles develop as desired.</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'background:yellow;mso-high=
light:
yellow'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB>If you are not ovulating, have no
periods and have been diagnosed with very low levels of FSH and LH hormones=
<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DEN-GB><span style=3D'mso-tab-count:1'> </span>The usual star=
ting
dose of Ovaleap is 75 to 150&nbsp;IU together with 75&nbsp;IU of lutropin a=
lfa.</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><span style=3D'mso-tab-count:1'>=
 </span>You
will use these two medicines each day for up to 5&nbsp;weeks.</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DEN-GB><span style=3D'mso-tab-count:1'> </span>Your dose of O=
valeap
may be increased every 7 or every 14&nbsp;days by 37.5 to 75&nbsp;IU, until=
 you
get the desired response.</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DEN-GB><span style=3D'mso-tab-count:1'> </span>When you get t=
he
desired response, you will be given hCG or r&#8209;hCG. The single injection
will be 250&nbsp;micrograms of r&#8209;hCG or 5,000 to 10,000&nbsp;IU of hC=
G,
24 to 48&nbsp;hours after your last injections of Ovaleap and lutropin alfa.
The best time to have sex is on the day of the hCG injection and the day af=
ter.
Alternatively, intrauterine insemination may be performed by placing the sp=
erm
into the womb cavity.</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>If your doctor cannot see a respons=
e after
5&nbsp;weeks, that treatment cycle should be stopped. For the following cyc=
le,
your doctor will give you a higher starting dose of this medicine than befo=
re.</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>If your body responds too strongly,=
 your
treatment with Ovaleap will be stopped and you will not be given any hCG [<=
/span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>see also =
section
2 under Ovarian Hyper&#8209;Stimulation Syndrome (OHSS)</span><span
lang=3DEN-GB>]. For the following cycle, your doctor will give you a lower =
dose of
Ovaleap than before.</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'background:yellow;mso-high=
light:
yellow'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><u><span lang=3DEN-GB>Men<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><span lang=3DEN-GB><span style=3D'mso-tab-count:1'=
> </span>The
usual dose of this medicine is 150&nbsp;IU together with hCG.</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><span style=3D'mso-tab-count:1'>=
 </span>You
will use these two medicines three times a week for at least 4&nbsp;months.=
</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DEN-GB><span style=3D'mso-tab-count:1'> </span>If you have not
responded to treatment after 4&nbsp;months, your doctor may suggest that you
continue using these two medicines for at least 18&nbsp;months.</span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><b style=3D'mso=
-bidi-font-weight:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>How are the
injections given?<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt'>This medicine is given as an injection =
into
the tissue just under the skin (subcutaneous injection) <span style=3D'mso-=
no-proof:
yes'>using the Ovaleap&nbsp;Pen. The Ovaleap&nbsp;Pen is a device (a pen)
used for giving injections </span>into the tissue just under the skin.<o:p>=
</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>Your doctor may suggest th=
at you
learn how to <span style=3D'mso-no-proof:yes'>inject yourself with this med=
icine</span>.
Your doctor or nurse will give you instructions on how to do this and </spa=
n><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-fareast-lan=
guage:
DE'>you can also find instructions</span><span lang=3DEN-GB style=3D'mso-bi=
di-font-size:
11.0pt;mso-no-proof:yes'> in the separate instructions for use of the pen</=
span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>. Do not attempt to self&#=
8209;administer
<span style=3D'mso-no-proof:yes'>this medicine</span> without this training=
 by
your doctor or nurse. <span style=3D'mso-no-proof:yes'>The very first injec=
tion
of </span></span><span lang=3DEN-GB>this medicine </span><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>should only be given i=
n the
presence of a doctor or nurse.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Ovaleap s=
olution
for injection in cartridges has been developed for use in the Ovaleap&nbsp;=
Pen.
You must follow the separate instructions for use of the Ovaleap&nbsp;Pen
carefully. The instructions for use of the pen will be provided together wi=
th
the Ovaleap&nbsp;Pen.</span><span lang=3DEN-GB style=3D'mso-bidi-font-size:=
11.0pt'>
Proper treatment of your condition,<span style=3D'mso-no-proof:yes'> howeve=
r,</span>
requires close and constant co&#8209;operation with your doctor.<o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Discard u=
sed
needles immediately after injection.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-outline-level:1;mso-li=
st:skip;
tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>If you use more Ovalea=
p than
you should</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-outline-level:1;mso-li=
st:skip;
tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-n=
o-proof:
yes'>The effects of using too much Ovaleap are unknown. Nevertheless one co=
uld
expect Ovarian Hyper&#8209;Stimulation Syndrome (OHSS) to occur, which is
described in section 4 under Serious side effects in women&quot;. However,=
 the
OHSS will only occur if hCG is also administered [see also section 2 under =
Ovarian
Hyper&#8209;Stimulation Syndrome (OHSS)].<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-outline-level:1;mso-li=
st:skip;
tab-stops:.5in'><i style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;background:yellow;mso-highlight:yellow;
mso-no-proof:yes'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-outline-level:1;mso-li=
st:skip;
tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>If you forget to use O=
valeap</span></b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Do not us=
e a
double dose to make up for a forgotten dose. Please talk to your doctor as =
soon
as you realise that you forgot a dose.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;background:yellow;mso-highl=
ight:
yellow;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;mso-list:skip;tab-stops:=
.5in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>If you ha=
ve any
further questions on the use of this medicine, ask your doctor, pharmacist =
</span><span
lang=3DEN-GB style=3D'mso-no-proof:yes'>or nurse.</span><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><a name=3D"OLE_LINK6"></a><a name=3D"OLE_LINK7"><span
style=3D'mso-bookmark:OLE_LINK6'><b style=3D'mso-bidi-font-weight:normal'><=
span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>4.<span
style=3D'mso-tab-count:1'> </span>Possible side effects</span></b></s=
pan></a><span
style=3D'mso-bookmark:OLE_LINK7'><span style=3D'mso-bookmark:OLE_LINK6'><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:=
p></span></span></span></p>

<span style=3D'mso-bookmark:OLE_LINK6'></span><span style=3D'mso-bookmark:O=
LE_LINK7'></span>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;mso-list:skip;tab-stops:=
.5in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Like all
medicines, this medicine can cause side effects, although not everybody gets
them.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;mso-list:skip;tab-stops:=
.5in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;mso-list:skip;tab-stops:=
.5in'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>Important side effects<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;mso-list:skip;tab-stops:=
.5in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;mso-list:skip;tab-stops:=
.5in'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Serious s=
ide
effects in men and women<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:
skip;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><span style=3D'mso-tab-count:1'> </span>Allergic
reactions such as skin rash, raised itchy areas of skin and severe allergic
reactions with weakness, drop in blood pressure, difficulty breathing and
swelling of the face have been reported very rarely (may affect up to 1 in
10,000&nbsp;people). If you think you are having this type of reaction, you
must stop your Ovaleap injection and get medical help immediately.<o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;mso-list:skip;tab-stops:=
.5in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;mso-list:skip;tab-stops:=
.5in'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Serious s=
ide
effects in women<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:
skip;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><span style=3D'mso-tab-count:1'> </span>Lower sto=
mach
ache together with nausea or vomiting may be the symptoms of Ovarian Hyper&=
#8209;Stimulation
Syndrome (OHSS). This may indicate that the ovaries over&#8209;reacted to t=
he
treatment and that large ovarian cysts developed [see also section 2 under =
Ovarian
Hyper&#8209;Stimulation Syndrome (OHSS)]. This side effect is common (may
affect up to 1 in 10&nbsp;people).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:
skip;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><span style=3D'mso-tab-count:1'> </span>OHSS may =
become
severe with clearly enlarged ovaries, decreased urine production, weight ga=
in,
difficulty in breathing and/or possible fluid accumulation in your stomach =
or
chest. This side effect is uncommon (may affect up to 1 in 100&nbsp;people)=
.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:
skip;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><span style=3D'mso-tab-count:1'> </span>Complicat=
ions
of OHSS such as twisting of ovaries or blood clotting may occur rarely (may
affect up to 1 in 1,000&nbsp;people).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.45pt;margin-bo=
ttom:
0in;margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:
skip;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;
mso-no-proof:yes'><span style=3D'mso-tab-count:1'> </span>Serious b=
lood
clotting complications (thromboembolic events), sometimes independent of OH=
SS,
may be found very rarely (may affect up to 1 in 10,000&nbsp;people). This c=
ould
cause chest pain, breathlessness, stroke or heart attack [see also section =
2 under
Blood clotting problems (thromboembolic events)].<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;mso-list:skip;tab-stops:=
.5in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>If you no=
tice any
of the above-listed side effects you should immediately contact your doctor=
 who
may ask you to stop using Ovaleap.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;mso-list:skip;tab-stops:=
.5in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;background:yellow;mso-highl=
ight:
yellow;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Other side effects=
 in
women<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;mso-list:skip;tab-stops:=
.5in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;background:yellow;mso-highl=
ight:
yellow;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><u><span
lang=3DEN-GB>Very common</span></u><span lang=3DEN-GB> (</span><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>may affect more than 1=
 in
10&nbsp;people)</span><u><span lang=3DEN-GB><o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><span lang=3DEN-GB><span style=3D'mso-tab-count:1'>=
 </span>Local
reactions at the injection site, such as pain, redness, bruising, swelling =
and/or
irritation</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><span lang=3DEN-GB><span style=3D'mso-tab-count:1'>=
 </span>Headache</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><span lang=3DEN-GB><span style=3D'mso-tab-count:1'>=
 </span>Sacs
of fluid within the ovaries (ovarian cysts)</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><u><span lang=3DEN-GB>Common</span></u><span lang=3DEN-GB> =
(</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>may affec=
t up to
1 in 10&nbsp;people)</span><u><span lang=3DEN-GB><o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><span lang=3DEN-GB><span style=3D'mso-tab-count:1'>=
 </span>Stomach
ache</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><span lang=3DEN-GB><span style=3D'mso-tab-count:1'>=
 </span>Abdominal
bloating</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><span lang=3DEN-GB><span style=3D'mso-tab-count:1'>=
 </span>Abdominal
cramps</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><span lang=3DEN-GB><span style=3D'mso-tab-count:1'>=
 </span>Feeling
sick</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><span lang=3DEN-GB><span style=3D'mso-tab-count:1'>=
 </span>Vomiting</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><span lang=3DEN-GB><span style=3D'mso-tab-count:1'>=
 </span>Diarrhoea</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><u><span lang=3DEN-GB>Very rare</span></u><span lang=3DEN-G=
B> (</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>may affec=
t up to
1 in 10,000&nbsp;people)</span><u><span lang=3DEN-GB><o:p></o:p></span></u>=
</p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><span lang=3DEN-GB><span style=3D'mso-tab-count:1'>=
 </span>Your
asthma may get worse.</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB=
>Other
side effects in men<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><u><span lang=3DEN-GB>Very common</span></u><span lang=3DEN=
-GB> (</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>may affec=
t more
than 1 in 10&nbsp;people)</span><u><span lang=3DEN-GB><o:p></o:p></span></u=
></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><span lang=3DEN-GB><span style=3D'mso-tab-count:1'>=
 </span>Local
reactions at the injection site, such as pain, redness, bruising, swelling
and/or irritation</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><u><span lang=3DEN-GB>Common</span></u><span lang=3DEN-GB> =
(</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>may affec=
t up to
1 in 10&nbsp;people)</span><u><span lang=3DEN-GB><o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><span lang=3DEN-GB><span style=3D'mso-tab-count:1'>=
 </span>Swelling
of the veins above and behind the testicles (a varicocele)</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><a name=3D"OLE_LINK4"></a><a name=3D"OLE_LINK5"><span
style=3D'mso-bookmark:OLE_LINK4'><span lang=3DEN-GB><span style=3D'mso-tab=
-count:
1'> </span></span></span></a><span lang=3DEN-GB>Breast development</=
span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><span lang=3DEN-GB><span style=3D'mso-tab-count:1'>=
 </span>Acne</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><span lang=3DEN-GB><span style=3D'mso-tab-count:1'>=
 </span>Weight
gain</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><u><span lang=3DEN-GB>Very rare</span></u><span lang=3DEN-G=
B> (</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>may affec=
t up to
1 in 10,000&nbsp;people)</span><u><span lang=3DEN-GB><o:p></o:p></span></u>=
</p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><span lang=3DEN-GB><span style=3D'mso-tab-count:1'>=
 </span>Your
asthma may get worse.</span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt'>Reporting of side effects<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt'>If you get any side effects, </span><sp=
an
lang=3DEN-GB>talk to your doctor, pharmacist or nurse.</span><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt'> This includes any possible side effect=
s not
listed in this leaflet. You can also report side effects directly via <span
style=3D'background:lightgrey;mso-highlight:lightgrey'>the national reporti=
ng
system listed in </span></span><span lang=3DEN-GB><a
href=3D"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_fo=
rm/2013/03/WC500139752.doc"><span
style=3D'mso-bidi-font-size:11.0pt;mso-fareast-font-family:Verdana;backgrou=
nd:
lightgrey;mso-highlight:lightgrey'>Appendix V</span></a></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>.</span><=
span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'>. By reporting side effect=
s you
can help provide more information on the safety of this medicine.<o:p></o:p=
></span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-farea=
st-language:
EN-US;mso-bidi-language:AR-SA;mso-no-proof:yes'><br clear=3Dall style=3D'ms=
o-special-character:
line-break;page-break-before:always'>
</span>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-28.35pt;mso-list:ski=
p;
tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>5.<span style=3D'mso-t=
ab-count:
1'> </span>How to store Ovaleap<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Keep </sp=
an><span
lang=3DEN-GB style=3D'mso-no-proof:yes'>this medicine </span><span lang=3DE=
N-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>out of the sight and r=
each of
children.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Do not us=
e this
medicine after the expiry date which is stated on the label and outer carton
after EXP. The expiry date refers to the last day of that month.<o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Store in a refrigerator (2&nbsp;C&nbs=
p;&#8209;&nbsp;8&nbsp;C).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Do not freeze.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Keep the cartridge in the outer carton=
 in
order to protect from light.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Before opening and within its shelf li=
fe, you
may remove this medicine from the refrigerator, without being refrigerated
again, for up to 3&nbsp;months. Do not store above 25&nbsp;C. You must dis=
card
this medicine if it has not been used after 3&nbsp;months.<o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;color:black;mso-no-proof:yes'>Once opened, the cartridge in&#8209;us=
e in
the pen may be stored for a maximum of 28&nbsp;days. Do not store above
25&nbsp;C. Write down the date of first use in the patient diary, which wi=
ll be
provided with the Ovaleap Pen.<span style=3D'background:yellow;mso-highligh=
t:
yellow'><o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;background:yellow;mso-highl=
ight:
yellow;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Put the p=
en cap back
on the <span style=3D'color:black'>Ovaleap Pen</span> after each injection =
<span
style=3D'color:black'>in order to protect the cartridge from light.</span><=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Do not us=
e this
medicine if you notice i</span><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt'>t
is cloudy or there are particles in it.<span style=3D'mso-no-proof:yes'><o:=
p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Do not </=
span><span
lang=3DEN-GB style=3D'mso-no-proof:yes'>throw away any medicines </span><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>via waste=
water.
Ask your pharmacist how to </span><span lang=3DEN-GB style=3D'mso-no-proof:=
yes'>throw
away </span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-pr=
oof:
yes'>medicines you no longer use. These measures will help protect the
environment.<i><o:p></o:p></i></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'>6.<span style=3D'mso-tab-count:1'> </span></=
span><span
lang=3DEN-GB style=3D'mso-no-proof:yes'>Contents of the pack and other info=
rmation</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bidi-=
font-size:
11.0pt;mso-no-proof:yes'><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>What Oval=
eap
contains <o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l10 level1 lfo15;tab-stops:.5in'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><span style=3D'mso-lis=
t:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
mso-no-proof:yes'>The active substance is follitropin alfa.<br>
Ovaleap 300&nbsp;IU/0.5&nbsp;mL: Each cartridge contains 300&nbsp;IU <span
style=3D'color:black'>(equivalent to 22&nbsp;micrograms) </span>follitropin=
 alfa
in 0.5&nbsp;mL solution.<br>
Ovaleap 450&nbsp;IU/0.75&nbsp;mL: Each cartridge contains 450&nbsp;IU <span
style=3D'color:black'>(equivalent to 33&nbsp;micrograms) </span>follitropin=
 alfa
in 0.75&nbsp;mL solution.<br>
Ovaleap 900&nbsp;IU/1.5&nbsp;mL: Each cartridge contains 900&nbsp;IU <span
style=3D'color:black'>(equivalent to 66&nbsp;micrograms) </span>follitropin=
 alfa
in 1.5&nbsp;mL solution.<br>
<span style=3D'color:black'>Each mL of the solution contains 600&nbsp;IU
(equivalent to 44&nbsp;micrograms) follitropin alfa.</span><o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;mso-=
list:
l10 level1 lfo15;tab-stops:.5in'><![if !supportLists]><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><span style=3D'mso-lis=
t:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-si=
ze:11.0pt;
mso-no-proof:yes'>The other ingredients</span><span lang=3DEN-GB
style=3D'mso-no-proof:yes'> </span><span lang=3DEN-GB style=3D'mso-bidi-fon=
t-size:
11.0pt;mso-no-proof:yes'>are sodium dihydrogen phosphate dihydrate, sodium
hydroxide (2&nbsp;M) (for pH adjustment), mannitol, methionine,
polysorbate&nbsp;20, benzyl alcohol, benzalkonium chloride and water for
injections.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;tab-stops:.5in'><span lan=
g=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>All strengths listed a=
bove
contain the other ingredients.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>What Oval=
eap
looks like and contents of the pack<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;mso-no-proof:yes'>Ovaleap</span><span lang=3DEN-GB style=3D'mso-bidi=
-font-size:
11.0pt'> is a solution for injection (injection). <span style=3D'mso-no-pro=
of:
yes'>Ovaleap</span> is a clear and colourless solution.<o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;mso-no-proof:yes'>Ovaleap 300&nbsp;IU/0.5&nbsp;mL is available in pa=
cks
containing 1&nbsp;cartridge and 10&nbsp;injection needles.<br>
Ovaleap 450&nbsp;IU/0.75&nbsp;mL is available in packs containing
1&nbsp;cartridge and 10&nbsp;injection needles.<br>
Ovaleap 900&nbsp;IU/1.5&nbsp;mL is available in packs containing
1&nbsp;cartridge and 20&nbsp;injection needles.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt'>Not all pack sizes may be marketed.<o:p></o:p></span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-farea=
st-language:
EN-US;mso-bidi-language:AR-SA;mso-no-proof:yes'><br clear=3Dall style=3D'ms=
o-special-character:
line-break;page-break-before:always'>
</span>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-size:
11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Marketing=
 Authorisation
Holder<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Theramex Ireland Limited<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DEN-GB style=3D'm=
so-bidi-font-family:
Verdana;color:black'>3<sup>rd</sup> Floor, </span><span lang=3DNL
style=3D'mso-ansi-language:NL'>Kilmore House,<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Park Lane, Spencer Dock,<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>Dublin 1<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span lang=3DNL style=3D'mso-=
ansi-language:
NL'>D01 YE64<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DNL style=3D'mso-ansi-language:NL'>Ireland</span><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-no-proof:yes'><o:p></o:p=
></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><b><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>Manufactu=
rer<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><a name=3D"OLE_=
LINK8"></a><a
name=3D"OLE_LINK9"><span style=3D'mso-bookmark:OLE_LINK8'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>Teva Biotech =
GmbH<o:p></o:p></span></span></a></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span style=3D'=
mso-bookmark:
OLE_LINK9'><span style=3D'mso-bookmark:OLE_LINK8'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>Dornierstrae=
 10<o:p></o:p></span></span></span></p>

<p class=3DMsoNormal style=3D'mso-list:skip;tab-stops:.5in'><span style=3D'=
mso-bookmark:
OLE_LINK9'><span style=3D'mso-bookmark:OLE_LINK8'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-weight:bold'>89079 Ulm<o:p=
></o:p></span></span></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span style=3D'mso-bookmark:O=
LE_LINK9'><span
style=3D'mso-bookmark:OLE_LINK8'><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:11.0pt'>Germany<o:p></o:p></span></span></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in'><span style=3D'mso-bookmark:O=
LE_LINK9'><span
style=3D'mso-bookmark:OLE_LINK8'><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:11.0pt'><o:p>&nbsp;</o:p></span></span></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in;background:silver'><span
style=3D'mso-bookmark:OLE_LINK9'><span style=3D'mso-bookmark:OLE_LINK8'><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-color-alt:w=
indowtext'>Teva
Pharmaceuticals Europe B.V.</span></span></span><span style=3D'mso-bookmark=
:OLE_LINK9'><span
style=3D'mso-bookmark:OLE_LINK8'><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:11.0pt'><o:p></o:p></span></span></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in;background:silver'><span
style=3D'mso-bookmark:OLE_LINK9'><span style=3D'mso-bookmark:OLE_LINK8'><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-color-alt:w=
indowtext'>Swensweg
5</span></span></span><span style=3D'mso-bookmark:OLE_LINK9'><span
style=3D'mso-bookmark:OLE_LINK8'><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:11.0pt'><o:p></o:p></span></span></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in;background:silver'><span
style=3D'mso-bookmark:OLE_LINK9'><span style=3D'mso-bookmark:OLE_LINK8'><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-color-alt:w=
indowtext'>2031
GA Haarlem</span></span></span><span style=3D'mso-bookmark:OLE_LINK9'><span
style=3D'mso-bookmark:OLE_LINK8'><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:11.0pt'><o:p></o:p></span></span></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in;background:silver'><span
style=3D'mso-bookmark:OLE_LINK9'><span style=3D'mso-bookmark:OLE_LINK8'><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;color:black;mso-color-alt:w=
indowtext'>The
Netherlands</span></span></span><span style=3D'mso-bookmark:OLE_LINK9'><span
style=3D'mso-bookmark:OLE_LINK8'><span lang=3DEN-GB style=3D'mso-bidi-font-=
size:11.0pt'><o:p></o:p></span></span></span></p>

<span style=3D'mso-bookmark:OLE_LINK8'></span><span style=3D'mso-bookmark:O=
LE_LINK9'></span>

<p class=3DMsoNormal style=3D'margin-right:-28.4pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in;background:silver'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-color-alt:windowtext'>Me=
rckle
GmbH</span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:=
p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in;background:silver'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-color-alt:windowtext'>Gr=
af-Arco-Strae
3</span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p><=
/span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in;background:silver'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-color-alt:windowtext'>89=
079
Ulm, </span><span lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in;background:silver'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;color:black;mso-color-alt:windowtext'>Ge=
rmany</span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-outline-level:1;mso-li=
st:skip;
tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>This leaflet was last =
</span><span
lang=3DEN-GB style=3D'mso-no-proof:yes'>revised in </span></b><span lang=3D=
EN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-fareast-font-family:"MS Mincho";
mso-fareast-language:JA'>{<b style=3D'mso-bidi-font-weight:normal'>month YY=
YY</b>}<b
style=3D'mso-bidi-font-weight:normal'>.</b></span><span lang=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic;mso-no-proof:=
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-size:11.0pt;mso-bidi-font-style:italic;mso-no-proof:=
yes'>Detailed
information on this medicine is available on the European Medicines Agency =
web
site: </span><span lang=3DEN-GB><a href=3D"http://www.ema.europa.eu"><span
style=3D'color:windowtext;text-decoration:none;text-underline:none'>http://=
www.ema.europa.eu</span></a></span><span
lang=3DEN-GB style=3D'mso-bidi-font-size:11.0pt;mso-no-proof:yes'>.<o:p></o=
:p></span></p>

</div>

</body>

</html>

------=_NextPart_01D75948.5EEE6C80
Content-Location: file:///C:/C467A08E/Ovaleap_clean_files/item0001.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"utf-8"?><p:properties xmlns:p=3D"http://s=
chemas.microsoft.com/office/2006/metadata/properties" xmlns:xsi=3D"http://w=
ww.w3.org/2001/XMLSchema-instance" xmlns:pc=3D"http://schemas.microsoft.com=
/office/infopath/2007/PartnerControls"><documentManagement/></p:properties>
------=_NextPart_01D75948.5EEE6C80
Content-Location: file:///C:/C467A08E/Ovaleap_clean_files/props002.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{E3E1C33F-7DC1-488A-AC61-3D7A44A4C5DD}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.microsoft.com/office/in=
fopath/2007/PartnerControls"/><ds:schemaRef ds:uri=3D"http://schemas.micros=
oft.com/office/2006/documentManagement/types"/><ds:schemaRef ds:uri=3D"http=
://purl.org/dc/terms/"/><ds:schemaRef ds:uri=3D"http://schemas.microsoft.co=
m/office/2006/metadata/properties"/><ds:schemaRef ds:uri=3D"http://purl.org=
/dc/elements/1.1/"/><ds:schemaRef ds:uri=3D"http://purl.org/dc/dcmitype/"/>=
<ds:schemaRef ds:uri=3D"http://schemas.openxmlformats.org/package/2006/meta=
data/core-properties"/><ds:schemaRef ds:uri=3D"http://www.w3.org/XML/1998/n=
amespace"/></ds:schemaRefs></ds:datastoreItem>
------=_NextPart_01D75948.5EEE6C80
Content-Location: file:///C:/C467A08E/Ovaleap_clean_files/item0003.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"utf-8"?><ct:contentTypeSchema ct:_=3D"" m=
a:_=3D"" ma:contentTypeName=3D"Document" ma:contentTypeID=3D"0x010100726F91=
DD1AE57B44B1BCEB7F1056F5D0" ma:contentTypeVersion=3D"6" ma:contentTypeDescr=
iption=3D"Create a new document." ma:contentTypeScope=3D"" ma:versionID=3D"=
80d1dd17cb0c17b7740334051d5d16b2" xmlns:ct=3D"http://schemas.microsoft.com/=
office/2006/metadata/contentType" xmlns:ma=3D"http://schemas.microsoft.com/=
office/2006/metadata/properties/metaAttributes">
<xsd:schema targetNamespace=3D"http://schemas.microsoft.com/office/2006/met=
adata/properties" ma:root=3D"true" ma:fieldsID=3D"c170dc105f61f60cf84b7b3e6=
d807e4f" ns2:_=3D"" ns3:_=3D"" xmlns:xsd=3D"http://www.w3.org/2001/XMLSchem=
a" xmlns:xs=3D"http://www.w3.org/2001/XMLSchema" xmlns:p=3D"http://schemas.=
microsoft.com/office/2006/metadata/properties" xmlns:ns2=3D"a6a35199-84b7-4=
ca5-aa1c-39e9ca4c46ff" xmlns:ns3=3D"0ac2e3cc-46bd-4320-b2ac-d7f7d167e1a9">
<xsd:import namespace=3D"a6a35199-84b7-4ca5-aa1c-39e9ca4c46ff"/>
<xsd:import namespace=3D"0ac2e3cc-46bd-4320-b2ac-d7f7d167e1a9"/>
<xsd:element name=3D"properties">
<xsd:complexType>
<xsd:sequence>
<xsd:element name=3D"documentManagement">
<xsd:complexType>
<xsd:all>
<xsd:element ref=3D"ns2:MediaServiceMetadata" minOccurs=3D"0"/>
<xsd:element ref=3D"ns2:MediaServiceFastMetadata" minOccurs=3D"0"/>
<xsd:element ref=3D"ns2:MediaServiceAutoKeyPoints" minOccurs=3D"0"/>
<xsd:element ref=3D"ns2:MediaServiceKeyPoints" minOccurs=3D"0"/>
<xsd:element ref=3D"ns3:SharedWithUsers" minOccurs=3D"0"/>
<xsd:element ref=3D"ns3:SharedWithDetails" minOccurs=3D"0"/>
</xsd:all>
</xsd:complexType>
</xsd:element>
</xsd:sequence>
</xsd:complexType>
</xsd:element>
</xsd:schema>
<xsd:schema targetNamespace=3D"a6a35199-84b7-4ca5-aa1c-39e9ca4c46ff" elemen=
tFormDefault=3D"qualified" xmlns:xsd=3D"http://www.w3.org/2001/XMLSchema" x=
mlns:xs=3D"http://www.w3.org/2001/XMLSchema" xmlns:dms=3D"http://schemas.mi=
crosoft.com/office/2006/documentManagement/types" xmlns:pc=3D"http://schema=
s.microsoft.com/office/infopath/2007/PartnerControls">
<xsd:import namespace=3D"http://schemas.microsoft.com/office/2006/documentM=
anagement/types"/>
<xsd:import namespace=3D"http://schemas.microsoft.com/office/infopath/2007/=
PartnerControls"/>
<xsd:element name=3D"MediaServiceMetadata" ma:index=3D"8" nillable=3D"true"=
 ma:displayName=3D"MediaServiceMetadata" ma:hidden=3D"true" ma:internalName=
=3D"MediaServiceMetadata" ma:readOnly=3D"true">
<xsd:simpleType>
<xsd:restriction base=3D"dms:Note"/>
</xsd:simpleType>
</xsd:element>
<xsd:element name=3D"MediaServiceFastMetadata" ma:index=3D"9" nillable=3D"t=
rue" ma:displayName=3D"MediaServiceFastMetadata" ma:hidden=3D"true" ma:inte=
rnalName=3D"MediaServiceFastMetadata" ma:readOnly=3D"true">
<xsd:simpleType>
<xsd:restriction base=3D"dms:Note"/>
</xsd:simpleType>
</xsd:element>
<xsd:element name=3D"MediaServiceAutoKeyPoints" ma:index=3D"10" nillable=3D=
"true" ma:displayName=3D"MediaServiceAutoKeyPoints" ma:hidden=3D"true" ma:i=
nternalName=3D"MediaServiceAutoKeyPoints" ma:readOnly=3D"true">
<xsd:simpleType>
<xsd:restriction base=3D"dms:Note"/>
</xsd:simpleType>
</xsd:element>
<xsd:element name=3D"MediaServiceKeyPoints" ma:index=3D"11" nillable=3D"tru=
e" ma:displayName=3D"KeyPoints" ma:internalName=3D"MediaServiceKeyPoints" m=
a:readOnly=3D"true">
<xsd:simpleType>
<xsd:restriction base=3D"dms:Note">
<xsd:maxLength value=3D"255"/>
</xsd:restriction>
</xsd:simpleType>
</xsd:element>
</xsd:schema>
<xsd:schema targetNamespace=3D"0ac2e3cc-46bd-4320-b2ac-d7f7d167e1a9" elemen=
tFormDefault=3D"qualified" xmlns:xsd=3D"http://www.w3.org/2001/XMLSchema" x=
mlns:xs=3D"http://www.w3.org/2001/XMLSchema" xmlns:dms=3D"http://schemas.mi=
crosoft.com/office/2006/documentManagement/types" xmlns:pc=3D"http://schema=
s.microsoft.com/office/infopath/2007/PartnerControls">
<xsd:import namespace=3D"http://schemas.microsoft.com/office/2006/documentM=
anagement/types"/>
<xsd:import namespace=3D"http://schemas.microsoft.com/office/infopath/2007/=
PartnerControls"/>
<xsd:element name=3D"SharedWithUsers" ma:index=3D"12" nillable=3D"true" ma:=
displayName=3D"Shared With" ma:internalName=3D"SharedWithUsers" ma:readOnly=
=3D"true">
<xsd:complexType>
<xsd:complexContent>
<xsd:extension base=3D"dms:UserMulti">
<xsd:sequence>
<xsd:element name=3D"UserInfo" minOccurs=3D"0" maxOccurs=3D"unbounded">
<xsd:complexType>
<xsd:sequence>
<xsd:element name=3D"DisplayName" type=3D"xsd:string" minOccurs=3D"0"/>
<xsd:element name=3D"AccountId" type=3D"dms:UserId" minOccurs=3D"0" nillabl=
e=3D"true"/>
<xsd:element name=3D"AccountType" type=3D"xsd:string" minOccurs=3D"0"/>
</xsd:sequence>
</xsd:complexType>
</xsd:element>
</xsd:sequence>
</xsd:extension>
</xsd:complexContent>
</xsd:complexType>
</xsd:element>
<xsd:element name=3D"SharedWithDetails" ma:index=3D"13" nillable=3D"true" m=
a:displayName=3D"Shared With Details" ma:internalName=3D"SharedWithDetails"=
 ma:readOnly=3D"true">
<xsd:simpleType>
<xsd:restriction base=3D"dms:Note">
<xsd:maxLength value=3D"255"/>
</xsd:restriction>
</xsd:simpleType>
</xsd:element>
</xsd:schema>
<xsd:schema targetNamespace=3D"http://schemas.openxmlformats.org/package/20=
06/metadata/core-properties" elementFormDefault=3D"qualified" attributeForm=
Default=3D"unqualified" blockDefault=3D"#all" xmlns=3D"http://schemas.openx=
mlformats.org/package/2006/metadata/core-properties" xmlns:xsd=3D"http://ww=
w.w3.org/2001/XMLSchema" xmlns:xsi=3D"http://www.w3.org/2001/XMLSchema-inst=
ance" xmlns:dc=3D"http://purl.org/dc/elements/1.1/" xmlns:dcterms=3D"http:/=
/purl.org/dc/terms/" xmlns:odoc=3D"http://schemas.microsoft.com/internal/ob=
d">
<xsd:import namespace=3D"http://purl.org/dc/elements/1.1/" schemaLocation=
=3D"http://dublincore.org/schemas/xmls/qdc/2003/04/02/dc.xsd"/>
<xsd:import namespace=3D"http://purl.org/dc/terms/" schemaLocation=3D"http:=
//dublincore.org/schemas/xmls/qdc/2003/04/02/dcterms.xsd"/>
<xsd:element name=3D"coreProperties" type=3D"CT_coreProperties"/>
<xsd:complexType name=3D"CT_coreProperties">
<xsd:all>
<xsd:element ref=3D"dc:creator" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element ref=3D"dcterms:created" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element ref=3D"dc:identifier" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element name=3D"contentType" minOccurs=3D"0" maxOccurs=3D"1" type=3D"x=
sd:string" ma:index=3D"0" ma:displayName=3D"Content Type"/>
<xsd:element ref=3D"dc:title" minOccurs=3D"0" maxOccurs=3D"1" ma:index=3D"4=
" ma:displayName=3D"Title"/>
<xsd:element ref=3D"dc:subject" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element ref=3D"dc:description" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element name=3D"keywords" minOccurs=3D"0" maxOccurs=3D"1" type=3D"xsd:=
string"/>
<xsd:element ref=3D"dc:language" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element name=3D"category" minOccurs=3D"0" maxOccurs=3D"1" type=3D"xsd:=
string"/>
<xsd:element name=3D"version" minOccurs=3D"0" maxOccurs=3D"1" type=3D"xsd:s=
tring"/>
<xsd:element name=3D"revision" minOccurs=3D"0" maxOccurs=3D"1" type=3D"xsd:=
string">
<xsd:annotation>
<xsd:documentation>
                        This value indicates the number of saves or revisio=
ns. The application is responsible for updating this value after each revis=
ion.
                    </xsd:documentation>
</xsd:annotation>
</xsd:element>
<xsd:element name=3D"lastModifiedBy" minOccurs=3D"0" maxOccurs=3D"1" type=
=3D"xsd:string"/>
<xsd:element ref=3D"dcterms:modified" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element name=3D"contentStatus" minOccurs=3D"0" maxOccurs=3D"1" type=3D=
"xsd:string"/>
</xsd:all>
</xsd:complexType>
</xsd:schema>
<xs:schema targetNamespace=3D"http://schemas.microsoft.com/office/infopath/=
2007/PartnerControls" elementFormDefault=3D"qualified" attributeFormDefault=
=3D"unqualified" xmlns:pc=3D"http://schemas.microsoft.com/office/infopath/2=
007/PartnerControls" xmlns:xs=3D"http://www.w3.org/2001/XMLSchema">
<xs:element name=3D"Person">
<xs:complexType>
<xs:sequence>
<xs:element ref=3D"pc:DisplayName" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:AccountId" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:AccountType" minOccurs=3D"0"></xs:element>
</xs:sequence>
</xs:complexType>
</xs:element>
<xs:element name=3D"DisplayName" type=3D"xs:string"></xs:element>
<xs:element name=3D"AccountId" type=3D"xs:string"></xs:element>
<xs:element name=3D"AccountType" type=3D"xs:string"></xs:element>
<xs:element name=3D"BDCAssociatedEntity">
<xs:complexType>
<xs:sequence>
<xs:element ref=3D"pc:BDCEntity" minOccurs=3D"0" maxOccurs=3D"unbounded"></=
xs:element>
</xs:sequence>
<xs:attribute ref=3D"pc:EntityNamespace"></xs:attribute>
<xs:attribute ref=3D"pc:EntityName"></xs:attribute>
<xs:attribute ref=3D"pc:SystemInstanceName"></xs:attribute>
<xs:attribute ref=3D"pc:AssociationName"></xs:attribute>
</xs:complexType>
</xs:element>
<xs:attribute name=3D"EntityNamespace" type=3D"xs:string"></xs:attribute>
<xs:attribute name=3D"EntityName" type=3D"xs:string"></xs:attribute>
<xs:attribute name=3D"SystemInstanceName" type=3D"xs:string"></xs:attribute>
<xs:attribute name=3D"AssociationName" type=3D"xs:string"></xs:attribute>
<xs:element name=3D"BDCEntity">
<xs:complexType>
<xs:sequence>
<xs:element ref=3D"pc:EntityDisplayName" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityInstanceReference" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityId1" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityId2" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityId3" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityId4" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityId5" minOccurs=3D"0"></xs:element>
</xs:sequence>
</xs:complexType>
</xs:element>
<xs:element name=3D"EntityDisplayName" type=3D"xs:string"></xs:element>
<xs:element name=3D"EntityInstanceReference" type=3D"xs:string"></xs:elemen=
t>
<xs:element name=3D"EntityId1" type=3D"xs:string"></xs:element>
<xs:element name=3D"EntityId2" type=3D"xs:string"></xs:element>
<xs:element name=3D"EntityId3" type=3D"xs:string"></xs:element>
<xs:element name=3D"EntityId4" type=3D"xs:string"></xs:element>
<xs:element name=3D"EntityId5" type=3D"xs:string"></xs:element>
<xs:element name=3D"Terms">
<xs:complexType>
<xs:sequence>
<xs:element ref=3D"pc:TermInfo" minOccurs=3D"0" maxOccurs=3D"unbounded"></x=
s:element>
</xs:sequence>
</xs:complexType>
</xs:element>
<xs:element name=3D"TermInfo">
<xs:complexType>
<xs:sequence>
<xs:element ref=3D"pc:TermName" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:TermId" minOccurs=3D"0"></xs:element>
</xs:sequence>
</xs:complexType>
</xs:element>
<xs:element name=3D"TermName" type=3D"xs:string"></xs:element>
<xs:element name=3D"TermId" type=3D"xs:string"></xs:element>
</xs:schema>
</ct:contentTypeSchema>
------=_NextPart_01D75948.5EEE6C80
Content-Location: file:///C:/C467A08E/Ovaleap_clean_files/props004.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{EDD0FC2A-F0DE-417B-96F0-9AB120AA2288}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.microsoft.com/office/20=
06/metadata/contentType"/><ds:schemaRef ds:uri=3D"http://schemas.microsoft.=
com/office/2006/metadata/properties/metaAttributes"/><ds:schemaRef ds:uri=
=3D"http://www.w3.org/2001/XMLSchema"/><ds:schemaRef ds:uri=3D"http://schem=
as.microsoft.com/office/2006/metadata/properties"/><ds:schemaRef ds:uri=3D"=
a6a35199-84b7-4ca5-aa1c-39e9ca4c46ff"/><ds:schemaRef ds:uri=3D"0ac2e3cc-46b=
d-4320-b2ac-d7f7d167e1a9"/><ds:schemaRef ds:uri=3D"http://schemas.microsoft=
.com/office/2006/documentManagement/types"/><ds:schemaRef ds:uri=3D"http://=
schemas.microsoft.com/office/infopath/2007/PartnerControls"/><ds:schemaRef =
ds:uri=3D"http://schemas.openxmlformats.org/package/2006/metadata/core-prop=
erties"/><ds:schemaRef ds:uri=3D"http://purl.org/dc/elements/1.1/"/><ds:sch=
emaRef ds:uri=3D"http://purl.org/dc/terms/"/><ds:schemaRef ds:uri=3D"http:/=
/schemas.microsoft.com/internal/obd"/></ds:schemaRefs></ds:datastoreItem>
------=_NextPart_01D75948.5EEE6C80
Content-Location: file:///C:/C467A08E/Ovaleap_clean_files/item0005.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?><b:Sources Sele=
ctedStyle=3D"\APA.XSL" StyleName=3D"APA" xmlns:b=3D"http://schemas.openxmlf=
ormats.org/officeDocument/2006/bibliography" xmlns=3D"http://schemas.openxm=
lformats.org/officeDocument/2006/bibliography"></b:Sources>
------=_NextPart_01D75948.5EEE6C80
Content-Location: file:///C:/C467A08E/Ovaleap_clean_files/props006.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{5ADAA4FC-0182-4DC8-B5F2-7C35F0A66014}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.openxmlformats.org/offi=
ceDocument/2006/bibliography"/></ds:schemaRefs></ds:datastoreItem>
------=_NextPart_01D75948.5EEE6C80
Content-Location: file:///C:/C467A08E/Ovaleap_clean_files/item0007.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?mso-contentType?><FormTemplates xmlns=3D"http://schemas.microsoft.com/sha=
repoint/v3/contenttype/forms"><Display>DocumentLibraryForm</Display><Edit>D=
ocumentLibraryForm</Edit><New>DocumentLibraryForm</New></FormTemplates>
------=_NextPart_01D75948.5EEE6C80
Content-Location: file:///C:/C467A08E/Ovaleap_clean_files/props008.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{5A386652-B88B-418B-A37C-ECDBF80AC211}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.microsoft.com/sharepoin=
t/v3/contenttype/forms"/></ds:schemaRefs></ds:datastoreItem>
------=_NextPart_01D75948.5EEE6C80
Content-Location: file:///C:/C467A08E/Ovaleap_clean_files/themedata.thmx
Content-Transfer-Encoding: base64
Content-Type: application/vnd.ms-officetheme
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------=_NextPart_01D75948.5EEE6C80
Content-Location: file:///C:/C467A08E/Ovaleap_clean_files/colorschememapping.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"yes"?>
<a:clrMap xmlns:a=3D"http://schemas.openxmlformats.org/drawingml/2006/main"=
 bg1=3D"lt1" tx1=3D"dk1" bg2=3D"lt2" tx2=3D"dk2" accent1=3D"accent1" accent=
2=3D"accent2" accent3=3D"accent3" accent4=3D"accent4" accent5=3D"accent5" a=
ccent6=3D"accent6" hlink=3D"hlink" folHlink=3D"folHlink"/>
------=_NextPart_01D75948.5EEE6C80
Content-Location: file:///C:/C467A08E/Ovaleap_clean_files/header.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="windows-1252"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"
xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:w=3D"urn:schemas-microsoft-com:office:word"
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dwindows-125=
2">
<meta name=3DProgId content=3DWord.Document>
<meta name=3DGenerator content=3D"Microsoft Word 15">
<meta name=3DOriginator content=3D"Microsoft Word 15">
<link id=3DMain-File rel=3DMain-File href=3D"../Ovaleap_clean.htm">
<![if IE]>
<base href=3D"file:///C:/C467A08E/Ovaleap_clean_files/header.htm"
id=3D"webarch_temp_base_tag">
<![endif]><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext=3D"edit" spidmax=3D"4097"/>
</xml><![endif]-->
</head>

<body lang=3DEN-US link=3Dblue vlink=3Dpurple>

<div style=3D'mso-element:footnote-separator' id=3Dfs>

<p class=3DMsoNormal><span lang=3DEN-GB><span style=3D'mso-special-characte=
r:footnote-separator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1 width=3D"33%">

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:footnote-continuation-separator' id=3Dfcs>

<p class=3DMsoNormal><span lang=3DEN-GB><span style=3D'mso-special-characte=
r:footnote-continuation-separator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1>

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:endnote-separator' id=3Des>

<p class=3DMsoNormal><span lang=3DEN-GB><span style=3D'mso-special-characte=
r:footnote-separator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1 width=3D"33%">

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:endnote-continuation-separator' id=3Decs>

<p class=3DMsoNormal><span lang=3DEN-GB><span style=3D'mso-special-characte=
r:footnote-continuation-separator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1>

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:footer' id=3Df1>

<p class=3DMsoFooter align=3Dcenter style=3D'margin-right:4.8pt;text-align:=
center;
tab-stops:28.35pt center 3.15in right 415.3pt 446.55pt'><!--[if supportFiel=
ds]><span
lang=3DEN-GB><span style=3D'mso-element:field-begin'></span><span
style=3D'mso-spacerun:yes'></span>EQ </span><![endif]--><!--[if supportFie=
lds]><span
lang=3DEN-GB><span style=3D'mso-element:field-end'></span></span><![endif]-=
-><!--[if supportFields]><span
class=3DMsoPageNumber><span lang=3DEN-GB style=3D'font-family:"Arial",sans-=
serif'><span
style=3D'mso-element:field-begin'></span>PAGE<span style=3D'mso-spacerun:ye=
s'>
</span><span style=3D'mso-element:field-separator'></span></span></span><![=
endif]--><span
class=3DMsoPageNumber><span lang=3DEN-GB style=3D'font-family:"Arial",sans-=
serif'>14</span></span><!--[if supportFields]><span
class=3DMsoPageNumber><span lang=3DEN-GB style=3D'font-family:"Arial",sans-=
serif'><span
style=3D'mso-element:field-end'></span></span></span><![endif]--></p>

</div>

<div style=3D'mso-element:footer' id=3Dff1>

<p class=3DMsoFooter align=3Dcenter style=3D'margin-right:4.8pt;text-align:=
center;
tab-stops:28.35pt center 3.15in right 415.3pt 446.55pt'><!--[if supportFiel=
ds]><span
lang=3DEN-GB><span style=3D'mso-element:field-begin'></span><span
style=3D'mso-spacerun:yes'></span>EQ </span><![endif]--><!--[if supportFie=
lds]><span
lang=3DEN-GB><span style=3D'mso-element:field-end'></span></span><![endif]-=
-><!--[if supportFields]><span
class=3DMsoPageNumber><span lang=3DEN-GB style=3D'font-family:"Arial",sans-=
serif'><span
style=3D'mso-element:field-begin'></span>PAGE<span style=3D'mso-spacerun:ye=
s'>
</span><span style=3D'mso-element:field-separator'></span></span></span><![=
endif]--><span
class=3DMsoPageNumber><span lang=3DEN-GB style=3D'font-family:"Arial",sans-=
serif'>1</span></span><!--[if supportFields]><span
class=3DMsoPageNumber><span lang=3DEN-GB style=3D'font-family:"Arial",sans-=
serif'><span
style=3D'mso-element:field-end'></span></span></span><![endif]--></p>

</div>

</body>

</html>

------=_NextPart_01D75948.5EEE6C80
Content-Location: file:///C:/C467A08E/Ovaleap_clean_files/filelist.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml; charset="utf-8"

<xml xmlns:o=3D"urn:schemas-microsoft-com:office:office">
 <o:MainFile HRef=3D"../Ovaleap_clean.htm"/>
 <o:File HRef=3D"item0001.xml"/>
 <o:File HRef=3D"props002.xml"/>
 <o:File HRef=3D"item0003.xml"/>
 <o:File HRef=3D"props004.xml"/>
 <o:File HRef=3D"item0005.xml"/>
 <o:File HRef=3D"props006.xml"/>
 <o:File HRef=3D"item0007.xml"/>
 <o:File HRef=3D"props008.xml"/>
 <o:File HRef=3D"themedata.thmx"/>
 <o:File HRef=3D"colorschememapping.xml"/>
 <o:File HRef=3D"header.htm"/>
 <o:File HRef=3D"filelist.xml"/>
</xml>
------=_NextPart_01D75948.5EEE6C80--
